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ABSTRACT 
With a cure for HIV and AIDS still absent, non-nucleoside reverse transcriptase inhibitors 
(NNRTIs) play a major role in the current antiretroviral treatments used, which have shown 
to improve and prolong the lives of HIV patients significantly. However, with rapid 
mutations of the HI virus, the use of these drugs is becoming limited, thereby highlighting the 
need for the development of new NNRTIs. 
Previous work by our research team has led to the development of a cyclopropyl-containing 
indole-based compound with an inhibition activity (IC50 value) of 0.1 µM, as determined in 
an in vitro single-cycle, non-replicative phenotypic assay. Therefore, in this project, we 
focussed on enhancing the intermolecular interactions of our compound to three major areas 
in the NNRTI binding pocket, namely the Tyr181, the Val179, and the Lys101 binding 
pockets. Hereby we were able to obtain both improved and lower potencies, with our most 
active compound having an inhibition activity (IC50 value) of 1 nM. 
For the interaction to the Tyr181 binding pocket, we were thus unable to synthesise a 
heterocyclic ring system onto our molecule as opposed to the previously used phenyl ring. 
Secondly, for the interaction to the Lys101 binding pocket we were able to synthesise a 
tetrazole ring system and an amide functionality onto the 2-position of the indole.  
Lastly, in our quest to synthesise the cyclopropyl moiety onto our compound for the 
interaction in the Val179 binding pocket, we were able to investigate the full inhibition effect 
of this interaction by synthesising a similar compound with no interaction in this binding 
pocket. Moreover, we were able to synthesise a new compound with a methoxy moiety for 
this interaction with an inhibition activity (IC50 value) of 1 nM. With this compound only 
being submitted for efficacy evaluation as a racemic compound mixture, this opened a new 
door for research possibilities for our team. 
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UITTREKSEL 
In die awesigheid van ‗n geneesmiddel vir MIV en VIGS, speel nie-nukleosied omkeerbare 
transkripsie inhibitore (―NNRTIs‖)‗n groot rol in die huidige antiretrovirale behandeling. 
Ongelukkig ondergaan die MI virus mutasies, wat dus die gebruik van hierdie antiretrovirale 
middels beperk. Hierdie beklemtoon dus die noodsaaklikheid vir die ontwikkeling van nuwe 
―NNRTIs‖. 
Vorige werk wat deur ons navorsings groep verrig is, het gelei tot die ontwikkeling van ‗n 
siklopropiel bevattende indol verbinding, met ‗n inhibisie aktiwiteit (―IC50‖ waarde) van  
0.1 µM. Gevolglik, het ons in hierdie projek gefokus om die intermolekulêre interaksies van 
hierdie verbinding in drie hoof areas in die ―NNRTI‖ bindings ruimte te verbeter, genaamd 
die Tyr181, die Val179, en die Lys101 bindings ruimtes. Hierdie projek het dus beide 
verbeterde en ook laer inhibisie aktiwiteits resultate gelewer, waar die mees aktiewe 
verbinding ‗n inhibisie aktiwiteit (―IC50‖ waarde) van 1 nM behaal het.  
Vir die interaksie na die Tyr181 bindings ruimte, was ons dus onsuksesvol om ‗n 
heteroaromatiese ring te sintetiseer as plaasvervanger vir die oorspronklike feniel ring. 
Tweedens, vir die interaksie na die Lys101 bindings ruimte, was ons in staat om ‗n tetrazol 
ring en ‗n amied funksionaliteit aan die 2-posisie van die indol te sintetiseer.  
In ons stryd om die siklopropiel ring aan ons verbinding te sintetiseer vir die interaksie in die 
Val179 bindings ruimte, was ons in staat om die volledige effek van hierdie interaksie te 
bepaal deur ‗n soortgelykke verbinding te sintetiseer met geen interaksie in die Val179 
bindings ruimte nie. Daarenbowe, het ons ‗n verbining gesintetiseer met ‗n inhibisie aktiwiet 
(―IC50‖ waarde) van 1 nM, waarvan die aktiwitiet van slegs die rasemiese mengsel van die 
verbinding bepaal is. Hierdie vinding het dus ‗n nuwe navorsings deur  vir ons groep geopen. 
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PREFACE 
A NOTE TO THE READER 
Regarding the thesis layout 
As with many organic synthesis projects, this project was not completed in a linear fashion. 
For the ease of reading, we have given our best attempt to group the work into separate 
chapters. However, in some cases the results have overlapped and have affected the decisions 
made on specific areas of synthesis.  
 
Using molecular modelling as a research tool 
We have made use of molecular modelling in this synthesis thesis, therefore it is thus 
important to note the position it holds. The molecular modelling was used as design tool, 
where designed molecules were docked and visually analysed before the binding energy 
calculations was considered. With 95% of the time spent on this project being spent on 
synthesis, the molecular modelling played a significantly smaller role. However, the binding 
energy results allows for a great discussion, in which case it is used as an aid in presenting 
our proposed ideas. 
 
Interpretation of 
1
H and 
13
C NMR spectra 
For interpreting NMR spectra, an unconventional labelling system is used. Once an atom has 
received a label, this label is used throughout the thesis for that atom. This is only to ease the 
analysis of spectra and also to ease the reading when we refer to these atoms in the text. 
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CHAPTER 1  
1.1 HIV AND AIDS 
1.1.1 History and the impact of antiretroviral treatment 
With an estimate of 34 million people living with HIV (human immune deficiency virus) in 
2011 and with more than 25 million AIDS (acquired immune deficiency syndrome) related 
deaths in the last three decades,
1
 we are facing one of the worst pandemics known to 
mankind. HIV is affecting lives globally with the largest populations affected being in Africa, 
and more specifically the sub-Saharan countries, where more than 50% of persons infected 
are women, mostly between the ages of 15 and 24. These statistics are only estimated results 
as it is established that within the sub-Saharan countries alone, only about half of the persons 
living with HIV know their HIV status.
2
 
AIDS was first identified as a disease in 1981 and it was only two years later that the cause of 
this disease was identified as HIV.
3
 This discovery was enhanced by the latest work done in 
the 1970‘s on leukemogenic retroviruses, with the discovery of T-cell leukemia virus types  
1 and 2 (HTLV-1 and HTLV-2), where lymphadenopathy was first believed to be a precursor 
of AIDS. This, together with the development of biochemical assays based on reverse 
transcriptase finally led to the identification of HIV.
4
 
First evidence of the origins of HIV indicated that this disease originated from central Africa, 
and the  disease spread to the rest of the world as a result of emerging globalisation in the 
1970‘s.4 It was believed that it originated from a primate-to-man transmission, as many 
related retrovirus strains (such as HTLV-1 and HTLV-2) were found in African and Asian 
primates.
4
 More recently, epidemiology data indicated that the HIV-1 strain arose from the 
SIVcpz retrovirus from the chimpanzee, Pan troglodytes troglodytes (Ptt),
5
 and the HIV-2 
strain was transmitted from the sooty mangabey monkeys, Cercocebus atys.
6
 It is believed 
that the transmission from these primates to humans occurred through the contact of blood. 
These monkeys are considered a food source, where the human contact with the infected 
blood could have occurred. 
In 1987 the first drug, azidothymidine (AZT), also known as zudovidine,  was licensed for 
the treatment of HIV infection, where it managed to prolong the lives of HIV patients for up  
to 6 to 18 months.
7
 The development of this drug was a major breakthrough in HIV treatment 
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and created the basis for further antiretroviral drug development. However, the use of this 
drug was short-lived due to the development of viral resistance and more antiretrovirals were 
needed.
8
 
With the development of additional antiretrovirals, these drugs were classified according to 
the target area in the HIV replicative cycle.
3
 As a result, the treatment known as Highly 
Active Antiretroviral Therapy (HAART) was developed where this treatment consists of a 
cocktail of three drugs from two different classes of antiretrovirals.
3
 Not only has this 
treatment been more effective than the initial monotherapy used, but the cocktail of drugs 
was far more effective in preventing complications due to the onset of viral resistance.  
With the latest antiretroviral treatments used, recent statistics have shown that the mother-to-
child transmission rates have drastically declined from an estimated 26% in 2009 to 17% in 
2012.
2
  Moreover, a recent study in South Africa has shown that the HIV infection rate fell by 
17% for every 10% increase in the number of people taking antiretroviral treatment.
2
 This is a 
significant decline in the HIV infection rate.  
Currently, according to the World Health Organisation, of the 26 million people that should 
be receiving antiretroviral treatment, only 9.7 million people have access to medication. The 
largest number of people requiring medication are in the African region.
2
 The criteria for 
receiving antiretroviral treatment has recently been reduced to a CD4 threshold of  
500 cells/mm
3
, where children under the age of 5 and pregnant women automatically qualify 
for immediate treatment. This would allow more HIV patients to receive antiretroviral 
treatment.  
 
1.1.2 HIV life cycle and replication 
HIV is an enveloped RNA virus form the family Retroviridae,
9
 as it inserts a copy of the viral 
DNA into the host cell for replication. Once HIV has been transmitted, a 2- to 3-week 
incubation period follows, in which the virus becomes well established within the lymphatic 
tissues.
10
  It is there where the virus replicates and finally depletes the immune system of 
CD4
+
T cells.
11
 During the first few weeks the virus rises to quite high levels in the blood 
stream, which in return are suppressed by the immune system. However, over time the 
amount of CD4
+
T cells slowly decreases, which then finally leads to the onset of AIDS.
11
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In short, the HIV life cycle consists of three key steps (Figure 1). The virus attaches to the 
host cell before the process of  viral replication ensues, where it then concludes with the 
release of the virions from the host cell.
12
 
Figure 1 
The HIV life cycle 
This image was created with information obtained from images published by De Clercq
12
  
and Reynolds et al.
13
 
 
 
Infected virions initially bind to the cellular receptors via envelope glycoproteins, where 
these proteins consists of two parts, namely docking glycoproteins (gp120) and 
transmembrane glycoproteins (gp41).
14
 The gp120 protein binds to the CD4 receptor on the 
host cell lipid membrane, where it then binds to a co-receptor (CCR5 or CXCR4) on the host 
cell lipid membrane. The co-receptor used varies for the different HIV strains.
12
  The T-tropic 
or X4 HIV strains would use the chemokine (C-X-C) motif receptor 4 (CXCR4) and the  
M-tropic or R5 HIV strains would use the chemokine (C-C) motif receptor 5 (CCR5).
12
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To this end, the gp120 protein undergoes a conformational change, which allows for the gp41 
protein to anchor to the host cell lipid membrane in order to bring the two membranes closer 
together.
12
  Fusion of the viral and envelope membranes follows and the viral core enters the 
host cell cytoplasm. Once it enters the cytoplasm, the viral core capsid is removed by the host 
enzymes and as a result the viral RNA and viral enzymes are released into the host cell 
cytoplasm.
13
   
With the viral RNA and viral enzymes released, the viral enzyme reverse transcriptase uses 
the RNA to catalyse the formation of the complementary single-stranded DNA, and thereby 
forms a DNA/RNA hybrid.
13
 The initial RNA strand is then destroyed by the RNaseH 
domain of the enzyme reverse transcriptase. Following this, the enzyme reverse transcriptase 
again catalyses the single-stranded DNA to the complementary double-stranded DNA.
13
  
The newly formed double-stranded DNA migrates into the host cell nucleus where it is 
incorporated into the cell‘s chromosome by means of the catalytic integration by the viral 
enzyme integrase.
15
 This integrated form of the viral DNA is known as the provirus which 
serves as a template for the host enzymes to form viral RNA and mRNA by means of 
transcription.
15
 
The RNA and the mRNA is transported to the cytoplasm, where the mRNA it is translated by 
the host ribosomes to form Gag and Gagpol poly-proteins.
14
 These non-functional  
poly-proteins, together with the viral RNA migrate to the cell surface where these are 
combined by the host enzymes to form new virus particles. These newly formed virus 
particles contains two copies of viral RNA and the necessary proteins.
14
 As the viral particle 
bud through the host plasma membrane, it is encapsulated by the host cell membrane that 
carries the viral envelope glycoproteins.
15
 
Finally, coincident with budding of the immature viral particle, the viral enzyme protease 
cleaves the non-functional poly-proteins into their functional forms.
14
 This allows for the 
maturing of the viral particles, which then becomes infective virions.
13
 These infective 
virions can now enter another host cell and undergo viral replication, in which case the HIV 
life cycle is again repeated. 
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1.2 HIV ANTIRETROVIRALS 
1.2.1 Different classes of antiretrovirals 
Since the identification of HIV as the disease causing virus and the development of 
zidovudine (AZT) as the first antiretroviral drug, a significant amount of research was done 
into the development of more antiretroviral drugs and on investigating the HIV life cycle.
4
 As 
mentioned before, these antiretroviral drugs are classified according to their different target 
areas in the HIV life cycle.
3
 Currently, there are 6 classes of antiretroviral drugs available, 
which includes nucleoside reverse transcriptase inhibitors (NRTIs) and nucleotide reverse 
transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), 
protease inhibitors (PIs), cell entry inhibitors (fusion inhibitors (FIs) and co-receptor 
inhibitors (CRIs)), and integrase inhibitors.
3
 A total of more than 30 antiretroviral drugs are 
currently used for HIV treatment, often available as combination treatments. Combination 
treatments used includes Atripla
®
, Complera
®
 , Stribild
®
, Combivir
®
, Epzicom
®
 , Retrovir
®
, 
Tritivir
®
, Truvada
®
, Kaletra
®
 and Trizivir
®
 , where these are mainly manufactured by Gilead 
Sciences and GlaxoSmithKline.
16
 
 
1.2.2 Protease inhibitors (PIs) 
The first protease inhibition by an antiretroviral compound was reported in 1990 by  
Meek et al. which encouraged the development of protease inhibitors as active anti-HIV 
compounds.
17
 Protease inhibitors are mainly classified into two groups, the peptidomimetic 
inhibitors and the non-peptides.
18
  The peptidomimetic inhibitors are flexible linear molecules 
with a defined backbone, from which four or more functional groups are projected into the 
sub sites of the HIV protease active site for inhibition.
18
 The second group, the non-peptides, 
are usually more rigid molecules with a cyclic scaffold in the centre, from which the 
functional groups are projected into the central sub sites of the HIV protease active site.
18
 The 
protease inhibitors contain a scaffold that mimics the normal peptide linkage, which cannot 
be cleaved by the HIV enzyme protease, as the enzyme would have done with the  
non-functional Gag and Gagpol poly-proteins in order to form functional proteins.
3
 As a 
result, the function of the HIV enzyme protease is inhibited and the maturing of the viral 
particle is suppressed. 
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Currently there are 8 licenced protease inhibitors on the market, which includes tipranavir 
(Aptivus
®
), indinavir (Crixivan
®
), saquinavir mesylate (Invirase
®
), fosamprenavir (Lexiva
®
), 
ritonavir (Norvir
®
), atazanavir sulphate (Reyataz
®
), nelfinavir mesylate (Viracept
®
),  
a combination treatment of lopinavir and ritonavir (Kaletra
®
), and the latest, darunavir 
(Prezista
®
) (Figure 2). The protease inhibitors saquinavir (Fortovase
®
) and amprenavir 
(Agenerase
®
) are no longer available on the market. 
Figure 2 
Latest protease inhibitors 
  
 
darunavir (Prezista
®
) fosamprenavir (Lexiva
®
) tipranavir (Aptivus
®
) 
   
 
1.2.3 Cell entry inhibitors 
The cell entry inhibitors groups two classes of inhibitors, the fusion inhibitors (FIs) and  
co-receptor inhibitors (CRIs). The fusion inhibitors prevent the fusion of the viral particle and 
the host cell, and the co-receptor inhibitors hinder the binding of the virus glycoproteins to 
the host cell co-receptors.
3
 
Currently there is only one fusion inhibitor on the market, enfuvirtide (Fuzeon
®
)(Figure 3),
16
 
which is a 36-amino-acid peptide which corresponds to the amino acid residues 643-678 of 
the HIV-1 gp160. This thus promotes the selectivity to HIV-1.
19
 The proteolytic cleavage of 
gp160 produces the polypeptides gp120 and gp41, where this inhibitor interacts with the 
glycoprotein gp41, thereby hindering the fusion of the viral and the host cell membranes.
19
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Figure 3 
Fusion inhibitor 
 
enfuvirtide (Fuzeon®) 
 
The co-receptor inhibitor on the market, maraviroc (Selzentry
®
) (Figure 4), was only licenced 
in August 2007 by Pfizer, making this the first of the latest class of antiretrovirals.
16
 This 
inhibitor is a CCR5 antagonist, where it binds to this co-receptor and thereby prevents the 
binding of the glycoprotein gp120 to the CCR5 receptor.
20
 It has been shown that maraviroc 
blocks the replication of M-tropic or R5 HIV strains almost entirely. However, this inhibitor 
is only active against these strains and not against the T-tropic or X4 HIV strains, in which 
case a CXCR4 antagonist is required.
20
 
Figure 4 
Co-receptor inhibitor 
 
maraviroc (Selzentry®) 
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1.2.4 Integrase inhibitors 
The HIV enzyme integrase was considered as a good target area for antiretroviral treatment 
for a long time.
3
 However, it was not until October 2007 that the first integrase inhibitor, 
raltegravir (Isentress
®
) was approved by the U.S. Food and Drug Administration (FDA). The 
latest integrase inhibitor, dolutegravir (Tivicay
®
), has just been approved for the treatment of 
HIV infection in August 2013 (Figure 5).
16
  
Figure 5 
Integrase inhibitors 
 
 
dolutegravir (Tivicay®) raltegravir (Isentress®) 
 
 
1.2.5 Nucleoside reverse transcriptase inhibitors (NRTIs) 
Nucleoside reverse transcriptase inhibitors are the oldest class of antiretrovirals with the first 
antiretroviral drug, azidothymidine (AZT) licenced in 1987.
7
 These compounds interact at the 
active site of the enzyme reverse transcriptase and thereby inhibit the synthesis of viral DNA 
by acting as a chain terminator.
3
  
NRTIs are administered as precursors of active inhibitors, where a three step phosphorylation 
process by cell nucleoside phosphotransferases are required to activate the NRTIs as active 
inhibitors.
21
 The compounds are considered as 2‘-3‘-dideoxynucleoside (ddN) analogues and 
are first phosphorylated to their 5-monophosphate (ddNMP) form, and then to the  
5-diphosphate (ddNDP) and 5-triphosphate (ddNTP) forms.
3
 Once in the ddNTP form, it acts 
as a competitive inhibitor and is incorporated by the enzyme reverse transcriptase into the 
growing DNA chain. As a result, the DNA chain growth is terminated.
3, 21
 
Current NRTIs in the market include azidothymidine (Retrovir
®
), didanosine (Videx
®
), 
emtricitabine (Emtriva
®
), abacavir sulphate (Ziagen
®
), lamivudine (Epivir
®
), stavudine 
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(Zerit
®
), and tenfovir disoproxil fumarate (Viread
®
) (Figure 6).
16
 The NRTI zalcitabine 
(Hivid
®
) was used until recently,
21
 but it is no longer available on the market.
16
 
Figure 6 
NRTIs available on the market 
 
   
azidothymidine 
(Retrovir®) 
didanosine  
(Videx®) 
emtricitabine  
(Emtriva®) 
lamivudine  
(Epivir®) 
  
 
 
zalcitabine  
(Hivid®) 
Stavudine 
(Zerit®) 
abacavir sulphate  
(Ziagen®) 
 
 
 
1.2.6 Nucleotide reverse transcriptase inhibitors (NtRTIs) 
The only nucleotide reverse transcriptase inhibitor on the market is tenfovir disoproxil 
fumarate (Viread
®
) (Figure 7), which was first approved by the U.S. Food and Drug 
Administration (FDA) in October 2001.
16
 This NtRTI is also the most prescribed 
antiretroviral drug and it has been more recently approved for the use of chronic Hepatitis B 
virus infections.
3, 22
 
For the NtRTI, the mechanism of inhibition is similar to that of NRTIs. However, NtRTIs 
only require two phosphorylation steps to be converted into the active inhibition form.
3
 
Moreover, the NtRTI possesses a large phosphate group that is not cleaved by hydrolysis, 
making this compound much more efficient than the NRTIs. With the first phosphate already 
present, the other two are more easily introduced. Thus, making a drug with one phosphate 
group, is an advantage. 
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Figure 7 
The only NtRTI on the market 
 
tenfovir disoproxil fumarate  
(Viread®) 
 
 
1.2.7 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) 
Non-nucleoside reverse transcriptase inhibitors bind to the enzyme reverse transcriptase and 
induce a conformational change, resulting in the inhibition of enzymatic activity.
3
 However, 
unlike the other reverse transcriptase inhibitors, NNRTIs bind selectively in an allosteric site 
10Å away from the catalytic site, making these compounds the least toxic of the reverse 
transcriptase inhibitors.
23
 
According to the description of this class of antiretrovirals, 1-[(2-hydroxyethoxy)methyl]-6-
(phenylsulphonyl)thymine (HEPT, TS-II-25) was the first NNRTI developed (Figure 8), even 
though at that time the exact mechanism of action was not yet clear.
24
  
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 1 – Introduction – HIV and AIDS 
_______________________________ 
11 
 
Figure 8 
Examples of HEPT analogues, DABO analogues and TIBO analogues
24, 25
 
HEPT analogues 
                                              
                                                    TS-II-25 
         
          I-EBU, MKC-442 
                Emivirine 
 
DABO analogues TIBO analogue 
   
S-DABO derivative 
(+)-3W 
N-DABO derivative 8-chloro-TIBO R86183 
Tivirapine 
 
Soon after the development of the HEPT analogues, the DABO analogues, and then the 
structurally different TIBO analogues were developed, which showed great activity against 
HIV-1.
24
 This finally led to the development of nevirapine and related compounds, and later 
efavirenz. These compounds were classified as NNRTIs, where these compounds bound to 
the reverse transcriptase in a similar way as the TIBO analogues. The TIBO binding site was 
later referred to as the NNRTI binding site.
24
 
Currently there are 5 licenced NNRTIs on the market (Figure 9), namely nevirapine 
(Viramune
®
, Viramune XR
®
), efavirenz (Stocrin™; Sustiva™), delavirdine (Rescriptor®), 
etravirine (Intelence™), and rilpivirine (Edurant®), with nevirapine and efavirenz the most 
frequently used in HAART treatment. Etravirine was recently licenced in Europe and the 
USA, and rilpivirine recently received Food and Drug Administration (FDA) approval in the 
USA.
26
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Nevirapine, delavidine and efavirenz are first generation NNRTIs and served as cornerstones 
for the first line HAART. Etravirine and rilpivirine are second generation NNRTIs and have 
been designed as part of lead optimizing campaigns, with the aim on developing new 
NNRTIs with enhanced resistance profiles.
27, 28
  
Figure 9 
Licenced NNRTIs available 
 
  
Nevirapine  
(BI-RG-587; Viramune®) 
Delavirdine 
(U-90152; Rescriptor®) 
Efavirenz 
(DMP266; Stocrin™; 
Sustiva™) 
                            
                  Etravirine  
                  (TMC125; Intelence™) 
                     Rilpivirine  
             (TMC278, Edurant®) 
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CHAPTER 2 – NNRTIS 
2.1 NNRTIS AS THERAPEUTIC AGENTS IN CONTROLLING HIV REPLICATION 
2.1.2 Why NNRTIs? 
Current NNRTIs on the market and non-licenced inhibitors have been studied extensively, 
where binding in the allosteric site was investigated. NNRTIs are known for their great 
structural variance and together with the availability of crystal structures of the HIV reverse 
transcriptase enzyme, it enables for great opportunity in creating new NNRTIs.  
Our interest in NNRTIs is mainly due to the mode of binding in the NNRTI binding site, 
where this group of compounds show great selectivity towards HIV-1.
29
 Because NNRTIs 
differ from the nucleoside analogues and do not bind to the host polymerases, low values of 
cytotoxicity have been reported.
23
 This makes NNRTIs among the least toxic of the clinically 
approved antiretrovirals,
30
 allowing for a higher  drug dosage.   
NNRTIs are lipophilic in nature and have a low molecular weight,
31
 making them the only 
anti-HIV drugs which are able to cross the blood brain barrier (BBB).
32
 This is important to 
tackle viral reservoirs located across the BBB in order to control the viral load and to prevent 
other complications such as HIV-associated neurocognitive disorders (HANDs).
7
  
 
2.2 THE NNTRI BINDING SITE 
2.2.1 HIV reverse transcriptase 
As mentioned before, NNRTIs bind in an allosteric site, 10Å away from the active site and 
induce a slight conformational change due to the flexibility of the side chains.
7
 This small 
conformational change is enough to cause inhibition of enzymatic activity, thereby 
preventing the conversion of single stranded RNA to double stranded DNA. The formation of 
DNA is a crucial step in the HIV life cycle and for this reason exposes the reverse 
transcriptase as an ideal drug target.
33
  
Initially, the NNRTI binding site is not observed in the crystal structure of the HIV reverse 
transcriptase and is only created upon binding of an inhibitor.
34-36
 Only a small cleft is 
observed. The NNRTIs work their way into this cleft, in which case it expands and allows for 
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the formation of the NNRTI binding site. We refer to the NNRTI binding site as the area 
where it is located in the reverse transcriptase and the NNRTI binding pocket as the area 
inside the cleft where the NNRTI is located. 
The HIV reverse transcriptase consists of two different non-covalently bound 
macromolecules and is therefore described as an asymmetric heterodimer. It  contains a p66 
and p51 subunit, with an integrated RNaseH at the last 120 amino acids of the p66 subunit.
37
 
The reverse transcriptase is associated with the shape of a right hand (Figure 10), where the 
finger domain consists of amino acids 1-85 and 118-155, the palm domain consists of amino 
acids 86-117 and 156-237, and the thumb domain consists of amino acids 238-318.  
Figure 10 
HIV reverse transcriptase 
This image was created with the use of Accylrys Discovery Studio3.5, where the crystal structure, 3V81 was 
obtained from the Protein Data Bank with a resolution of 2.85 Å. 
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During transcription, the nucleic acid passes on the palm domain, between the fingers domain 
and the thumb domain, where the catalytic site is formed by the finger domain folding into 
the palm domain. The NNRTI binding site is located 10Å away from the catalytic site, 
between the sheets of the palm domain and the thumb domain. This position is shown with 
nevirapine in Figure 10. 
 
2.2.2 Inhibitor-receptor interactions within the NNRTI binding pocket 
The NNRTI binding pocket consists of four main regions. Three of these in the vicinity of 
Leu234, Val179 and Tyr181 are hydrophobic in nature, whilst the fourth in the vicinity of 
Lys101 is hydrophilic. In general, first generation NNRTIs occupy the binding pocket in a 
way that is described as a ―butterfly-like‖ manner with the wings fitting into the hydrophobic 
pockets (Figure 11).
38
. The two wings mostly contain aromatic rings that form  
π-π interactions with the aromatic side chains of the amino acids. 39  
Figure 11 
Efavirenz in the NNRTI binding site 
 
It is of significance that all of the licenced NNRTIs show intermolecular interactions towards 
the NNRTI binding pocket while maintaining a minimum energy conformation. The more 
potent inhibitors (in increasing order of activity: Nevirpine, Efavirenz, Entravirine and 
Rilpivirine) have more than one interaction. Nevirapine only shows a π-π interaction between 
one of the aromatic rings and Tyr181. The more potent inhibitors all interact to Lys101 by 
means of intermolecular hydrogen bonding, indicating the significance thereof. Moreover, the 
second interaction of importance is the π-π stacking interaction to Tyr181 as seen with the 
larger, more flexible inhibitors such as rilpivirine and etravirine (Figure 12). Close to this is a 
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small hydrophobic pocket in the vicinity of Val 179. This allows for a small hydrophobic 
functionality as seen with the CF3 moiety of efavirenz. Lastly, the potency has been 
significantly enhanced by a halogen interaction towards the back of the binding pocket in the 
vicinity of Leu234.
40
 This interaction is also observed with efavirenz.  
Figure 12 
NNRTIs in the binding site 
  
Efavirenz Rilpivirine 
 
Etravirine 
 
2.2.3 Mutations causing HIV resistance 
The most challenging aspect in antiretroviral research is that some of the amino acids can 
undergo mutations. For NNRTIs, these resistant mutations decreases the affinity of certain 
NNRTIs in binding to the NNRTI binding pocket.
41
 Most of these mutated residues are 
present at amino acids 100-108, 179, 181-190 and 230, with the most common being in the 
vicinity of Tyr181 as well as in the solvent channel near Lys101.
42
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As reported by Johnson et al.,
42
 sixteen mutations alone have been associated with decreasing 
rilpivirine susceptibility, with the most common being K101E/P, E138A/G/K/Q/R, V179L, 
Y181C/I/V, H221Y, F227C, M230I/L and Y188L. In addition to this, more than 13 
mutations have been reported for etravirine such as V90I, A98G, L100I, K101E/P, V106I, 
V179D/F, Y181C/I/V, and G190A/S.
43, 44
 
Not only are there many resistant mutations for each licenced NNRTI drug, but phenomena 
of cross resistance also occur, thus complicating the treatment of HIV infected patients even 
more.
45, 46
 In an attempt to overcome these mutations the second generation NNRTIs have 
been designed as part of lead optimizing campaigns. Rilpivirine and etravirine show 
enhanced resistance profiles compared to the first generation NNRTIs nevirapine and 
efavirenz.
27, 28
 It has been strategized that one way to overcome mutations is to design 
compounds with greater flexibility that might allow for small changes in the NNRTI binding 
pocket, together with  involving additional interactions for enhanced inhibition activity.
47
 
 
2.2.4 Our strategy 
Our strategy is to combine the best features of the available NNRTIs and then, as an 
extension of previous work done by our research team, design and synthesise new 
compounds with enhanced inhibition. Our focus mainly shifted towards efavirenz and 
rilpivirine as these two are the most potent NNRTIs and show the essential hydrogen bonding 
interaction to Lys101.  
Previously, our team has embarked upon a study to develop new NNRTIs which offer the 
four key interactions described above. They were able to synthesise a cyclopropyl-containing 
compound (Figure 13) with an IC50 value of 0.08 µM and low toxicity, with a CC50 value of 
30.3 µM as determined in an in vitro single-cycle, non-replicative phenotypic assay.
48
 These 
interactions could be built onto the indole scaffold to fit the NNRTI binding pocket 
comfortably. The amine formed an interaction to Lys101, where the ester functionality could 
be included at the 2-position of the indole and the chlorine atom at the 5-position. The phenyl 
ring and the cyclopropyl moieties were connected by means of an extension onto the 3-
position of the indole. It was found that by replacing the chlorine atom at the 5-position with 
a bromine atom, an increase in activity was seen.
48
 However, due to the cost of the starting 
reagent, we will use the chlorine atom at the 5-position for this project.  
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Figure 13  
 Cyclopropyl-indole inhibitor 
 
 
With other research groups also investigating similar compounds, it is evident that the indole 
serves as a promising scaffold for novel NNRTIs. It was found that indolylarylsulfoxides 
showed potent HIV reverse transcriptase inhibition
49
 and soon more of these derivatives were 
developed such as the indolylarylsulfones and indolylarylsulfonamides (Figure 14). 
40, 50, 51
 In 
addition to this, another group has published phosphorus containing compounds instead of 
sulphur where these compounds have shown significantly greater activity.
52
 On 4 September 
2008 Indenix Pharmaceuticals reported the completion of the proof-of-concept study of 
IDX899 where Mayers stated that patients receiving this drug achieved potent viral 
suppression at all doses tested.
53
 In Febraury 2011, to their dismay, they were informed by 
the ViiV healthcare Company who was in charge of the development at this stage, that the 
clinical trial was set on hold by the U.S. Food and Drug Administration (FDA) due to 
complications.
54
 By this time the drug already made it to phase II clinical trials. 
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Figure 14 
Sulphur and phosphorus containing compounds 
Sulphur containing compounds 
   
indolylarylsulfoxides indolylarylsulfones Indolylarylsulfonamides 
 
Phosphorus containing compounds 
 
 
 IDX899 
 
With a cure for HIV and AIDS still absent, together with growing resistance towards 
available HIV antiretrovirals, it is thus crucial to develop new anti-HIV drugs with enhanced 
activity and improved resistance profiles. 
In this project, we aim to further enhance the activity of the compound developed by our 
group, by improving the molecular interactions to the NNRTI binding pocket. This would be 
utilized by means of molecular modelling-based design strategies and more importantly, 
synthesis. 
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CHAPTER 3 –THE VAL179 BINDING POCKET 
3.1 TOWARDS THE CYCLOPROPYL-INDOLE INHIBITOR 
For the purpose of this project, we would first discuss the research strategies we have used, 
followed by a short discussion on the relevant reactions that were used. Subsequently, an in 
depth discussion would follow on the synthesis, the problems encountered, and the triumphs 
we have accomplished. Finally, the efficacy results of these synthesised compounds would 
then be discussed, whereupon the overall contribution of each chapter is summarised.  
3.1.1 An extension on previous research 
With previous success in our laboratories, based on the use of cyclopropyl-based inhibitors, 
we decided to start this project as an extension on this work.
48
 We strategized that by 
synthesising the modified version of the cyclopropyl-indole inhibitor 2, enhancements could 
be made to the Lys101 interaction (Scheme 1). Since the synthetic procedures are known and 
have been proven to work,
48
 this would allow for  swift output of new compounds with 
enhanced molecular interactions to the NNRTI binding pocket. 
Scheme 1 
 
The total synthesis comprised of four steps in order to produce compound 2 (Scheme 2).
48
 
The initial step was a Friedel-Crafts acylation, where the benzoyl moiety was introduced by 
means of benzoyl chloride and aluminium chloride in good yield. At this stage the indole was 
protected as the Boc carbamate, not only to serve as a protecting group, but also to withdraw 
electron density from the indole system in order to stabilize the product of the impending 
Wittig reaction. By omitting the protecting group, it was found that the Wittig reaction gave 
significantly lower yields due to polymerization of the starting material and the reaction did 
not proceed at all under milder reaction conditions. With the Boc protection, the Wittig 
reaction produced a mixture of protected and unprotected alkene products 5 and 6, where the 
Boc protecting group was removed due to the reaction conditions used. However, both these 
compounds could be converted into the cyclopropyl product 2 by means of the Furukawa 
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modification of the Simmons-Smith reaction.
55
 Once again, the protecting group was released 
during the reaction.  
Scheme 2 
Reaction procedures discussed by Hassam et al.
48
 
 
 
3.1.2 Friedel-Crafts acylation 
The Friedel-Crafts acylation reaction involves the formation of a ketone by reacting an 
aromatic substrate with an acyl compound in the presence of a catalyst, like the Lewis acids 
(such as ZnCl2, AlCl3, FeCl3, SnCl4 and TiCl4) or strong protic acids (such as HF and 
H2SO4).
56
 The first mention of the Friedel-Crafts acylation with Al2Cl6 was reported as early 
as 1873 by Grucarevic and Merz, which was similar to the Friedel-Crafts alkylation.
57
 
It was first believed that acyl halides form oxonium complexes under the acidic conditions 
utilised (Scheme 3). X-ray structures of these complexes confirmed co-ordination via the 
oxygen atom, where a decrease in the carbonyl stretching frequency in infrared analysis, 
together with an increase in bond length indicated weakening of the C=O bond.
58-62
  
A downfield shift of the α-protons in the 1H NMR spectrum was observed and served as an 
indication of the possible existence of a partial positive charge on the carbonyl carbon.
63
 
Scheme 3 
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In contrast to this, many acylium salts have been isolated (Scheme 4). A shortened C=O bond 
length, together with an increase in the carbonyl stretching frequency in the infrared spectra 
served as indication of strengthening of the C=O bond.
64, 65
 Once again, a downfield shift of 
the α-protons in the 1H NMR spectrum, and deshielding of the carbonyl carbon in the  
13
C NMR spectrum was seen.
66
 This served as an indication that a positive charge was mainly 
localized on the carbonyl carbon. 
Scheme 4 
 
It is believed that acyl halides and Lewis acids form oxonium complexes and acylium salts, 
or even a mixture of these.
67
 It has also been stated that although the oxonium complexes are 
likely to be active acylating species, acylation is unlikely to proceed via a small concentration 
of acylium ions.
68
  
For an indole system, the Friedel-Crafts acylation would usually occur on the 2- and 
3-positions of the indole. However, by having the ester in the 2-position, the acylation 
reaction would not occur at this position. We expect the acylation reaction to occur only at 
the 3-position of the indole, and thereby we hope to be able to obtain the desired product in 
good yield (Scheme 5). 
Scheme 5 
 
 
3.1.3 The Wittig reaction 
Upon the discovery of the Wittig reaction in the 1950‘s by Wittig and Geissler,69 a door to a 
new era on olefin synthesis was opened. Due to its simplicity and efficiency it has become 
widely used, with major advances in the 1960‘s.70 The Wittig reaction is simply described as 
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a condensation between a phosphorus ylide and an aldehyde or ketone, producing an olefin 
and a phosphine oxide.
71
 
Great curiosity was attracted by chemists due to a high selectivity displayed towards (Z)- and 
(E)-alkenes by this reaction, which as a result drove the persistence in finding a truly 
satisfying mechanistic explanation.
70
  ―Stabilized‖ ylides characteristically have strong 
conjugating substituents (such as COOMe, CN or SO2Ph) and favour the formation of  
(E)-alkenes, whereas ―non-stabilized‖ ylides without these functionalities favour the 
formation of (Z)-alkenes. 
Wittig first proposed a four-membered cyclic phosphorane (a 1,2-oxaphosphetane), but soon 
came to favour the zwitterionic phosphorus betaine as intermediate due to experimental 
observations.
69, 72, 73
 It was believed that the reaction proceeded via a nucleophilic addition of 
the phosphorus ylide to the carbonyl compound. This resulted in the formation of the betaine 
species, which could undergo irreversible decomposition to give the alkene and the 
phosphine oxide (Scheme 6). 
Scheme 6 
 
In 1973 Vedejs showed that the oxaphosphetanes are the only observable intermediates by 
means of 
31
P NMR analysis.
74
 In addition to this, in 1981 he reported that  
1,2-oxaphosphetanes are the primary intermediates in various reactions involving 
―nonstabilized‖ phosphorus ylides at low temperatures (Scheme 7).75 
Scheme 7 
 
For our indole system, we propose that the alkene product obtained from the Wittig reaction 
might not be stable, in which case it might undergo polymerisation (Scheme 8). However, we 
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propose that the ester functionality being somewhat electron-withdrawing (Scheme 9), would 
make the product less nucleophilic, thereby stabilising the alkene product just enough for the 
product to be isolated.
48
 For this reason, we propose that by introducing an electron-
withdrawing Boc protecting group onto the indole, together with having the ester 
functionality in the 2-position, we would be able to stabilise the alkene product enough in 
order to obtain it in good yield. 
Scheme 8 
Possible polymerisation 
 
Scheme 9 
Electron delocalisation in the presence of the ester functionality 
 
 
3.1.4 The Simmons-Smith reaction 
The first addition of an unsubstituted methylene group to an olefin was reported by  
Simmons and Smith in 1958.
76
 This particular stereospecific synthesis was carried out with 
methyl iodide and a zinc-copper couple. 
Soon after this, Furukawa et al. developed a faster and more reliable synthesis of 
cyclopropyls by using methyl iodide and diethylzinc.
55
 The Furukawa reagent is prepared by 
a halogen-metal exchange reaction between methyl iodide and diethylzinc. Until recently 
there has been much debate as to whether the addition proceeds via a methylene transfer 
pathway or a carbometalation mechanism. Nakamura et al. concluded with experimental 
evidence that this reaction takes place via a methylene pathway (Scheme 10).
77
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Scheme 10 
 
In our synthesis, we do not expect the Simmons-Smith reaction as such to be the problem, but 
rather the alkene starting material from the Wittig reaction that would be used. With the 
alkene starting material being somewhat nucleophilic, which thereby might promote 
polymerisation, it poses a challenge in finding the right balance in stabilising the alkene long 
enough for the cyclopropanation to occur, without stabilising it too much and thereby 
preventing the Simmons-Smith reaction from occuring. 
With our research strategy outlined, we now pursued on an endeavour to synthesise the 
desired indole-based cyclopropyl compound 2. 
 
3.1.5 Synthesis of ethyl 3-benzoyl-5-chloro-1H-indole-2-carboxylate - 3 
 
Scheme 11 
 
For the first step in our synthetic route we proceeded with a Friedel-Crafts alkylation 
(Scheme 11), which was carried out without difficulty. The reaction flask was fitted with a 
reflux condenser and charged with dry dichloroethane under nitrogen gas. This was cooled to 
0°C and aluminium chloride was added, followed by the dropwise addition of benzoyl 
chloride and then 1. We found that by refluxing the reaction mixture at 85°C instead of just 
heating it to 80°C as previously carried out by our group, a 15% higher yield of 86% was 
achieved. 
We also found that the product was more soluble in ethyl acetate and therefore, upon workup  
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we switched to ethyl acetate instead of dichloromethane for extracting the product. Attempted 
recrystallization was unfortunately not successful as impurities co-crystallised with the 
desired product. It was thus more efficient to purify the product by means of column 
chromatography. 
The 
1
H NMR spectrum correlated with that reported in 
literature,
48
  where the presence of the aromatic protons could be 
seen as a doublet of doublets, integrating for 2 at 7.86 ppm and a 
multiplet integrating for 1 at 7.61-7.54 ppm for H15. The signals 
of two aromatic protons overlapped with that of H7, resulting in a 
multiplet integrating for 3 at 7.48-7.40 ppm. The doublet for H4 
at 7.72 ppm and the doublet of doublets for H6 at 7.34 ppm, together with that of H7 served 
as an indication that the benzoyl moiety added onto the 3 position of the indole. The result of 
the mass spectral analysis of 328.0734 amu correlated with the expected mass of 
328.0740 amu. 
 
3.1.6 Synthesis of 1-tert-butyl 2-ethyl 3-benzoyl-5-chloro-1H-indole-1,2-dicarboxylate - 4 
 
Scheme 12 
 
Before proceeding with the Wittig reaction, we first introduced the Boc protecting group  
to serve as an electron-withdrawing group (Scheme 12). Here it would serve as an electron-
withdrawing group in order to stabilise the impending alkene product that would be 
synthesised by means of the Wittig reaction.  A catalytic amount of 4-dimethylaminopyridine 
was added to the reaction vessel charged with 3 in tetrahydrofuran and di-tert-butyl 
dicarbonate under nitrogen gas.  
The reaction was completed after 30 minutes as determined by monitoring it by means of 
TLC, whereupon the solvent was removed in vacuo and the product purified by column 
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chromatography. A yield of 94% was achieved and a clean 
1
H NMR spectrum was obtained, 
which served as an indication of the purity of the sample. 
The absence of the broad indole -NH signal indicated the 
successful protection onto the nitrogen of the indole. The newly 
formed doublet integrating for 9 at 1.64 ppm is an indication of 
H22 of the Boc protecting group. Here we expected a singlet, but 
the observed doublet may be a result of long range coupling from 
H7. The result of the mass spectral analysis of 428.1267 amu 
correlated with the expected mass of 428.1267 amu. 
 
3.1.7 Synthesis of 1-tert-butyl 2-ethyl 5-chloro-3-(1-phenylvinyl)-1H-indole-1,2-
dicarboxylate -6  
and ethyl 5-chloro-3-(1-phenylvinyl)-1H-indole-2-carboxylate -5 
 
Scheme 13 
 
Upon treatment of compound 4 with the freshly prepared ylide (Scheme 13), it was found that 
the reaction did not proceed at 0°C, as monitored by means of TLC. A key step in this 
reaction is to generate the ylide properly. This was only achieved by the slow addition of  
1.4M n-butyllithium to methyltriphenylphosphonium bromide in tetrahydrofuran at 0°C 
under nitrogen gas, followed by slowly heating the reaction mixture to 30°C for 30 minutes 
to form the ylide. 
The ylide reaction mixture was again cooled to 0°C and added dropwise to the starting 
material 4 in tetrahydrofuran, which was also pre-cooled to 0°C under nitrogen gas. For this 
dropwise addition, a syringe with a thick needle was used rather than a canula, since the ylide 
reaction mixture was a thick suspension. Finally, the reaction mixture was heated to 30°C for 
the Wittig reaction to proceed within 2 hours.  
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Purification by means of column chromatography yielded a modest 35% for 5 and 22% for 6. 
We surmised that the Boc protecting group was not stable enough to withstand the reaction 
conditions, which consisted of a high concentration of ylide. However, by conducting the 
reaction at a lower concentration of the ylide, since this could be added dropwise, or by using 
a lower temperature, this reaction did not proceed.  
The newly formed alkene (H18a and H18b) was observed in the  
1
H NMR spectrum as two doublets, each integrating for 1 at  
5.96 ppm (J = 0.8 Hz) and 5.43 ppm (J = 0.8 Hz) for 6, and at 
5.96 ppm (J = 1.1 Hz) and 5.32 ppm (J = 1.1 Hz) for 5. For 6, the 
singlet integrating for 9 at 1.58 ppm served as an indication of 
H22 of the Boc protecting group, whereas for 5, a broad signal at 
12.14 ppm integrating for 1 for H1 was observed with the absence 
of the singlet for the Boc protecting group. 
The masses found by means of mass spectral analysis were 
426.1484 amu and 326.0948 amu for 6 and 5 respectively, and 
correlated well to the expected masses of 426.1472 amu and  
326.0948 amu. 
 
 
3.1.8 Attempted synthesis of ethyl 5-chloro-3-(1-phenylcyclopropyl)- 
1H-indole-2-carboxylate -2 
 
Scheme 14 
 
Having the alkene products in hand, we attempted the Simmons-Smith cyclopropanation on 
compound 6 (Scheme 14). After many attempts, we were able to optimise this particularly 
tricky reaction and obtained the desired product, though in poor yield. 
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A 50 mL three-neck round bottom flask was fitted with a rubber septum and charged with dry 
dichloromethane under nitrogen gas. This was cooled to 0°C. Diethyl zinc (20 equivalents) 
was added dropwise by means of a syringe, followed by the slow addition of glacial acetic 
acid, diiodomethane and lastly 6. The reaction proceeded promptly and the starting material 
was consumed within 90 minutes. After purification by means of column chromatography, 
we were finally able to obtain a low 14% yield of a 7:3 mixture of the product 2 and the 
deprotected staring material 5.  
The ratio of the two compounds formed was determined by integrating the 
1
H NMR spectrum 
(Figure 15), where two signals at 5.96 ppm and 5.43 ppm, each integrating for 1, gave an 
indication of the unreacted alkene and the two multiplets at 1.52 ppm and 1.36 ppm, each 
integrating for 2, served as an indication that the cyclopropyl ring had formed. These two 
compounds have the same Rf in 60% to 5% ethyl acetate/hexane, in which case we were 
unable to purify the desired product 2.  
Figure 15 
1
H NMR signals indicating the presence of the alkene and the cyclopropyl 
 
 
 
 
With the impure cyclopropyl compound obtained, we attempted various different reaction 
conditions, to optimise the yield of the reaction, varying one condition at a time. By allowing 
a longer reaction time, increasing the amount of equivalents of reagents used or by heating 
the reaction mixture to 30°C, the starting material decomposed. This decomposition was 
  1 1 
H
18a/b
 H
18a/b
 
6.05-5.30 ppm 
    2 2 
Cpr Cpr 
1.55-1.32 ppm 
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detected by the fading of the starting material on the TLC plate, together with the formation 
of a dark spot on the baseline. This might have been due to the deprotection of the starting 
material, followed by the possible polymerization thereof under the Lewis acid conditions. 
Seeing that the reaction proceeded within 1½ hours, we thought that by cooling the reaction 
to ─20°C, and in a second attempt to ─75°C, we might be able to slow the reaction rate and 
prevent the starting material from being deprotected in advance, but these reactions did not 
proceed. By attempting the Simmons-Smith reaction without the Boc protection at 0°C, the 
alkene starting material 5 decomposed as before, indicating once more that the alkene is 
unstable without the protecting group under the Lewis acid conditions. 
In addition to these attempts, we omitted the acid from the reaction mixture in order to 
prevent the deprotection of the starting material. However, the reaction did not proceed and 
the starting material 6 was recovered. Upon this we concluded that a protecting group is 
indeed needed for the Simmons Smith reaction to stabilise the alkene, in which case it needs 
to be able to withstand the Lewis acid conditions. 
 
3.1.9 An alternative to the Boc protecting group 
Evaluating the results obtained from the attempted synthesis of the cyclopropyl compound 2, 
it was thus clear that the Boc protecting group posed problems. Not only did we get a mixture 
of protected and unprotected products for the Wittig reaction, but the deprotection during the 
Simmons-Smith reaction made it hard to monitor the reaction progress and to purify the 
product that formed. We suspect that the poor yields obtained in the Wittig and Simmons-
Smith reactions were because the Boc protecting group was removed, exposing the reactive 
alkene to polymerisation. 
As discussed earlier, we needed a protecting group that would withdraw electron density 
from the indole system for the Wittig reaction to proceed, and that would be stable enough to 
survive the reaction conditions of both the Wittig and Simmons-Smith reactions.  We 
envisaged that a tosyl protecting group might be more stable, and offer similar, if not better 
electron-withdrawing capabilities, leading to a more stable alkene. 
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3.1.10 Synthesis of ethyl 3-benzoyl-5-chloro-1-tosyl-1H-indole-2-carboxylate - 7 
 
Scheme 15 
 
The indole compound 3 was thus subjected to deprotonation by means of sodium hydride in 
dry dimethylformamide at 0°C in order to facilitate a nuclephilic attack on p-toluenesulfonyl 
chloride (Scheme 15). This reaction proceeded smoothly within several hours as monitored 
by means of TLC. Once the starting material had been consumed, the reaction was quenched 
and the crude material was purified by means of column chromatography. 
The absence of the broad indole -NH signal served as an 
indication that the reaction had proceeded as desired. An 
additional 4 protons were observed in the aromatic region, 
together with the benzylic methyl protons H24 as a singlet 
integrating for 3 at 2.41 ppm. The result of the mass spectral 
analysis of 482.0822 amu correlated with the expected mass of 
482.0829 amu. 
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3.1.11 Synthesis of ethyl 5-chloro-3-(1-phenylvinyl)-1-tosyl-1H-indole-2-carboxylate - 8 
 
Scheme 16 
 
With the tosyl-protected compound in hand, we were now able to test our first problematic 
reaction, the Wittig reaction (Scheme 16). The Wittig reaction was conducted under exactly 
the same reaction conditions as described earlier, producing a significantly improved yield of 
98% of the protected product 8.  This significant improvement in the yield lends testimony to 
our theory that the unprotected indole-alkene system is susceptible to polymerization. 
As with 6, the presence of the new alkene (H18a and H18b) was 
observed in the 
1
H NMR spectrum as two singlets at 5.93 ppm 
and 5.40 ppm, both integrating for 1. The result of the mass 
spectral analysis of 480.1028 amu correlated with the expected 
mass of 480.1036 amu. 
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3.1.12 Attempted synthesis of ethyl 5-chloro-3-(1-phenylcyclopropyl)- 
1H-indole-2-carboxylate - 2 
 
Scheme 17 
 
Following with the Simmons-Smith reaction under the exact same reaction conditions as 
before, the reaction unfortunately did not proceed (Scheme 17). We then attempted harsher 
reaction conditions such as greater equivalents of reagents and higher reaction temperatures 
up to 60°C. However, the reaction still did not proceed and in all cases more than 90% of the 
starting material 8 was recovered. 
The tosyl protecting group showed enhanced electron-withdrawing ability and stability 
during the Wittig reaction, but seemed to not be suited for the Simmons-Smith reaction. This 
might be due to various reasons. We propose that it might be that the tosyl protecting group is 
too electron-withdrawing. The Boc-protecting group does not offer as much electron-
withdrawing capabilities, thereby striking the right balance between stabilising the alkene and 
facilitating the Simmons-Smith reaction. Moreover, with the Boc protecting group being 
removed in situ, the question arises as to whether this is necessary for the Simmons-Smith 
reaction to proceed. However, if this is the case, the right balance must be found between 
removing the Boc protecting group to facilitate the Simmons-Smith reaction, and stabilising 
the alkene in order to prevent polymerisation of the starting material. 
 
3.2 TOWARDS THE CYCLOPROPYL INDOLE INHIBITOR – A NEW APPROACH 
3.2.1 Preparing the cyclopropyl moiety separately 
With our previous attempts of introducing the cyclopropyl moeity being unsuccessful, we 
decided to form the cyclopropyl-containing side chain separately and then add it onto the 
3-position of the indole by means of a Friedel-Crafts alkylation (Scheme 18). With this 
proposed route, not only would we be able to investigate the importance of the ester 
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interaction, but we would be able to introduce other functionalities at the 2-position of the 
indole by means of Sonogashira or Stille coupling reactions in the absence thereof. 
Scheme 18 
 
We proposed that by reacting acetophenone with a protecting group such as  
tert-butyldimethylsilyl chloride in the presence of a strong base, the enolate could be trapped 
as an enol silane (Scheme 19).
78
 This method has been widely used,
79, 80
 with a more recent 
interest being in combination with Mukaiyama adol reactions.
81, 82
  
Scheme 19 
 
Once the alkene is formed, it could be converted into a cyclopropyl ring by means of the  
Simmons-Smith reaction, whereupon the OTBDMS group could be converted into a chloride 
atom with the use of thionyl chloride (Scheme 20).
78
 In fear of the cleavage of the 
cyclopropyl group, caution needs to be taken when proceeding with this reaction. We propose 
that by adding only 1.2 equivalents of thionyl chloride to a very dilute mixture of 14 in 
acetonitrile, pre-cooled to ─15°C, this would be sufficient for the reaction to proceed.  
Scheme 20 
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In proceeding with the Friedel-Crafts alkylation, the same caution needs to be exercised in 
order to prevent the cyclopropyl ring from opening. We fear that this might happen since the 
Friedel-Crafts reaction proceeds via a carbocation intermediate. The cyclopropyl carbocation 
intermediate might not be stable enough and the ring might open. 
 
3.2.2 The Friedel-Crafts alkylation 
Since its discovery in 1877 by Friedel and Crafts,
83, 84
 the Friedel-Crafts alkylation  has been 
used extensively for industrial applications. However, since the discovery of this reaction, 
early publications were rare and it was only until 1999 that tremendous growing research 
interest was shown.
85
  
The Friedel-Crafts alkylation reaction forms new carbon-carbon bonds by the 
functionalisation of aromatic systems with carbon electrophiles. The alkylation reactions, as 
with the acylation reactions, are catalysed by Lewis acids (such as ZnCl2, AlCl3, FeCl3, SnCl4 
and TiCl4) or strong protic acids (such as HF and H2SO4).
56
  
Even though the Friedel-Crafts alkylation reaction is extensively used in industry and 
academia, the success is still limited by the fact that the alkylation products are significantly 
more reactive than the starting material. This results in multiple alkylated side products,
86
 for 
instance, in our case the alkylation might occur at the 2- and the 3-position of the indole. 
However, indoles have been proven to be good substrates for this reaction because of the 
different reactivities at different sites of the indole ring.
86
 Not only is the reactivity of the 
alkylation products a problem, but the reaction proceeds via a carbocation intermediate 
(Scheme 21), allowing for rearrangements to occur. This imposes restrictions on the 
electrophiles that can be used.
87
 We were also concerned that the cyclopropyl moiety might 
undergo rearrangements, in which case the cyclopropyl ring might cleave (Scheme 22). 
Scheme 21 
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Scheme 22 
 
With the new synthetic strategy in mind, we began a second endeavour to synthesise the 
desired indole-based cyclopropyl compound 2. 
 
3.2.3 Synthesis of tert-butyldimethyl(1-phenylvinyloxy)silane - 13 
 
Scheme 23 
 
In the preparation of the enol silane 13, acetophenone 12 was added to dry diethyl ether and 
cooled to 0°C (Scheme 23). Potassium bis(trimethylsilyl)amide was added and the reaction 
mixture was heated to 30°C for 1 hour to ensure the formation of the enolate. After this,  
tert-butyldimethylsilyl chloride was added to ―trap‖ the enolate as an enol silane, isolated as 
colourless oil. 
Initially, very low yields were obtained after workup when using ethyl acetate as the solvent. 
We considered that the product might have a low boiling point, in which case it could be 
removed on the rotary evaporator. We found that acetophenone could be removed on the 
rotary evaporator, which indicated that it might also be the case for the enol silane 13. By 
using diethyl ether as a solvent for extraction, a lower temperature and thus a milder vacuum 
is needed to remove the solvent, thereby we were able to prevent the product from being 
removed with the solvent. 
Initially, by purifying the product with column chromatography, a very low yield of 33% was 
obtained. This was disconcerting, seeing that the starting material was not recovered and a 
quantitative mass was obtained after workup. We proposed that the compound may have 
decomposed on the silica gel column. By analysing the behaviour of compound 13 on silica 
by means of 2D TLC, we found that it did indeed decompose on silica (Figure 16). After each 
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turn of the TLC, we found a residue left behind that had moved in the previous run. This 
served as an indication of decomposition. 
Figure 16  
2D TLC (Rf = 0.68, 5% EtOAc/Hexane) 
                               
 
In terms of the spectroscopic analysis of compound 13, the 
presence of the alkene (H8a and H8b) was observed in the  
1
H NMR spectrum as two doublets, both integrating for 1, at 
5.01 ppm and 4.42 ppm. The presence of the OTBDMS group 
could be seen by a multiplet integrating for 9 at 0.99-0.94 ppm for H22 and a multiplet 
integrating for 6 at 0.21-0.18 ppm for H20. These multiplets might have been due to long 
range coupling to each other. The 
13
C signals were as expected, where the signal indicating 
the presence of C18 was observed at 91.3 ppm. The result of the mass spectral analysis of 
235.1518 amu correlated with the expected mass of 235.1523 amu. 
 
3.2.4 Synthesis of tert-butyldimethyl(1-phenylcyclopropoxy)silane - 14 
 
Scheme 24 
 
With the enol silane 13 finally in hand, we were able to continue with the Simmons-Smith 
reaction (Scheme 24). The reaction was carried out with the same procedure as before with 
no difficulties. This compound was purified by means of column chromatography and an 
excellent yield of 98% was obtained. 
Decomposition spot 
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The two multiplets in the 
1
H NMR spectrum, both integrating for 2 
at 1.10 ppm and 1.03 ppm for H18 and H19, served as an indication 
that the cyclopropyl ring has indeed formed and the remaining 
1
H 
NMR signals were as expected. The result of the mass spectral 
analysis of 249.1675 amu correlated with the expected mass of 
249.1666 amu. 
 
3.2.5 Synthesis of (1-chlorocyclopropyl)benzene - 10 
 
Scheme 25 
 
With the cyclopropyl compound 14 synthesised successfully, the next reaction needed to be 
approached with caution in order to prevent the cyclopropyl ring from cleaving. Compound 
14 was added to dry acetonitrile and this was cooled to ─15°C (Scheme 25). Only  
1.2 equivalents of thionyl chloride was added slowly, whereupon the reaction mixture was 
left to slowly warm to 0°C. A crude yield of 79% was obtained, however after purification by 
means of column chromatography, a yield of 10% was obtained. We proposed that the 
compound might again be decomposing on the silica column. By analysing the crude 
compound by 
1
H NMR spectroscopic analysis, we found that the compound was of sufficient 
purity and it was used without further purification for the next reaction. 
A crude 
1
H NMR spectrum was obtained in which two multiplets, each 
integrating for 2 at 1.28-1.23 ppm and 1.06-1.01 ppm were seen. These 
served as an indication that the cyclopropyl ring survived the reaction 
conditions. 
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3.2.6 Attempted synthesis of 5-chloro-3-(1-phenylcyclopropyl)-1H-indole - 11 
 
Scheme 26 
 
In terms of the Friedel-Crafts alkylation, we proceeded once again with caution as were 
worried that the cyclopropyl ring might cleave open (Scheme 26). To this end, 10 was treated 
with aluminium chloride, and the indole 9. After 2 hours, a small amount of a new compound 
could be seen on the TLC just above the starting material 9 and below 10. The reaction was 
kept at 0°C for another 4 hours, only to discover that the reaction did not proceed any further. 
The reaction mixture was then allowed to slowly warm to room temperature for the 
remaining of the 18 hours, after which only a small indication of starting material was left on 
the TLC. 
Upon workup, two compounds were seen on the TLC (Rf = 0.31, 0.53, 20% EtOAc/Hexane) 
and by means of 
1
H NMR spectroscopic analysis, it was found that the one with the highest 
Rf value was the starting material 9 (6 mg). The one with the lower Rf was the product 15 
(23mg), with a cleaved cyclopropyl ring, which indicated that the unwanted rearrangement 
did indeed occur (Scheme 27). 
Scheme 27 
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The cleaved cyclopropyl moiety was indicated by a triplet integrating 
for 1 at 5.26 ppm for H11, and a triplet integrating for 3 at 1.25 ppm for 
H19, together with two multiplets for H18 at 3.48 ppm and 3.21 ppm 
each integrating for 1. The two multiplets might result from long range 
coupling from H2. 
 
 
After attempting introducing the cyclopropyl moiety by means of a Friedel-Crafts alkylation, 
it was clear that the cyclopropyl moiety needs to be formed on the indole scaffold and not be 
introduced separately. Moreover, considering the difficulties we encountered with the 
cyclopropyl moiety, we decided to investigate other functional groups for the interaction in 
the Val179 binding pocket. 
 
3.3 CONCLUDING REMARKS PERTAINING TO THE SYNTHESIS OF THE CYCLOPROPYL 
COMPOUND 
In order to investigate new possibilities at the 2-position of the indole, we first needed to 
build the cyclopropyl scaffold. We were able to successfully repeat the first two reaction 
steps of the previous work from our research group in greater yields. However, the Wittig 
reaction did not proceed as anticipated,
48
 and we had to change the reaction conditions for the 
reaction to proceed. Unfortunately, low yields were obtained.  
The Simmons-Smith reaction did indeed proceed, but the starting material was deprotected 
during the reaction and had the same Rf as the cyclopropyl product, which made these 
compounds inseparable. Moreover, by omitting the protecting group before the reaction, the 
compound decomposed, and by using a more stable protecting group, the Simmons-Smith 
reaction did not proceed. 
We envisaged circumventing these problems by synthesising the cyclopropyl-containing 
side-chain separately. Unfortunately, the carbocation intermediate was unstable and the 
cyclopropyl moiety cleaved. Thus, having encountered so many difficulties associated with 
the cyclopropyl ring, we decided to investigate other functional groups at this position to 
establish if this troublesome functional group was worth the effort in terms of HIV inhibitory 
activity.  
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CHAPTER 4 – THE VAL179 BINDING POCKET – A NEW APPROACH 
4.1 INVESTIGATING NEW INTERACTIONS 
4.1.1 Examining the cyclopropyl interaction 
In light of the need for enhanced interactions towards the NNRTI binding pocket, together 
with the difficulties in synthesising the cyclopropyl moiety, we questioned whether this 
particular functional group really was crucial for good inhibition. In our group, the 
cyclopropyl moiety was designed by means of molecular modelling and was considered as 
the conformation that would best fit the Val179 pocket. However, other less problematic 
functional groups may also facilitate the same interactions, and we now focussed our 
attention in this direction. 
 By omitting functionality in this position, or in any other position of interest, we would 
expect a decrease in inhibition activity simply because there is one less interaction. As 
discussed earlier, enhanced activity is directly affected by enhanced intermolecular 
interactions. Moreover, we envisaged that by introducing a functionality with a similar 
conformation as the cyclopropyl, we would be able to mimic the interaction and at the same 
time probe the internal space of the Val179 pocket.  
Upon this, we proposed that by having the efficacy results of compound 2 available, we 
would be able to compare it with new compounds, where only one change has been made 
(Scheme 28). We proposed that a dimethyl moiety 17 would fit the Val179 pocket in a 
similar way as the cyclopropyl compound 2, but with a slightly larger angle between the two 
methyl moieties than that of the cyclopropyl ring. This larger angle might cause the dimethyl 
moiety to fit a slightly larger area in the binding pocket than the cyclopropyl ring. In addition 
to this, the cyclopropyl moiety could be omitted in compound 16, in which case it would 
result in a lower inhibition activity. This would allow us to investigate the full effect of the 
cyclopropyl ring on biological activity.  
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Scheme 28 
 
2 
  
16 17 
 
4.1.2 Molecular modelling 
For a small part of this project, time was spent on molecular modelling analysis where new 
functionalities were introduced and the interactions towards the NNRTI binding pocket 
investigated. Upon docking the newly designed molecules into the binding pocket, it was first 
examined visually to ensure that it made physical and chemical sense. Only after this, we 
proceeded with molecular calculations to refine the results.   
The modelling was performed using Accelrys Discovery Studio 3.5 (DS).  The HIV reverse 
transcriptase receptor used for these exercises was obtained from the Protein Data Bank 
(PDB 2RF2) with a resolution of 2.4 Å and was subjected to several preparative steps. These 
included ionization of the receptor at pH 7.4, manually correcting incorrect histidine 
tautomeric states and deletion of all the water molecules. Finally, the receptor was subjected  
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to a CHARMm minimization,
88
 whist employing fixed atom constraints to the protein 
backbone in order to minimise the newly optimised side chains while keeping the overall 
protein structure intact. 
For this minimization, the Generalized Born with simple Switching (GBSW) implicit 
solvation model was used,
89
 therefore making use of previous minimization steps as well as 
the current gradient to determine the next step, while utilizing a van der Waals based surface 
with a smooth dielectric boundary. With the Generalized Born with simple Switching 
solvation model being faster than the Generalised Born implicit solvation model, and without 
too much compromise on accuracy,
90
 we considered this method to be more computationally 
efficient for our purposes. 
CDocker was used as the main docking tool,
91
 whereupon optimization of the receptor-ligand 
system was carried out by using the binding energy calculation protocol
92
 that included a 
minimization of the docked ligand and surrounding residues at a 5Å radius. In these 
calculations the Distant-Dependant Dielectrics implicit solvation model was employed.
90, 93
 
In order to ensure that the ligands were in their lowest energy conformations, the ligands 
were removed from the receptor and consequently minimised using the same implicit 
solvation model. The minimisation energies were compared to that of the bound ligands. 
Lastly, the Root Mean Square Deviation (RMSD) was calculated and compared to that of the 
docked ligands to ensure that the docked ligands were indeed in minimum energy 
conformations.
94
 
Docked and optimized ligands were selected by binding energy as well as visual inspection. 
 
4.1.3 Comparing the dimethyl interaction to that of the cyclopropyl 
In order for us to consider different functional groups to replace the cyclopropyl ring, it is 
thus of utmost importance that this functionality must be well accommodated in the Val179 
binding pocket. We do not want to introduce a functionality that will cause a complete 
change in the binding orientation, as this will affect the other interactions to the NNRTI 
binding pocket, and might therefore result in a lower activity. Moreover, if there is a change 
in the binding orientation, we would not be able to compare the interaction in the Val179 
binding pocket alone, as the other interactions being affected would also contribute to a 
change in activity. 
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When comparing the docking of compound 17 and the cyclopropyl compound 2, we found 
that the dimethyl moiety seemed to be well accommodated in the binding pocket, and 
therefore the indole adopted the desired pose, very similar to that of 2 (Figure 17). In addition 
to this, we were able to visually compare the angle of the dimethyl moiety to that of the 
cyclopropyl. It was observed that the dimethyl moiety occupies a larger space in the NNRTI 
binding pocket. Moreover, it was found that by visually comparing the docking of compound 
16 and compound 2 (Figure 18), 16 adopts the same conformation as 2, just without the 
cyclopropyl ring. 
Figure 17 
Overlaying compound 17 (yellow) and compound 2 (blue) 
 
 
 
Figure 18 
Overlaying compound 16 (pink) and compound 2 (blue) 
 
By comparing the binding energies (Table 1), we found that the binding energy of compound 
17 was the lowest, followed by that of compound 2, and then compound 16. However, with 
these values being very close, we would rather not use these values to predict which of the 
three compounds would be the most active inhibitor. We proposed that it would be best to 
synthesise these compounds in order to determine and compare the efficacy results. 
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Table 1 
Calculated Binding Energies (kcal/mol) 
Compound 
   
Binding Energy 
(kcal/mol) 
─ 65.6820 ─ 68.6419 ─ 60.4864 
 
 
4.2 SYNTHESIS PERTAINING TO THE VAL 179 BINDING POCKET INTERACTIONS 
4.2.1 Introducing the dimethyl moiety 
Having concluded the modelling studies and verified that the dimethyl compound 17 was a 
viable candidate for this NNRTI binding pocket, we set about its synthesis, as well as that of 
the compound lacking all functionality in this position, compound 16. The binding energy 
was slightly better for 17 in comparison to 2, but the question arose as to how much this 
would really affect the potency.  
We strategized that we would be able to introduce the dimethyl moiety by means of a  
Friedel-Crafts alkylation (Scheme 29). Previously, we attempted to introduce the cyclopropyl 
moiety in a similar way, though unfortunately the cyclopropyl ring was not stable under these 
conditions. We propose that the dimethyl moiety might be a better candidate for this reaction 
as it is not strained and thus more stable. We proposed to first investigate the feasibility of the 
reaction on a simpler model system 9, this being the indole without the ester functionality. 
We were concerned that the electron-withdrawing effect of the ester might inhibit the 
nucleophilicity of the indole and by doing so prevent the alkylation. If necessary, the ester 
functionality could be introduced later by the introduction of the carboxylate, followed by an 
esterification reaction (Scheme 30). 
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Scheme 29 
 
Scheme 30 
 
In addition to this, examples were found of alkylation of indoles with alcohols by using 
Lewis and Brønsted acids as catalysts.
95, 96
 Sanz et al. reported a selective alkylation onto the 
3-position of the indole by using p-toluenesulfonic acid as catalyst, where Jana et al. reported 
the same selectivity by using iron(III) chloride as catalyst.  
Scheme 31 
 
 
4.2.2. Establish the importance of the Val179 binding pocket interaction 
As a validation of the importance of the hydrophobic interaction within the small Val179 
binding pocket, we decided to synthesise an indole derivative 16 that would purposefully not 
have any functionality to interact in this region of the NNRTI binding pocket. We envisage 
that 16 could easily be obtained from 3 (Scheme 32). Thus we would be able to establish the 
importance of this interaction by comparing the biological phenotypic assay results of 
compounds 2 and 16, where molecular modelling results have already indicated a slightly less 
favourable interaction for 16. We suggest that the ketone 3 could be reduced by using 
triethylsilane and trifluoroacetic acid,
97, 98
 where it is proposed that the reduction of the 
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carbonyl to the methylene occurs as a two-step reduction with an alcohol or an alcohol 
derivative as an intermediate (Scheme 33).
99
  Other known reduction methods such as sodium 
borohydride or lithium borohydride,
100, 101
 could also be considered. In either of these 
reductions caution needed to be exercised to prevent the ester from being reduced. 
Scheme 32 
 
Scheme 33 
 
4.2.3. Attempted synthesis of 5-chloro-3-(2-phenylpropan-2-yl)-1H-indole - 19 
With our previous attempt on introducing the cyclopropyl-containing side chain, we were 
able to alkylate the indole, even though the cyclopropyl moiety cleaved open. For this reason 
we proceeded with the Friedel–Crafts alkylation as before. 
Scheme 34 
 
Compound 18 was easily prepared by reacting compound 20 with thionyl chloride, in a 
similar procedure to the preparation of the cyclopropyl derivative 10. In dry acetonitrile 
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at 0°C, 1.2 equivalents of thionyl chloride was added slowly, whereupon the reaction mixture 
was allowed to warm to 30°C and stirred for 18 hours. The product 18 was obtained in a 79% 
yield and purification was not necessary as the crude product that was isolated was pure. 
In the crude infrared spectrum, the broad O-H stretch was absent, and the 
C-H stretch was observed at 2954-2858 cm
-1
. This indicated that the alcohol 
20 was successfully converted to the chloride 18. 
Proceeding with the alkylation (Scheme 35), a 50 mL two-neck round bottom flask was 
charged with dichloroethane and cooled to 0°C. Compounds 9 and 18 were added, followed 
by the addition of 1 equivalent of aluminium chloride. The reaction was warmed to 30°C and 
stirred for 18 hours. The reaction did not proceed and another equivalent aluminium chloride 
was added. With no result, the reaction was heated to 60°C for another 18 hours. This 
reaction did not proceed and the full amount of starting material was recovered (Table 2). 
Scheme 35 
 
Failing in this attempt we considered the other two suggested procedures (Scheme 36). Both 
of these reactions were carried out in nitromethane at 30°C, with only 0.1 equivalents of 
catalyst. With no success in this endeavour, we adjusted the amount of equivalents to 1 each, 
with no success. The indole was thus once more not nucleophilic enough and a new catalyst 
was needed. 
Scheme 36 
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Finally, by returning to the traditional aluminium chloride (1 equivalent) and by changing the 
solvent to nitromethane, we were able to alkylate the indole 9 with compound 20  
(Table 2). However, this reaction was not selective for the 3-position of the indole and two 
products formed. To our surprise, the one product had a higher Rf (Rf = 0.48,  
20% EtOAc/Hexane) than the indole 9 and the other a lower Rf (Rf = 0.19,  
20% EtOAc/Hexane). In light of the fact that the 
1
H NMR spectra were inconclusive in 
elucidating these structures, hampered by difficulties in purification, we decided to try and 
introduce a Boc protecting group onto the indole. We were able to introduce Boc protection 
onto both these compounds, indicating that alkylation possibly occurred at the 2 and  
3-positions of the indole (Scheme 37).  
Scheme 37 
 
 
Table 2 
Different reaction conditions used 
Attempt Reagent used  Solvent Conditions used Result 
1 18, 1 eq AlCl3 DCE 0-30°C, 18h Reaction did not proceed 
2 18, 2 eq AlCl3 DCE 0-60°C, 18h Reaction did not proceed 
3 20, 1 eq FeCl3 MeNO2 0-30°C, 18h Reaction did not proceed 
4 20, 1 eq PTSA MeNO2 0-30°C, 18h Reaction did not proceed 
5 20, 1 eq AlCl3 MeNO2 0-30°C, 18h 2 products formed 
 
To our dismay, we were unable to identify at which position the alkylation occurred for each 
of these compounds. By overlaying the 
1
H NMR spectra to that of the starting material, 
together with the analysis of 2D NMR such as HSQC and Cosy, we suggested that the one 
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with the higher Rf, was the desired product. Moreover, with indoles generally being more 
nucleophilic at the 3-position, this served as more confirmation for this being the desired 
product, since this product was obtained in twice the yield (17%) of the other. However, we 
did not have sufficient proof for this. The aromatic region in the NMR spectra was too 
complex with the presence of impurities. The 
1
H NMR spectra of the Boc protected products 
presented the same problems. 
Interestingly, this reaction proceeded on a maximum scale of 100 mg starting material. In our 
attempts to increase the scale at which the reaction proceeded, the same yields in mass were 
obtained. By combining the yields of three reactions, we were still unable to remove the 
impurities by means of column chromatography and recrystallization. 
 
4.2.4 Attempted synthesis of ethyl 5-chloro-3-(2-phenylpropan-2-yl)- 
1H-indole-2-carboxylate - 17  
In an attempt to investigate as to whether the alkylation occurred at the 2- or 3-position of the 
indole, we now focussed our attention on the ester containing indole 1 for alkylation  
(Scheme 37). We argued that by having the ester at the 2-position of the indole, we would 
eliminate the possibility for alkylation at this position, thereby circumventing the undesired 
side reactions as described above and forming the desired compound 17  cleanly. 
Scheme 38 
 
The reaction was attempted as above with 1 equivalent of aluminium chloride at 30°C for  
18 hours. However, once again we observed that the reaction was not proceeding, as 
monitored by means of TLC, and it was thus heated to reflux for 18 hours. This was 
ineffective and more than 90% of the starting material was recovered.  
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4.2.5 Synthesis of ethyl 3-benzyl-5-chloro-1H-indole-2-carboxylate - 16 
In light of the fact that the Friedel-Crafts alkylation reactions were proving to be problematic, 
we once again returned to the more reliable acylation reaction. In fact, for the synthesis of the 
desired indole 16, which does not contain any functionality to fill the small Val179 pocket, 
only one step was required (Scheme 39). A 100 mL two-neck flask was charged with 
trifluoroacetic acid and cooled to 0°C. The starting reagent 3 was added, followed by the 
addition of triethylsilane. The reaction was allowed to warm to 30°C and was stirred for  
4 hours. Interestingly, by monitoring the reaction by using TLC, we found that the reaction 
did not actually proceed until it was warmed to 30°C. Moreover, in the absence of an organic 
solvent, the product precipitated out and no further purification was required. However, as a 
result of this, a low yield of 32% was obtained, but with a purity of 99.5%, as determined by 
LC-MS. 
Scheme 39 
 
Immediately apparent was the presence of a newly formed singlet 
integrating for 2 at 4.42 ppm for H11 in the 
1
H NMR spectrum, 
clearly a sign that the ketone had been converted to the 
corresponding methylene group. The presence of the ester was 
verified by a quartet integrating for 2 at 4.36 ppm for H9 and a 
triplet integrating for 3 at 1.32 ppm for H10.  
 
Finally, with our first compound synthesised, it was submitted for efficacy evaluation, where 
the inhibition activity (IC50 value) and the toxicity (CC50 value) of this compound were 
determined. 
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4.3 EFFICACY RESULTS 
4.3.1 Procedures for determining the IC50 and CC50 values 
A critical part of this project was the biological evaluation of our target compounds. These 
studies were conducted by our collaborators at the National Institute for Communicable 
Diseases (NICD) in Johannesburg, a division of the National Health Laboratory Services 
(NHLS). Here the phenotypic assays, as well as the toxicity assays, were employed against 
wild type HIV. An in vitro single-cycle, non-replicative phenotypic assay was utilised. For 
the production of virus-like particles (VLPs) an HIV-1 retroviral vector system was used. The 
VLPs, together with the synthesised compounds were subjected to incubation with 293T cells 
for 48 hours. Finally, the inhibition of HIV was evaluated by luminescence  
measurements.
102, 103
 
The phenotypic assay results were reported as the resultant drug concentration needed to 
inhibit the HIV reverse transcriptase activity by 50% (IC50/µM).
104
 The corresponding 
toxicity results were reported as the drug concentration required to reduce the host cell 
number by 50% (CC50/µM), which in this case were human cells.  
 
4.3.2. Efficacy results pertaining to the Val179 binding pocket interactions 
With compound 16 successfully synthesised in high purity, we were able to compare the 
efficacy results obtained with that of compound 2 (Table 3). We found that by omitting the 
cyclopropyl ring, the compound was almost three times less active. This significant reduction 
in activity proves the importance of having an interaction to the NNRTI binding pocket in the 
vicinity of Val179 (Figure 19). 
Table 3 
Efficacy results (IC50/µM and CC50/µM) 
Compound 
  
IC50/µM 0.085±0.015 0.238±0.040 
CC50/µM 30.3±3.3 >100 
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Figure 19 
Compounds 2 (left) and 16 (right) in the NNRTI binding pocket 
  
When we considered the calculated binding energies of these compounds (Table 1), we 
decided that since the difference in the results was small (─65.6820 kcal/mol for 2, and  
─60.4864 kcal/mol for 16), we would not be able to accurately predict which compound 
would be the more effective inhibitor. However, considering that the interaction to the 
Val179 binding pocket is absent for compound 16, we did expect a lower inhibition activity. 
What we did not expect, was that such a small difference in the binding energies would result 
in such a large difference in the efficacy results. This just highlights the important 
contribution of molecular modelling in the design of new compounds. 
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4.4 CONCLUDING REMARKS PERTAINING TO THE VAL179 BINDING POCKET 
INTERACTIONS 
In order for us to examine the importance of the cyclopropyl interaction of compound 2 to the 
NNRTI binding pocket in the vicinity of Val179, we proposed to introduce a similar 
interaction where we would be able to compare the reduced or enhanced inhibition effect. 
Secondly, by omitting the functionality, we would be able to examine the total inhibition 
effect thereof.  
After many attempts on introducing the dimethyl moiety by means of a Friedel-Crafts 
alkylation reaction, we were unable to identify the exact position of alkylation on the indole 
and therefore we cannot definitely say that we have successfully synthesised the products 19 
or 21. Similarly, we were unable to prepare the alkylation product 17 with the presence of the 
ester functionality. 
We were successful in synthesising compound 16 where the interaction in the vicinity of 
Val179 is omitted. By doing so, we were able to compare the efficacy results with that of 
compound 2. A significant decrease in activity was observed. This indicated the importance 
of the hydrophobic interaction to the NNRTI binding pocket in the vicinity of Val179.
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CHAPTER 5 – THE AROMATIC INTERACTION TO TYR181 
5.1 INVESTIGATING THE AROMATIC INTERACTIONS: Π-Π STACKING TO TYR181 
5.1.1 A six membered ring versus a heteroaromatic five membered ring 
In previous designs used, we focussed on modifying bioisosteres for the cyclopropyl ring, 
where we did not make any changes to the phenyl ring, which is known to form a  
π-π interaction to the Tyr181 amino acid side chain. The π-π stacking interaction is known to 
be an important interaction, and previously our group has synthesised a heterocyclic version 
of 2, in the form of thiophene 22 (Table 4).
48
 Interestingly, this compound was as effective at 
inhibiting HIV as the original phenyl containing compound. We therefore saw an opportunity 
to investigate other heterocyclic systems, which would increase the polarity of our inhibitors 
(a much needed characteristic), whilst retaining the binding efficacy. 
Table 4 
Efficacy results (IC50/µM and CC50/µM)
48
 
Compound 
  
IC50/µM 0.085±0.015 0.065±0.21 
CC50/µM 30.3±3.3 67.1±1.8 
 
If one considers the assay data for the two compounds (2 and 22), it is apparent that there is a 
slight increase in activity for the thiophene ring system. This might be that the thiophene ring 
is slightly better accommodated due to the smaller size thereof, or as a result of the slightly 
more polar heterocycle. We considered that if either of these were true, we would expect a 
difference in the binding energy ratio between that of the cyclopropyl and dimethyl moieties 
of the phenyl ring compared to that of the five membered ring systems. Great water solubility 
is a must for all drug candidates for good absorption and permeation.
105
 The calculated 
hydrophobicity parameter (cLogP) of 2 is 5.34 and that of 22 is 5.30.
106, 107
 More ideal cLogP 
values are that of nevirapine (2.29) and that of efavirenz (4.38), with 0 being the most water 
soluble. One thing to consider here is that we would introduce a more polar ring into a 
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hydrophobic pocket. With the two cLogP values being almost identical, we propose that this 
slight difference in activity might be as a result of the smaller ring size that might be better 
accommodated in the binding pocket. 
 
5.1.2 Investigating the ring systems by means of molecular modelling 
In order to investigate the effect of the ring size, we were able to compare the docking of 
compound 17, which contains a phenyl ring, to that of five-membered ring systems in the 
NNRTI binding pocket. We mainly focussed on the dimethyl moiety for the interaction to the 
Val179 binding pocket, since we considered that it would be the most probable to synthesise.  
As mentioned, we would like to introduce more heteroatoms into our molecule for improved 
water solubility. We strategized that a nitrile moiety could be introduced by means of a 
Mannich reaction, which could then be converted into different heterocycles (Scheme 40). 
Scheme 40 
 
Moreover, with us being unable to introduce the dimethyl and the cyclopropyl moieties up 
until now, considering heteroaromatic rings that could be synthesised from a nitrile moiety 
might pose such a possibility (Scheme 41). Nitriles, being high in electronegativity, allows 
for the deprotonation of the adjacent carbon atom. This promotes alkylation at this carbon by 
means of an SN2 mechanism.
108
 We envisaged that for these reasons an oxazole 24, an 
imidazole 25, an oxadiazole 26, or a tetrazole 27 might be suited for the interaction to 
Tyr181. 
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Scheme 41 
 
By analysing the binding energy results (Table 5), we found that with an increased amount of 
heteroatoms in the ring system, poorer binding (thus a higher binding energy) was found. 
However, with these values being very close together, we could argue that these heterocyclic 
rings might be good substitutes for the phenyl ring and would assist in solubilisation. 
Table 5 
Calculated Binding Energies (kcal/mol) 
 
Compound 17 24 25 26 27 
R Ph 
    
Binding Energy 
(kcal/mol) 
─ 68.6419 ─ 64.4570 ─ 66.8705 ─ 60.2564 ─ 60.2720 
 
Interestingly, we found that by overlaying compounds 17 and 24 docked in the binding 
pocket, a perfect overlap was seen, providing no obvious reason as to why a poorer binding 
(thus a higher binding energy) was found. However, by overlaying compounds 17 and 26, it 
was found that the bond angle had shifted, causing the dimethyl moiety not to fit the Val179 
binding pocket perfectly (Figure 20). This might have been as a result of the more 
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hydrophilic oxadiazole ring being somewhat unfavoured in the hydrophobic Tyr181 binding 
pocket, which resulted in an unfavoured binding.  
Figure 20 
Compounds 17 (left) and 26 (right) in the NNRTI binding pocket 
  
 
In investigating the calculated binding energy results for the oxadiazole compounds 26, 30 
and 31 (Table 6), we found that the binding energies were almost the same and therefore we 
could not predict with confidence which compound would be the better inhibitor. However, it 
was noticed that the binding energies of 26 and 31 were almost identical, where that of 30 
was slightly better. This might be as a result of (as discussed above) the oxadiazole ring not 
perfectly fitting the Tyr181 binding pocket, thereby resulting in the dimethyl moiety not 
fitting the Val179 binding pocket perfectly. 
 
Table 6 
Calculated Binding Energies (kcal/mol) 
Compound 
   
Binding Energy 
(kcal/mol) 
─ 60.2564 ─ 62.1151 ─ 60.5256 
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It is thus important to note once again that the molecular modelling simulation results only 
served as a tool to predict the binding of our molecules in the NNRTI binding site. Docked 
molecules were firstly inspected visually before we turned to the binding energy values to 
further refine our results. We were only able to prove our theories once the molecules were 
synthesised and tested for activity. As in any medicinal chemistry project, the synthetic 
aspects are the most important, as the true efficacy of compounds can only be evaluated once 
the compounds are in hand. 
 
5.2 TOWARDS INTRODUCING THE OXADIAZOLE RING 
5.2.1 Introducing the nitrile  
Considering the versatility of a nitrile group in the synthesis of heteroaromatic rings, we 
proposed that a nitrile moiety could easily be introduced by means of the Mannich 
reaction.
108
 This would imply a two-step reaction from the indole 1 to obtain the nitrile 
compound 23, in which case we would be able to investigate the synthesis of heteroaromatic 
rings (Scheme 42). 
Scheme 42 
 
 
5.2.2 The Mannich reaction 
The Mannich reaction is described as a three-component reaction with the addition of 
resonance-stabilised carbon nucleophiles to iminium salts.
109, 110
 It was first published in 1912 
by Mannich and his former PhD student Krösche.
111
 An imine was prepared by condensing 
formaldehyde with ammonia and a compound containing an acidic hydrogen atom such as 
acetic acid. For our purposes, dimethylamine would be used, where an iminium salt would be 
formed. 
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The mechanism for this reaction first involves the nucleophilic attack of the secondary amine 
on fomaldehyde. This addition product is then dehydrated by means of acid-catalysis to form 
the iminium salt (Scheme 43). The indole, being somewhat basic,  is added as nucleophile to 
the salt in order to form and isolate what is called the Mannich base.
112
 Upon obtaining this, 
the amine is methylated and thereby converted to the ammonium ion, which is a good leaving 
group. Finally, on treatment with potassium cyanide, the desired nitrile should be formed. 
Scheme 43 
 
 
 
 
5.2.3 Introduction of the dimethyl and cyclopropyl by means of alkylation 
Our interest in the nitrile was not solemnly to introduce the heteroaromatic rings. As 
mentioned before, due to the electronegativity of the nitrile, this allows for the alkylation of 
the carbon adjacent to the nitrile. In this way, we envisaged that we would be able to 
introduce the dimethyl and the cyclopropyl moieties to obtain compounds 28 and 29  
(Scheme 44).  
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Scheme 44 
 
This alkylation usually takes place via an SN2 reaction, with an anionic intermediate that is 
formed by deprotonation by a strong base (Scheme 45). This is then repeated for the second 
alkylation.
108
 
Scheme 45 
 
 
5.2.4. Introduction of the oxadiazole ring 
Having considered various heterocylces in our modelling studies, we proposed that we would 
be able to easily synthesise an oxadiazole ring as replacement of the phenyl ring. Moreover, 
by considering that we would be able to introduce both the dimethyl and the cyclopropyl 
moieties, introducing the oxadiazole ring would allow us to finally be able to compare the 
activity of these interactions to the NNRTI binding pocket in the presence of the aromatic  
π-π interactions to Tyr181. 
For introducing the oxadiazole ring, we proposed a two-step reaction with an amidoxime 
intermediate (Scheme 46). This could be isolated before continuing to the oxadiazole product, 
by refluxing  in triethyl orthoformate in the presence of  boron trifluoride diethyl etherate.
113
 
In the reaction mechanism, we propose that the amine would act as the nucleophile first, 
where the alcohol acts as the nucleophile in the ring closing step. However, the opposite 
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might also be true, where the alcohol acts as the nucleophile first, and the amine facilitates 
the ring closing. It is likely that the ring forms via both mechanistic routes, and not just via 
one. 
Scheme 46 
 
 
We also considered introducing the oxazole and the imidazole rings at this position. 
However, at this stage it is important to note that this project did not proceed in a linear 
fashion as presented for comfortable reading.  Work presented in this chapter was done at the 
same time as the work presented in the next chapter. We will discuss the synthesis of these 
heteroaromatic ring systems in Chapter 6, as this would allow for greater understanding as to 
why we did not introduce these ring systems as we proposed for the oxadiazole ring. 
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5.2.5 The 1,2,4-oxadiazole ring system 
The synthesis of 1,2,4-oxadiazoles was first reported by Tiemann and Krüger in 1884,
114
 
where the amidoxime intermediate was isolated. Since then, many advances have been made 
in the synthesis of oxadiazoles and the ring system has been widely used in the areas of 
medicinal chemistry and industry.
115-117
 
In the last two decades oxadiazoles have received a considerable amount of attention in drug 
discovery programs with more than 686 patents in the last decade alone.
115
 It has been used to 
contribute to ligand binding and has also been applied as bioisosteres for esters and amides to 
enhance absorption, distribution, metabolism and excretion (ADME) properties.
113, 115
  
With different synthetic routes used, some consistency is maintained since all of these routes 
still have the same basic mechanism in common, where the reaction proceeds via an 
amidoxime intermediate. The most common route to synthesise 1,2,4-oxadiazoles is by 
means of the acylation of the amidoxime, followed by cyclodehydration,
118
 where some of 
the activated carboxylic acid derivatives are acid chlorides, esters, orthoesters and 
anhydrides.
119-122
 Coupling reagents like N,N’-dicyclohexylcarbodiimide (DCC), N,N’-
diisopropylcarbodiimide (DIC) and N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) have also been used in the presence of carboxylic acids.
123-125
 
 Other methods have also been reported, such as the synthesis from amidoximes and nitriles 
with the use of zinc chloride and p-toluenesulphonic acid as catalyst,
126
 the use of platinum as 
catalyst
127
 and also a three-component one-pot microwave-assisted synthesis.
128
  
For the purpose of this project, we decided on the more classical approach, were we would 
proceed via an amidoxime intermediate, followed by the ring closure (Scheme 46). In order 
to finally introduce the 1,2,4-oxadiazole ring system, we first had to synthesise the nitrile-
containing compound 23, and the desired derivatives thereof. 
  
Stellenbosch University  http://scholar.sun.ac.za
Chapter 5 – The aromatic interaction to Tyr181 
_______________________________ 
64 
 
5.3 SYNTHESIS PERTAINING TO THE OXADIAZOLE RING 
5.3.1. Synthesis of 2-(5-chloro-1H-indol-3-yl)acetonitrile – 23 
 
Scheme 47 
 
Having established a viable strategy to not only introduce the heterocyclic ring systems, but 
also to introduce the dimethyl or cyclopropyl moiety, we set about introducing the nitrile 
moiety. To this end, we proceeded with a two-step Mannich reaction where the amine 
(―Mannich base‖) was isolated before the nitrile moiety was introduced (Scheme 47).108  
Diethylamine, glacial acetic acid, formaldehyde and water were added sequentially. The 
starting material 1 was added and the reaction was simply left to stir at room temperature 
(17°C). However, we observed that this reaction did not proceed after a few hours. By 
heating the reaction mixture to 30°C, the reaction went to completion within 2 hours, as 
monitored by means of TLC. Clearly, just slightly more activation energy was needed for this 
reaction to proceed. The amine that was obtained was treated with potassium cyanide and 
methyl iodide to obtain the nitrile compound 23. 
After the workup and purification, a very low yield of 7% was obtained over this 2-step 
synthesis, where Monge et al.
129
 reported a yield of 40%. This low yield obtained (the highest 
yield obtained of three attempts) was not sufficient for us to carry out more reaction steps in 
the synthetic route. 
 
Analysis of the 
1
H NMR spectrum showed the newly formed 
doublet at 4.21 ppm integrating for 2, indicating the presence of 
H11. The ester was still intact and was indicated by a quartet at 
4.48 ppm integrating for 2 for H9 and a multiplet at  
1.51-1.43 ppm integrating for 3 for H10. The result of the mass 
spectral analysis of 263.0581 amu correlated with the expected 
mass of 263.0585 amu. 
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5.3.2 Synthesis of 2-(5-chloro-1H-indol-3-yl)acetonitrile - 32 
 
Scheme 48 
 
With the reaction giving a very low yield with the ester at the 2-position of the indole 1, we 
decided to try a simpler indole system and attempt the Mannich reaction on 5-chloroindole 9 
(Scheme 48). The same reaction conditions and equivalents were used and the desired nitrile 
compound 32 was obtained in a good yield of 85% and with a purity of 80%. With this 
compound being difficult to purify by column chromatography, we first protected the indole 
with p-toluenesulfonyl chloride, purified the protected compound and then deprotected it 
again in order to obtain the product with a purity of 97% as determined by LC-MS. 
 
Analysis of the 
1
H NMR spectrum showed the newly formed doublet at 
4.05 ppm integrating for 2, which indicated the presence of H11. To 
ensure that the reaction occurred at the 3-position of the indole, the 
signal of H2 was observed, which overlapped with that of H7 as a 
multiplet at 7.45-7.39 ppm, integrating for 2. The result of the mass 
spectral analysis of 191.0372 amu correlated with the expected mass of 
191.0376 amu. 
 
This just once again shows how the electronegativity of the ester affects the nucleophilicity of 
the indole and inhibits some reactions to proceed by withdrawing the electrons to itself and 
rendering the 3-position of the indole less nucleophilic. At this stage, we strategized that we 
would be able to continue with the synthetic route as proposed, but without the ester at the  
2-position. This functionality could be introduced later as discussed earlier. 
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5.3.3 Synthesis of tert-butyl 5-chloro-3-(cyanomethyl)-1H-indole-1-carboxylate - 33 
 
Scheme 49 
 
We proposed that before we could introduce the dimethyl or the cyclopropyl group, the 
indole compound 32 needed to be protected to obtain compound 33 in order to prevent 
alkylation of the indole -NH (Scheme 49). A Boc protecting group was easily introduced as 
before by using 1.2 equivalents of di-tert-butyl dicarbonate and a catalytic amount of  
4-dimethylaminopyridine in dry tetrahydrofuran. 
 
The absence of the indole -NH was observed in the 
1
H NMR 
spectrum, indicating the successful protection of the indole nitrogen. 
A singlet at 1.67 ppm integrating for 9 indicated the presence of the 
H22 of the Boc group. The result of the mass spectral analysis of 
291.0905 amu correlated with the expected mass of 291.0900 amu. 
 
5.3.4 Attempted synthesis of tert-butyl 5-chloro-3-(2-cyanopropan-2-yl)- 
1H-indole-1-carboxylate – 34 
 
Scheme 50 
 
In proceeding to prepare the dimethyl 34 by performing an alkylation reaction on 33, we 
strategized that a strong base at low temperatures would be sufficient for the deprotonation to 
occur, followed by the alkylation (Scheme 50).
108
 The base, lithium diisopropylamide was 
therefore prepared in situ. This was done by the slow addition of 1.4M n-butyllithium to 
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diisopropylamine in tetrahydrofuran at ─78°C. The starting material 33 and iodomethane 
were then added and the reaction was allowed to slowly heat to 30°C for 1½ hours (Table 7). 
Unfortunately, under these reaction conditions numerous compounds have formed, as 
determined by means of TLC analysis. 
We considered the temperature to be too high and therefore carried out the reaction at ─78°C, 
without warming it as before. To our dismay, even after leaving the reaction mixture to stir 
overnight while allowing it to slowly warm to room temperature, there was still a significant 
amount of starting material left with the same compounds forming as in the previous reaction. 
After this, we only allowed the reaction to heat to 0°C in the third attempt and once again 
many compounds formed.  
We therefore considered a milder base, lithium hexamethyldisilazane, which was also 
prepared in situ from n-butyllithium and hexamethyldisilazane at ─78°C, where the 
formation of a compound with a lower Rf than that of the starting material was observed by 
means of TLC analysis. We suspected that the protecting group might have been removed, 
and therefore we considered changing the protecting group to one that might be more stable 
under the reaction conditions used. 
Table 7 
Different reaction conditions used 
Attempt Reagents used Solvent 
Time and 
temperature 
Result 
1 5 eq LDA DCE, THF ─78 - 30°C, 1½ h Many compounds formed 
2 5 eq LDA DCE, THF ─78, 18 h 
Many compounds 
formed. Some starting 
material was recovered. 
3 5 eq LDA DCE, THF ─78 - 0°C, 1½ h Many compounds formed 
4 5 eq LHMDS DCE, THF ─78 - 0°C, 18 h Many compounds formed 
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5.3.5 Synthesis of 2-(5-chloro-1-tosyl-1H-indol-3-yl)acetonitrile - 35 
We proposed that after the previous difficulties with the Boc protecting group, we would 
rather consider protecting compound 32 with a tosyl-protecting group to obtain 35  
(Scheme 51). We initially strategized that this could be introduced as before, by using sodium 
hydride in dimethylformamide. However, we learned that this was not ideal since we found 
that the nitrile group decomposed under these reaction conditions. 
Scheme 51 
 
The tosyl protecting group could be introduced by using 1.5 equivalents of sodium hydroxide 
in water and dichloromethane to deprotonate the indole.
130
 After purification by column 
chromatography, a yield of 66% was obtained.  
The new aromatic protons (H21 and H22) were indicated in the  
1
H NMR spectrum by a multiplet at 7.79 - 7.73 ppm integrating for 2 
and a multiplet at 7.29 – 7.24 ppm integrating for 2. The doublet at 
2.36 ppm integrating for 3 served as an indication of H24. The result 
of the mass spectral analysis of 367.0271 amu correlated with the 
expected mass of 367.0284 amu. 
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5.3.6 Synthesis of 2-(5-chloro-1-tosyl-1H-indol-3-yl)-2-methylpropanenitrile - 36 
 
Scheme 52 
 
With the indole protected with a tosyl protecting group, we attempted the alkylation reaction 
once more on 35, with lithium hexamethyldisilazane as base to obtain 36 (Scheme 52). The 
base was prepared as before at ─78°C and was then only allowed to warm to ─20°C for  
2 hours. This time, only two compounds appeared to have formed by TLC, one with a higher 
Rf (Rf = 0.39, 20% EtOAc/Hexane) and one with a lower Rf (Rf = 0.21, 20% EtOAc/Hexane) 
than that of the starting material 35 (Rf = 0.32, 20% EtOAc/Hexane). 
1
H NMR spectroscopic 
analysis showed that the one with the higher Rf was the desired product and it was obtained 
in a yield of 38%. The other compound was compound 37, without the protecting group.  
We expected to see the singly methylated product too, but this was not the case. During the 
reaction, a faint spot was noticed on the TLC between that of the dimethyl product and the 
starting material. However, as soon as the first methylation occured, the second methylation 
was favoured. When all the starting material had been consumed, the faint spot indicating the 
formation of the single methylated product was not present on the TLC anymore. 
With us finally being able to obtain the desired product, it provided proof that the reaction did 
indeed work. However, the reaction conditions were too harsh and as a result, the protecting 
group was removed. By keeping the reaction temperature at ─78°C for 2 hours, only the 
desired product was obtained in a yield of 65%. 
This result was quite a highlight in our project as this was the first time we were able to 
successfully introduce the dimethyl moiety, after many attempts and months of suffering. 
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In terms of characterisation, the newly formed singlet was observed 
in the 
1
H NMR spectrum at 1.80 ppm, integrating for 6. This 
indicated the presence of the dimethyl moiety at H18 and H19. In 
addition, the result of the mass spectral analysis of 395.0609 amu 
correlated with the expected mass of 395.0597 amu. 
 
 
For compound 37, in the 
1
H NMR spectrum, the indole -NH was 
observed at 11.41 ppm as a singlet integrating for 1. The result of the 
mass spectral analysis of 219.0689 amu correlated with the expected 
mass of 219.0689 amu. 
 
5.3.7 Synthesis of 2-(5-chloro-1H-indol-3-yl)-2-methylpropanenitrile - 37 
 
Scheme 53 
 
We strategized, that with the dimethyl compound 36 successfully synthesised, we could 
remove the tosyl protecting group to obtain 37 (Scheme 53), where we could also test the 
activity with only the nitrile group present instead of the aromatic ring. This would allow us 
to just test this interaction in the Val179 binding pocket. 
The tosyl protecting group was easily removed with 4 equivalents of potassium hydroxide in 
dry tetrahydrofuran and dry ethanol at 30°C for 4 hours. The desired product was obtained in 
a yield of 74%, with a 99% purity as determined by LC-MS. 
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As mentioned above, the indole -NH was observed at 11.41 ppm as a 
singlet integrating for 1 in the 
1
H NMR spectrum. The result of the mass 
spectral analysis of 219.0689 amu correlated with the expected mass of 
219.0689 amu. 
 
5.3.8 Synthesis of 1-(5-chloro-1-tosyl-1H-indol-3-yl)cyclopropanecarbonitrile – 38 
 
Scheme 54 
 
With the dimethyl compound 36 successfully synthesised, we proposed that we would be able 
to use the same procedure to obtain the cyclopropyl indole 38 from 35 (Scheme 54). We 
considered that only 6 equivalents LHMDS would be necessary. Once again, two products 
were obtained. We proposed that by introducing the 6 equivalents of base at once might have 
been a bit harsh. As a result, we added the base in two portions, 1 hour apart, in which case 
only the one product was obtained.  
To our dismay, after the reaction workup, the product obtained had the same Rf as the starting 
material. However, with it being a significant amount, we considered reusing this staring 
material 35 after confirming the purity by 
1
H NMR spectroscopic analysis. However, with the 
1
H NMR spectroscopic analysis, we found that this compound was after all our desired 
product 38 in a 43% yield and not the starting material 35. This was indeed a pleasant 
surprise. 
For this compound, the newly formed cyclopropyl was indicated on 
the 
1
H NMR spectrum as two doublet of doublets at 1.70 ppm and  
1.51 ppm, each integrating for 2. The result of the mass spectral 
analysis of 388.0884 amu correlated with the expected mass of 
388.0887 amu. 
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5.3.9 Synthesis of 1-(5-chloro-1H-indol-3-yl)cyclopropanecarbonitrile - 39 
 
Scheme 55 
 
Finally, being able to synthesise compound 38, we could remove the tosyl protecting group to 
obtain 39 (Scheme 55), whereby we would be able to test the cyclopropyl interaction to that 
of the dimethyl in the Val179 binding pocket. The tosyl protecting group was removed as 
with compound 37, and the desired product 39 was obtained in a 76% yield with a purity of 
99% as determined by LC-MS. 
In the 
1
H NMR spectrum, the indole -NH was observed at 11.40 ppm as 
a singlet integrating for 1. The result of the mass spectral analysis of 
217.0533 amu correlated with the expected mass of 217.0533 amu. 
 
 
5.3.10 Attempted synthesis of 3-(2-(5-chloro-1-tosyl-1H-indol-3-yl)propan-2-yl)- 
1,2,4-oxadiazole - 40 
With compounds 35, 36 and 38 in hand, we considered to introduce the oxadiazole ring for 
all three compounds, in which case we would be able to compare the interactions in the 
Val179 binding pocket with the presence of the aromatic interaction to Tyr181. 
Starting from 36, the oxadiazole ring was introduced via a two-step synthesis in order to 
obtain 40 (Scheme 56). The amidoxime intermediate was prepared by refluxing compound 36 
in dry ethanol in the presence of hydroxylamine hydrochloride and potassium carbonate at 
85°C for 18 hours. The intermediate was obtained by filtering the hot reaction mixture and 
washing the salts formed with hot ethanol. The filtrate was concentrated in vacuo to yield the 
amidoxime intermediate as a yellow solid which was dried under vacuum for  
2 hours. 
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Scheme 56 
 
This solid was again dissolved in triethyl orthoformate in a 100 mL two-neck round bottom 
flask fitted with a reflux condenser, upon which boron trifluoride diethyl etherate was added 
slowly. This mixture was refluxed at 100°C for 1 hour to yield the desired product in a yield 
of 35%. Diana et al. reported similar yields for the unsubstituted oxadiazole compounds.
113
 
In the 
1
H NMR spectrum of 40, a broad doublet integrating for 2 at 6.99 ppm was observed. 
This served as an indication that the ring might not have cyclised, in which case this would 
indicate the presence of the amine. If the ring had cyclised, we would have expected a singlet 
integrating for 1. However, the mass spectral analysis did not correlate with the expected 
mass of compound 40, or with that of the amidoxime intermediate. For this reason, we 
concluded that the desired product was thus not obtained.  
 
5.3.11 Attempted synthesis of 3-(2-(1H-tetrazol-5-yl)propan-2-yl)- 
5-chloro-1-tosyl-1H-indole - 41 
With the synthesis of the 1,2,4-oxadiazole ring being unsuccessful, we had to consider 
synthesising one of the other proposed ring systems for the interaction to the Tyr181 binding 
pocket. Based on work discussed in Chapter 6, we decided to synthesise a tetrazole ring for 
the interaction to Tyr181.  
Scheme 57 
 
In synthesising 41 from 36, sodium azide was used, together with ammonium chloride, 
whereupon the reaction was refluxed for 18 hours (Scheme 57). To our dismay, the formation 
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of many by-products was noticed by monitoring the reaction by means of TLC, and the 
desired product 41 was thus not obtained.  
Even though we were unsuccessful in synthesising a heterocyclic ring for the interaction to 
Tyr181, the work discussed in this chapter led to the synthesis of other interesting 
compounds, which were submitted for efficacy evaluation. 
 
5.4 EFFICACY RESULTS 
5.4.1 Efficacy results pertaining to the Val179 interaction 
In analysing the efficacy results of compounds 32, 37, and 39, the compounds were found to 
be inactive and we were unable to directly compare the inhibition activity of these 
compounds (Table 8). However, it was noticed that compound 32 had a slightly more 
favoured toxicity result with a CC50 value of 74.7 ± 5.9 µM. With these three compounds 
being inactive, it just highlights the importance of having more interactions to the NNRTI 
binding site, as all of these interactions contribute to the activity of the compound, forming an 
active inhibitor. 
Table 8 
Efficacy results (IC50/µM and CC50/µM) 
Compound 
   
IC50/µM >27.5 >29.0 >43.0 
CC50/µM 57.813 ± 4.7 51.6 ± 3.7 74.7 ± 5.9 
 
In addition to this, we were also able to synthesise the nitrile compound 23 with the ester 
functionality at the 2-position of the indole, even though the yield was very low. By 
comparing the activity of compound 23 to that of compound 32 (Table 9), we were able to 
investigate the significance of the interaction between the ester functionality and Lys101. By 
omitting the ester functionality, compound 32 was inactive, proving just how much the 
second interaction to Lys101 contributes to the potency of the inhibitor. 
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Table 9 
Efficacy results (IC50/µM and CC50/µM) 
Compound 
  
IC50/µM 19.8 ± 8.8 >43.0 
CC50/µM 125.5 ± 4.8 74.7 ± 5.9 
 
 
5.5 CONCLUDING REMARKS PERTAINING TO THE TYR181 INTERACTION 
In our endeavour to enhance the interactions to the Tyr181 pocket, we were thus unable to 
synthesise a heteroaromatic ring for this interaction. However, in our quest to synthesise the 
heteroaromatic ring systems, we were able to introduce the dimethyl and the cyclopropyl 
moieties. Unfortunately, with the absence of more functionalities for forming interactions to 
the NNRTI binding pocket, these compounds were inactive and we were thus unable to 
compare the interactions of these moieties in the Val179 binding pocket. 
With us being unable to determine the exact inhibition activity of these compounds, it 
highlights the importance of having multiple interactions to the NNRTI binding pocket as 
these interactions contribute to the overall activity of the compound.   
Moreover, we were able to investigate the interaction of the ester functionality at the  
2-position of the indole. We proved that by omitting this interaction, a significant decrease in 
activity was observed. 
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CHAPTER 6 – THE LYS101 INTERACTION 
6.1 KNOWN FUNCTIONALITIES  
6.1.1 The ester functional group 
In previous work, our research team relied on an ester functionality at the 2-position of the 
indole for a second interaction to Lys101 via the carbonyl group (Figure 21).
48
 This 
functional group has proven to be stable in the phenotypic assays, but we expect that this 
would not be the case in vivo as the ester could be hydrolysed to the carboxylate. Upon this, 
our team investigated the activity of the carboxylic acid at the 2-position of the indole. This 
showed a significantly lower activity, where it was suspected that this group inhibits the 
movement of the molecule across cell membranes and thereby prevented the inhibition of the 
HIV reverse transcriptase. With this information available, we strategized that the ideal 
interaction would be similar to that of the ester and the carboxylic acid, but without the 
discussed limitations. In fact, we propose that the ideal functional group for the interaction to 
Lys101 would be a bioisostere of the carboxylate, but one that is not charged, as the 
carboxylate allows for the necessary interactions. 
Figure 21 
Desired Lys101 interactions 
  
Interaction of the ester functional group Interaction of the carboxylate 
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6.1.2 The amide functional group 
A second functional group to consider is an amide at the 2-position of the indole. Many 
examples have been reported with this group contributing in a second interaction to 
Lys101.
48, 49, 52
 We envisaged that this functional group would perform similar interactions as 
the ester functionality (Figure 22), but without having the risk of hydrolysis in vivo. 
Figure 22 
The amide functional group 
 
In addition to this, we strategized that by having this functional group, together with a 
heteroaromatic ring binding in the Tyr181 binding pocket, we would be able to have an 
intramolecular hydrogen bonding interaction between these two functional groups  
(Figure 23). By doing so, we proposed that this would be entropically favoured by holding 
the molecule in the correct conformation for it to bind into the NNRTI binding pocket.  
Figure 23 
Intramolecular hydrogen bonding 
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6.2 CONSIDERING NEW FUNCTIONALITIES  
6.2.1 The heteroaromatic rings 
We proposed that by introducing heteroaromatic rings at the 2-position of the indole, we 
would be able to mimic the Lys101 interaction. Secondly, by introducing these rings, we 
would be able to enhance the water solubility of the molecule; not as much as with the 
carboxylic acid containing compound, but definitely more than that of the ester containing 
compound.  
For the best interaction, we considered the oxazole, thiazole and the 1,2,4-oxadiazole rings. 
The advantage of these ring systems are a hydrogen bond acceptor atom at both ortho 
positions, thereby overcoming the problem of the ring being in the incorrect conformation for 
hydrogen bonding (Figure 24). 
Figure 24 
The oxazole ring at the 2-position of the indole 
  
0° rotation of the oxazole ring 
 
180° rotation of the oxazole ring 
 
In addition to this, we also considered the imidazole and the tetrazole for this interaction. 
When considering the 180° rotation of the ring, we suppose that this would not have an effect 
due to the known tautomerisation of these rings (Figure 25).
131, 132
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Figure 25 
Tautomers of the tetrazole ring 
 
 
6.2.2 Molecular modelling results pertaining to the heteroaromatic rings 
Before synthesising compounds with the heteroaromatic rings at the 2-position, we first 
examined the docking thereof in the NNRTI binding pocket. We strategized that since we 
were able to synthesise compound 16, we would be able to use this scaffold to introduce the 
heteroaromatic rings at the 2-position of the indole, even though the interaction in the Val179 
binding pocket is absent. 
We found that the heteroaromatic ring systems 42-46 docked perfectly (Table 10), forming 
the second Lys101 interaction. Moreover, in analysing the docking of the imidazole and 
tetrazole rings by docking multiple rotations of the ring, we found that in each case the 
desired conformer was obtained.  
Table 10 
Calculated Binding Energies (kcal/mol) 
 
Compound 16 42 43 44 45 46 
R CO2Et 
     
Binding Energy 
(kcal/mol) 
─60.4864 ─50.9358 ─49.8963 ─50.1695 ─50.5324 ─48.1114 
 
Disappointingly, the binding energies of the compounds containing the heteroaromatic rings 
were poorer than that of the ester containing compound 16. However, we strategized that we 
would still consider synthesising some of these ring systems in order to compare the activity 
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results, as these ring systems showed the necessary interactions when analysing the docking 
results visually.  
 
6.3 TOWARDS INTRODUCING THE FUNCTIONAL GROUPS FOR THE INTERACTION TO 
LYS101 
6.3.1 Introducing the amide functional group 
In synthesising the amide 49, we considered that the ester containing indole 1 could first be 
hydrolysed to form the carboxylic acid 47 (Scheme 58).
48
 From there on we strategized to 
synthesise the amide in a one-pot, yet a two-step procedure by forming the acid chloride 48  
in situ and subsequently quenching the reaction with ammonium hydroxide on ice to obtain 
compound 49.
133, 134
 
Scheme 58 
 
 
Similarly, proceeding from compound 16, we would be able to synthesise the amide 
functional group at the 2-position of the indole to obtain 52, with 50 and 51 as intermediates 
(Scheme 59). This would allow us to directly compare the interaction of the amide to that of 
the ester group. 
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Scheme 59 
 
 
 
6.3.2 Introducing the heteroaromatic ring systems 
Once we considered the proposed heteroaromatic rings for synthesis (compounds 42 - 46), we 
realised that all of these could be synthesised from a nitrile group. From this, we suggested 
that the amide 52 could be dehydrated to a nitrile 53 with the use of phosphorus (V) 
oxychloride (Scheme 60).
135, 136
 
Scheme 60 
 
With previous success with the oxadiazole, we proposed that it could be introduced in a 
similar way at the 2-position of the indole to obtain 44 from 53 (Scheme 61). We suggested 
that the oxazole ring could be synthesised from 53, where the proposed reaction mechanism 
proceeds via a ß-hydroxy amide intermediate formed by refluxing compound 53 in the 
presence of sulphuric acid and 2,2-diethoxyethanol, followed by a cyclodehydration to obtain 
42 (Scheme 62).
137-139
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Scheme 61 
 
Scheme 62 
 
For the synthesis of the tetrazole ring 46, we considered a [2+3] ―click‖ chemistry approach 
with the use of sodium azide at relatively high temperatures (Scheme 63).
140
 Many different 
catalysts have been used for this synthesis, including where Das et al. reported the use of 
iodine as catalyst,
141
 and Dianna et al. reported the use of ammonium chloride in 
dimethylformamide for this reaction.
142
 
Scheme 63 
 
 
6.3.3 The oxazole ring 
Oxazoles have attracted significant attention in the area of medicinal chemistry. It was as 
early as Word War II when Cornforth contributed to this field with a significant amount of 
work on the synthesis of these heteroaromatic ring systems, with their research on the 
synthesis of penicillin.
143-146
 Naturally occurring oxazoles were first considered rare up until 
the 1980s where natural products containing these ring systems were isolated from marine 
organisms.
147
 These included products such as mono-oxazole calyculins, bisoxazole 
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hennoxazoles, and trisoxazole ulapualides, upon which Lewis published many review articles 
on this subject.
137, 148, 149
 
Since the first work done by Cornforth on the synthesis of oxazoles, many more procedures 
followed, upon which Turchi and Dewar produced a review article of early work done in this 
regard where the cyclisation mostly proceeded via a dehydration mechanism under harsh 
reaction conditions and high temperatures.
150
 With more than 300 papers published on the 
syntheses within a period of five years, Turchi published another review paper where he 
described more conventional methods for the synthesis of  oxazole rings.
151
 The methods 
described also included classical methods such as the Robinson-Gabriel method in preparing 
oxazoles from the cyclodehydration of 2-acylamino ketones,
152, 153
 and that of the Fisher 
oxazole synthesis in preparing oxazoles by the reaction of aromatic aldehydes with aromatic 
cyanohydrins in strong acid conditions.
154
 More recently the use of milder reaction conditions 
has been reported by means of gold-catalysed heterocycle formations, and also for the 
synthesis of oxazoles.
155-159
 
 
6.3.4 The tetrazole ring 
Among the stable synthetic heterocycles, tetrazoles are the compounds with the highest 
nitrogen content. With the use of these heteroaromatic groups in the photographic industry 
and in the production of special explosives, these compounds served the greatest role in the 
field of medicinal chemistry.
160
 In particular, tetrazole rings are often used as bioisosteres for 
carboxyl groups. However,  it has been shown to be more polar than the carboxyl groups, 
which would affect the movement across cell membranes.
161
 Moreover, when compared to 
other compounds, tetrazole analogues have shown a significantly slow rate of metabolic 
degradation, making these ring systems good candidates to use in drug discovery.
162
 
 The first tetrazole-containing compound, described as a five-membered ring containing  
four nitrogen atoms was synthesised and characterised by Bladin in 1885, where he 
introduced the term ―tetrazole‖ for the first time.163, 164  
In the early years of tetrazole synthesis and also for a very long time to follow, tetrazole rings 
were synthesised with the use of the highly toxic and explosive azoimide and a nitrile 
containing compound.
165, 166
 It was only in 1958 that Finnegan et al. reported the formation of 
tetrazole rings with sodium azide and a nitrile-containing compound in the presence of 
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ammonium chloride as Lewis acid, where only small traces of azoimide was detected.
167
 This 
was a major breakthrough which drastically changed the way tetrazole rings were 
synthesised. Since then, many different methods were developed and the mechanisms 
determined. However, to date, the exact mechanism of the formation of tetrazoles in the 
presence of Lewis acids is still unknown and is only speculated.
160
 
More recent literature on tetrazoles focus on the use of these heteroaromatic rings in the field 
of inorganic chemistry, where the coordination to metals was studied extensively.
168-171
  
In order to introduce new bioisosteres of the ester functionality for an improved interaction to 
Lys101, we proceeded with the synthesis of the heterocyclic rings, together with the synthesis 
of the amide functionality on the 2-position of the indole. 
 
6.4 SYNTHESIS PERTAINING TO THE AMIDE FUNCTIONAL GROUP 
6.4.1 Synthesis of 5-chloro-1H-indole-2-carboxylic acid – 47 
and 3-benzyl-5-chloro-1H-indole-2-carboxylic acid – 50 
In order to hydrolyse the ester functional group to a carboxylic acid, we considered refluxing 
compound 1 in a mixture of ethanol and water in the presence of 4 equivalents of potassium 
hydroxide to obtain 47 (Scheme 64).
48
 The reaction was readily completed within 1½ hours 
and the unreacted starting material was extracted with ethyl acetate. Upon this, the aqueous 
layer was acidified, in which case the product 47 precipitated out. For an optimum yield the 
product was extracted with ethyl acetate, dried on magnesium sulphate and filtered, 
whereupon the solvent was removed to obtain the final product 47 which needed no further 
purification, in quantitative yield.  
Scheme 64 
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Scheme 65 
 
In obtaining 50 from 16, the same reaction procedure was used. This reaction only proceeded 
within a longer reaction time of 2 hours (Scheme 65). The desired product 50 was also 
obtained in a quantitative yield and with a purity of 99%, as determined by LC-MS. 
For compound 47, the absence of the ester group was noticed in the  
1
H NMR spectrum, where in the infrared spectrum, an O-H stretch was 
seen at 3427 cm
-1
. The result of the mass spectral analysis of  
194.0011 amu correlated with the expected mass of 194.0009 amu. 
Similarly for compound 50, the absence of the ester group was noticed 
in the 
1
H NMR spectrum, where in the infrared spectrum, a broad O-H 
stretch was seen at 3029-2600 cm
-1
. The result of the mass spectral 
analysis of 286.0624 amu correlated with the expected mass of 
286.0635 amu. 
 
6.4.2 Synthesis of 5-chloro-1H-indole-2-carboxamide – 49  
and 3-benzyl-5-chloro-1H-indole-2-carboxamide – 52 
In proceeding towards the amide containing compound 49, we first considered introducing a 
chloride atom as a good leaving group, thereby forming the acid chloride intermediate 48 
from 47. This intermediate was then treated with ammonium hydroxide to obtain 49  
(Scheme 66).  
Scheme 66 
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By refluxing compound 47 in a small amount of chloroform and dimethylformamide in the 
presence of excess thionyl chloride 48  was obtained.
134
 Upon completion, the reaction 
mixture was slowly added by means of a dropping funnel to ammonium hydroxide at 0°C, 
where this was left to react while stirring for 2 hours. The amide precipitated out as an 
orange-brown solid which was filtered off and washed with water and then hexane. The 
precipitate was purified by means of column chromatography to obtain the desired product 49 
in an 82% yield and with a purity of 93%, as determined by LC-MS. 
Scheme 67 
 
Once again, in obtaining compound 52 from compound 50 (Scheme 67), the same reaction 
procedure was used, where the desired product 52 was obtained in a yield of 60% and with a 
purity of 93% as determined by LC-MS. 
For compound 49, the infrared spectrum indicated two N-H stretches 
at 3431 cm
-1
 and 3173 cm
-1
. The result of the mass spectral analysis of 
195.0337 amu correlated with the expected mass of 195.0325 amu. 
 
Similarly, for compound 52, the infrared spectrum indicated a broad 
N-H stretch at 3299-3023 cm
-1
. The result of the mass spectral 
analysis of 285.0795 amu correlated with the expected mass of 
285.0800 amu. 
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6.5 SYNTHESIS PERTAINING TO THE HETEROAROMATIC RING SYSTEMS 
6.5.1 Synthesis of 3-benzyl-5-chloro-1H-indole-2-carbonitrile - 53 
For us to consider introducing the heteroaromatic rings at the 2-position of the indole, we 
needed to introduce the nitrile functionality first. We proposed that we might be able to 
introduce these ring systems from this functional group. 
Scheme 68 
 
In obtaining the nitrile containing compound 53, the amide functionality of compound 52 was 
dehydrated by refluxing in dichloroethane in the presence of phosphorus (V) oxychloride 
(Scheme 68).
135
 This reaction proceeded at 85°C for 18 hours to yield the desired product 53 
in a moderate 40% yield. 
In the spectra for this compound, the amide protons‘ signal was no 
longer apparent in the 
1
H NMR spectrum, where the presence of the 
nitrile was clearly indicated by the nitrile stretch in the infrared 
spectrum at 2218 cm
-1
. In accordance with this, the result of the mass 
spectral analysis of 290.2642 amu correlated exactly with the expected 
mass of 290.2642 amu. 
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6.5.2 Attempted synthesis of 3-benzyl-5-chloro-2-(1H-tetrazol-5-yl)-1H-indole – 46 
 
Scheme 69 
 
We proposed that the tetrazole 46 could be synthesised from 53 by refluxing compound 53 in 
dimethylformamide, in the presence of sodium azide and ammonium chloride (Scheme 69). 
Unfortunately, this reaction did not proceed as expected and the formation of many 
by-products was noticed by monitoring the reaction by means of TLC. Here we proposed that 
this might have resulted from the unprotected indole, as the delocalisation of electrons might 
deactivate the nitrile, thereby preventing the reaction to proceed. We propose that the 
electron-withdrawing tosyl protecting group might stabilise the indole system during the 
reaction. 
 
6.5.3 Synthesis of 3-benzyl-5-chloro-1-tosyl-1H-indole-2-carbonitrile – 54 
 
Scheme 70 
 
The tosyl protecting group was thus introduced as before with sodium hydroxide as base to 
obtain 54 from 53 (Scheme 70). Thus, compound 53 was dissolved in a mixture of 
dichloromethane and water, and sodium hydroxide and p-toluenesulfonyl chloride was added. 
This reaction proceeded at 30°C for 18 hours to obtain the desired product 54 in a moderate 
40% yield. 
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In the 
1
H NMR spectrum for compound 54, two signals integrating 
for 4 aromatic protons were seen, together with the singlet integrating 
for 3 at 2.35 ppm, indicating the presence of H24. The result of the 
mass spectral analysis of 421.0782 amu correlated with the expected 
mass of 421.0778 amu. 
 
 
 
6.5.4 Synthesis of 3-benzyl-5-chloro-2-(1H-tetrazol-5-yl)-1H-indole – 46 
 
Scheme 71 
 
Finally, we considered synthesising the tetrazole ring to obtain compound 46 from 54 
(Scheme 71). The nitrile containing compound 55 was thus refluxed in dimethylformamide in 
the presence of ammonium chloride and sodium azide.
142
 The reaction proceeded at 125°C 
for 18 hours, upon which the newly formed tetrazole was observed on the baseline of the 
TLC (40% EtOAc/Hexane). 
We noticed that when analysing the prepared TLC (80% EtOAc/Hexane), the spot on the 
baseline appeared to be at least two compounds. The crude material, suspected to be a 
mixture of the protected and the unprotected product, was subjected to tosyl deprotection 
conditions, where the final product 46 was obtained in a 22% yield over two steps, with a 
purity of 82%, as determined by LC-MS. 
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Of course, in converting the nitrile to the tetrazole, no distinct new 
proton signals were observed in the 
1
H NMR spectrum, providing 
some evidence that the reaction had proceeded, based on differences 
in TLC mobility. However, given that the signals for the other protons 
on the compound had shifted, as well as the result of the mass spectral 
analysis of 310.0859 amu (correlated with the expected mass of 
310.0859 amu), we could safely conclude that the desired product was 
obtained. 
 
6.5.5 Attempted synthesis of 2-(3-benzyl-5-chloro-1H-indol-2-yl)oxazole – 42 
With the indole protected, we considered that fewer by-products would form. We proposed 
that we would be able to synthesise the oxazole 42 from 54 in the presence of  
2,2-diethoxyethanol in strong acidic conditions (Scheme 72).
137
 The 2,2-diethoxyethanol was 
prepared by refluxing 2-bromo-1,1-diethoxyethane in ethanol in the presence of potassium 
hydroxide.
172
 To our dismay, the cyclisation did not occur and an impure amide was isolated. 
We were unable to purify this crude material in order to obtain a clean 
1
H NMR spectrum for 
analysis.  
 
Scheme 72 
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Another procedure was considered by heating compound 54 in 6M sulphuric acid, whereupon 
the amide intermediate was isolated and refluxed in 1,4-dioxane in the presence of 2-bromo-
1,1-diethoxyethane (Scheme 73).
173
 We were unfortunately still unsuccessful in synthesising 
the desired product 42. The amide was again isolated and the ring closure did not occur. We 
proposed that for this reaction, we could have started from the previously synthesised amide, 
but we had more of compound 54 available to test the reaction procedure. 
Scheme 73 
 
 
However, having been able to have synthesised the tetrazole ring for the interaction to 
Lys101, we submitted this compound 46, together with the other interesting compounds 
synthesised in this chapter for efficacy evaluation.  
 
6.6 EFFICACY RESULTS PERTAINING TO THE AMIDE FUNCTIONALITY AND THE 
TETRAZOLE RING 
6.6.1 Comparing the amide and the ester functionalities 
When comparing the activity of the amide-containing compound 52 to that with the ester 
functionality 16, we found quite a significant decrease in activity (Table 11).This difference 
was greater than what we anticipated. Moreover, we were able to obtain the activity results of 
the carboxylic acid-containing compound 50 to prove to what extent the significantly greater 
polarity decreased the activity.  Lastly, and once more, by omitting the phenyl ring we were 
able to show how significant the aromatic interaction to Tyr181 contributes in the inhibition 
activity. 
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Table 11 
Efficacy results (IC50/µM and CC50/µM) 
Compound IC50/µM CC50/µM 
 
0.238 ± 0.04 >100 
 
45.6 ± 5.4 >100 
 
3.11 ± 0.99  22.9 ± 0.3 
 
>15 55.9 ± 0.9 
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6.6.2 The inhibition activity of the tetrazole ring 
When we considered the heteroaromatic rings and investigated the docking by means of 
molecular modelling, we proposed that the compounds with the heteroaromatic rings would 
be less active than that containing the ester functionality. However, the same interactions 
were observed in the NNRTI binding pocket for these compounds.  
When we compared the actual inhibition activity results, the tetrazole 46 was significantly 
less active than that of the ester-containing compound 16 (Table 12). It should be admitted 
that we did not expect such a low activity. Once again this showed what a poor relation a 
difference in the predicted binding energy has to the actual inhibition activity. We proposed 
that this significantly lower activity might have been due to the higher polarity of the ring as 
the tetrazole rings are known for their higher polarities compared to that of carboxylic acids. 
However, the tetrazole showed a significantly greater activity than that of the equally polar 
carboxylic acid 50. This serves as an indication that even though the tetrazole might be too 
polar for a bioisostere, it might still have the preferred interaction to Lys101. Therefore we 
propose that synthesising the oxazole or imidazole in this position, the activity results might 
be more positive. 
Table 12 
Efficacy results (IC50/µM and CC50/µM) 
Compound 
   
IC50/µM 0.238 ± 0.040 45.6 ± 5.4 25.0 ± 2.7 
CC50/µM >100 >100 67.3 ± 1.1 
 
In being unsuccessful in synthesising the oxazole ring, we have thereby considered 
introducing it by means of a Stille coupling reaction, since the reagents were commercially 
available. However, considering the time constraints for this project, we did not have the 
opportunity to synthesise these compounds. 
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6.7 CONCLUDING REMARKS PERTAINING TO CHAPTER 6 
The ester functionality at the 2-position of the indole shows really great inhibition activity; 
however, we propose that it might hydrolyse in vivo. For this reason we embarked on an 
endeavour in finding molecules with similar binding interactions to the NNRTI binding 
pocket, together with the similar or enhanced activity.  
We proposed that by introducing heteroaromatic rings at the 2-position of the indole, we 
would obtain similar results. To our dismay, the tetrazole ring that we were able to synthesise 
in this position, resulted in decreasing the activity significantly, but not as much as the 
equally polar carboxylate. We proposed that this decrease in activity might have been as a 
result of the higher polarity of the ring system in which case the transfer of the molecule 
across cell membranes would be inhibited. For this reason we proposed that the oxazole ring 
might be a better candidate for interacting to Lys101.  
In addition to this, on our route in synthesising the nitrile moiety from which the tetrazole 
ring was synthesised, we were able to test the activity of reaction intermediates. We were 
thus able to compare the activity of the ester functionality to that of the carboxylic acid and 
the amide functionalities. 
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CHAPTER 7 – THE LITTLE BIG EXTRAS 
7.1 THE ALTERNATIVE IDEA 
7.1.1 Moving away from the cyclopropyl moiety 
As every researcher knows, few projects proceed as expected and some goals take longer to 
reach than others. In this project, as mentioned before, the results were not obtained in a 
linear fashion as it is presented in this dissertation. This was mainly due to difficulties 
encountered in our endeavour to complete this project in a timely manner. 
In our quest to synthesise the cyclopropyl moiety, together with finding a suitable scaffold 
with an aromatic interaction to Tyr181 in order to investigate new interactions to Lys101, we 
needed to look into other options in case we were to be unsuccessful in our endeavour. For 
this we strategized that if we were able to synthesise a simpler scaffold without the 
cyclopropyl ring, we would at least be able to compare the proposed functionalities at the  
2-position of the indole relative to each other. 
For this reason we looked into other structural moieties that we could synthesise, instead of 
the cyclopropyl moiety, to form an interaction in the Val179 binding pocket. 
 
7.1.2 The proposed interactions in the Val179 binding pocket 
In our quest in finding other alternatives for the cyclopropyl ring, we first needed to consider 
the size of the Val179 binding pocket, which restricted the size of the moieties we could 
consider to synthesise. Besides from the dimethyl moiety we considered, we also considered 
synthesising a single methyl, ethyl, or methoxy group, and combinations thereof. 
When analysing the molecular modelling results obtained for the methyl and the ethyl 
moieties (Table 13), we found that the dimethyl containing compound 17 had a favoured 
lower binding energy. The diethyl moiety seemed to be too big for this interaction  
(Figure 26), with compound 56 having a calculated binding energy as high as that of 
compound 16. This thus showed that the smaller hydrophobic interaction was indeed 
favoured. 
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Figure 26 
Compounds 17 (left) and 56 (right) in the NNRTI binding pocket 
  
 
However, when we compared the calculated binding energies of the compounds with the 
single methyl and ethyl moieties, we found that in both cases, when only the methyl or ethyl 
moiety were facing to the front of the molecule, the S-enantiomers, the molecules did not 
dock properly (Table 13). It docked in an unfavoured inverted manner with the chlorine atom 
facing to the front of the NNRTI binding pocket and the ester functionality facing to the back. 
Moreover, compound 57-R had a more favoured lower binding energy than that of compound 
57-S. This result was in contradiction with the results discussed above. It seemed that having 
two larger hydrophobic moieties was unfavoured, but only having one was favoured. It might 
be that the two large moieties did not both fit comfortably into the Val179 binding pocket, 
whereas with only one moiety, the bond could slightly rotate to accommodate the single 
moiety into the Val179 binding pocket (Figure 27). 
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Table 13 
Calculated Binding Energies (kcal/mol) 
 
Compound R 
Binding Energy  
(kcal/mol) 
2 
 
─ 65.6820 
16  ─ 60.4864 
17 
 
─ 68.6419 
55-S 
 
Did not dock 
55-R 
 
─ 64.4042 
56 
 
─ 60.5860 
57-S 
 
Did not dock 
57-R 
 
─ 66.3465 
 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 7 – The little big extras 
_______________________________ 
98 
 
Figure 27 
Compounds 56 (left) and 57-R (right) in the NNRTI binding pocket 
  
 
As other research groups have had success in introducing sulphones and sulfoxides for 
interaction in the Val179 binding pocket,
40, 50, 51
 we had to consider as to whether this Val179 
binding pocket is really as hydrophobic in nature as it was claimed to be.
48
 For this reason we 
proposed that if the Val179 binding pocket is more hydrophilic in nature, a polar moiety 
would be favoured over the dimethyl or the ethyl moieties. 
When we introduced the methoxy moiety into the Val179 binding pocket, we noticed a 
significant improvement in the calculated binding energies (Table 14). The binding energy of 
compound 58 with the dimethyl acetal was the same as that of compound 59-S. We found 
that the S-enantiomer of the methoxy indole compound 59-S was favoured as opposed to the 
S-enantiomers of the methyl and ethyl indole compounds. The R-enantiomers of the ethyl and 
methyl indole compounds were again preferred, as opposed to the R-enantiomer of the 
methoxy indole compound 59-R. Interestingly, an even lower binding energy was obtained 
when combining the hydrophobic and hydrophilic moieties. The lowest binding energy was 
obtained for compound 60-S, which contains both the methyl and the methoxy moieties.   
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Table 14 
Calculated Binding Energies (kcal/mol) 
 
Compound R 
Binding Energy 
(kcal/mol) 
58 
 
─ 71.6579 
59-S 
 
─ 71.6452 
59-R 
 
─ 63.8776 
60-S 
 
─ 73.1881 
60-R 
 
─ 68.4295 
 
With these results at hand, compounds 59-S and 60-S showed the most promise, in which 
case we proposed that by synthesising these compounds, we would expect a greater inhibition 
activity result as compared to that of the cyclopropyl-containing compound 2. Moreover, if 
we could synthesise the enatiomerically pure compounds 59-S and 59-R, or be able to 
separate the two enantiomers, we would be able to compare the inhibition activity of the 
separate enantiomers. For the purpose of this project, we first focused on the synthesis of  
59-R/S to test for inhibition activity, before we set on an endeavour to synthesise 60-S, as this 
compound might require an entirely different, and a more challenging synthetic approach to 
synthesise. 
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7.2 TOWARDS COMPOUNDS 59-R/S, AND THE DERIVATIVES THEREOF 
7.2.1 Planned synthesis of compound 59-R/S 
In synthesising the enantiomerically pure compound, we proposed that this could have been 
accomplished by means of a chiral reduction of the ketone 7 by means of the chiral 
oxaborolidine Corey-Bakshi-Shibata catalyst (CBS-catalyst),
174, 175
 followed by treatment 
with dimethyl sulphate or iodomethane to form the methoxy moiety (Scheme 74).
176, 177
 
However, given that we could not find any literature precedence for this reaction on a  
keto-indole system such as 7, we decided to first synthesise the racemic compound and test 
the inhibition activity thereof. If the racemate showed good inhibition activity, we would 
consider spending more time to obtain the enantiomerically pure compounds. 
Scheme 74 
 
We proposed that the reduction could be achieved on 7 with the use of sodium 
borohydride,
178, 179
 a slightly milder reducing agent, to prevent the hydrolysis of the ester 
functionality, followed by methylation with either iodomethane or by means of an  
SN1 reaction with methanol in the presence of p-toluenesulphonic acid (Scheme 75).
180
 
Moreover, we proposed that once we had synthesised the racemic mixture, we would be able 
to convert the enantiomers into diastereomers by protecting the indole 59-R/S with (1R)-(-)-
10-camphorsulphonic acid chloride. By doing this, we hoped to be able to separate the 
diastereomeric compounds by means of preparative column chromatography, after which the 
chiral auxiliary could be removed to obtain the separate enantiomers  
(Scheme 76). 
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Scheme 75 
 
Scheme 76 
 
Similarly, we envisaged that we would be able to form the ethoxy derivative 63-R/S by 
alkylating with an ethyl moiety, where this would allow us to further investigate the size of 
the Val179 binding pocket (Scheme 77). 
Scheme 77 
 
 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 7 – The little big extras 
_______________________________ 
102 
 
We would also be able to synthesise a similar compound without the ester functionality by a 
simpler approach (Scheme 78). In addition, the methoxy indole compound 67-R/S could be 
brominated with treatment of N-bromosuccinimide (NBS), where this would allow for the 
addition of an oxazole ring by means of a Stille or a Sonogashira coupling reaction, and 
would also provide interesting data as we would be able to compare the efficacy of 
compounds 69-R/S and 59-R/S (Scheme 79). 
Scheme 78 
 
Scheme 79 
 
                                                                                
Finally, with the synthetic strategy outlined, we proceeded with the synthesis of these 
compounds, starting with the synthesis of compound 59-R/S. 
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7.3 SYNTHESIS PERTAINING TO COMPOUND 59-R/S  
AND THE DERIVATIVES THEREOF 
7.3.1 Synthesis of R/S-ethyl 5-chloro-3-(hydroxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate – 61-R/S 
 
Scheme 80 
 
In proceeding with the reduction of the ketone 7 to obtain 61-R/S (Scheme 80), compound 7 
was dissolved in a small amount of tetrahydrofuran (2 mL) and methanol (20 mL). This was 
cooled to 0°C by means of an ice-bath before the 3 equivalents sodium borohydride was 
added.
178, 179
 The formation of the product was only seen on TLC once the reaction mixture 
was heated to 30°C. The reaction was stirred for 18 hours until completion, whereupon the 
desired product 61-R/S was obtained in a 57% yield after purification by means of column 
chromatography. 
Analysing the infrared spectrum of this product, a broad O-H 
stretch at 3532-3337 cm
-1
 was observed, indicating the presence 
of the newly formed alcohol.  In the 
1
H NMR spectrum the 
presence of the ester functionality was indicated by a multiplet 
integrating for 2 at 4.52-4.41 ppm for H9, together with a 
multiplet integrating for 3 at 1.45-1.37 ppm for H10. The new 
singlet integrating for 1 at 6.13 ppm served as indication of the 
presence of H11.  
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7.3.2 Synthesis of R/S-ethyl 5-chloro-3-(methoxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate – 62-R/S 
 
Scheme 81 
 
For the methylation step, iodomethane could have been used. However, we proceeded by 
treating 61-R/S with p-toluenesulphonic acid in methanol, where the methoxy moiety was 
introduced via a SN1 mechanism in order to obtain 62-R/S.
180
 The reaction was heated to 
30°C for 18 hours, whereupon a low yield of 38% was obtained.  
It was only after we synthesised both compounds 59-R/S and 71-R/S that we realised that 
with the reaction proceeding via a SN1 mechanism, the protecting group was not necessary. 
Two steps could have been omitted from the synthetic route for introducing and removing the 
protecting group. Moreover, by using iodomethane, the yield would most probably have been 
higher. However, for the use of iodomethane, the indole had to be protected in order to 
prevent methylation at the nitrogen of the indole. 
For this compound, a new signal in the 
1
H NMR spectrum was 
observed as a singlet integrating for 3 at 3.31 ppm for H26. In 
addition, the broad O-H stretch was absent in the infrared 
spectrum, indicating the absence of the alcohol. The result of the 
mass spectral analysis of 520.0988 amu correlated with the 
expected mass of 520.0993 amu. 
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7.3.3 Synthesis of R/S-ethyl 5-chloro-3-(methoxy(phenyl)methyl)- 
1H-indole-2-carboxylate – 59-R/S 
 
Scheme 82 
 
In order to obtain the final compound 59-R/S from 62-R/S, the tosyl protecting group had to 
be removed (Scheme 82), in which case the reaction was conducted as with the general 
procedure used to remove the tosyl protecting group. Upon purification by means of column 
chromatography (20% EtOAc/Hexane), compound 59-R/S was obtained quantitatively with a 
purity of 96%, as determined by means of LC-MS analysis. 
In the 
1
H NMR spectrum for compound 59-R/S, the signals 
indicating the presence of the tosyl protecting group were 
absent, and the presence of H26 was observed as a multiplet 
integrating for 3 at 3.51-3.30 ppm. In addition, the result of the 
mass spectral analysis of 366.0878 amu correlated with the 
expected mass of 366.0873 amu. 
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7.3.4 Synthesis of R/S-ethyl 5-chloro-3-(ethoxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate -70-R/S 
 
Scheme 83 
 
As with synthesising compound 62-R/S, an ethoxy moiety was introduced with the use of 
ethanol as solvent to obtain compound 70-R/S from 61-R/S (Scheme 83). This reaction also 
proceeded at 30°C for 18 hours, but the yield was significantly greater. Compound 70-R/S 
was obtained in an 85% yield using the same reagents and proceeding from the same batch of 
starting material used for synthesising compound 62-R/S. Upon this, we proposed that the 
low yield obtained in the synthesis of compound 62-R/S, might have been as a result of 
moisture still present in the methanol used as solvent. 
In the 
1
H NMR spectrum for compound 70-R/S, the presence of 
the newly formed ethoxy moiety was indicated by a quartet 
integrating for 2 at 4.07 ppm for H26 and a multiplet integrating 
for 3 at 1.22-1.14 ppm for H27. A singlet was observed at  
5.73 ppm, integrating for 1 for H11. The result of the mass spectral 
analysis of 534.1200 amu correlated with the expected mass of 
534.1118 amu. 
 
 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 7 – The little big extras 
_______________________________ 
107 
 
7.3.5 Synthesis of R/S-ethyl 5-chloro-3-(ethoxy(phenyl)methyl)- 
1H-indole-2-carboxylate -71-R/S 
 
Scheme 84 
 
As with the synthesis of compound 59-R/S, the tosyl protecting group present on 70-R/S had 
to be removed in order to test the inhibition activity of the final product 71-R/S (Scheme 84). 
The standard procedure for removing the tosyl protecting group was used, where compound 
70-R/S was exposed to 4 equivalents of potassium hydroxide in dry ethanol and dry 
tetrahydrofuran as solvents. The final product 71-R/S was obtained in a low yield of only 
39% with a purity of 99%, as determined by means of LC-MS analysis. This low yield might 
have been as a result of the hydrolysis of the ester functionality. However, the temperature 
might be too low for this to occur. 
The ethyl moiety was shown to be cleaved by mass spectrometry 
analysis where the result of the mass spectral analysis of  
312.0786 amu correlated with the expected mass of  
312.0791 amu. The presence of the ethoxy moiety was seen in the 
1
H NMR spectrum where a multiplet integrating for 2 at  
3.50-3.37 ppm indicated the presence of H26 and a triplet 
integrating for 3 at 1.15 ppm indicated the presence of H27. 
 
7.3.6 Synthesis of R/S-ethyl 5-chloro-3-(hydroxy(phenyl)methyl)- 
1H-indole-2-carboxylate - 72-R/S 
With the methoxy containing compounds (58-60) having more favoured lower binding 
energies than the methyl (17 and 55-R/S) and ethyl containing compounds (56 and 57-R/S), 
we suspected that it might be due to the slight increase in hydrophobicity. We therefore 
considered synthesising the alcohol 72-R/S from compound 3. 
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Scheme 85 
 
As before, we dissolved compound 3 in dry ethanol and dry tetrahydrofuran. This was cooled 
to 0°C by means of an ice-bath before the sodium borohydride was added, whereupon the 
reaction mixture was heated to 30°C for 18 hours. Compound 72-R/S was subsequently 
obtained in a 53% yield with a purity of 95%, as determined by means of LC-MS analysis. 
 
For this compound, the O-H stretch was observed at 3339 cm
-1
 in 
the infrared spectrum and all the necessary signals were seen in 
the 
1
H NMR spectrum. A broad doublet integrating for 1 at  
5.95 ppm indicated the presence of the alcohol moiety. A doublet 
integrating for 1 at 6.71 ppm indicated the presence of H11 and 
the presence of the ester functionality were indicated with a 
multiplet integrating for 2 at 4.47-4.31 ppm for H9 and a triplet 
integrating for 3 at 1.36 ppm for H10.  
 
 
7.3.7 Synthesis of (5-chloro-1H-indol-3-yl)(phenyl)methanone - 73 
Since we realised that we would have been able to synthesise the methoxy-containing 
compounds without the use of the protecting group, we did not use it for the compounds 
without the ester groups, which shortened the proposed synthetic route to obtain 79-R/S 
(Scheme 86). 
Scheme 86 
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For the synthesis of compound 73, we considered the Friedel-Crafts acylation, as in Chapter 3 
for the synthesis of compound 3, from compound 1 by using aluminium chloride and benzoyl 
chloride (Scheme 87). The reaction mixture was only heated to 40°C and the starting material 
9 was consumed within 1½ hours. 
Scheme 87 
 
In the 
1
H NMR spectrum the presence of the new aromatic ring was 
observed as a multiplet integrating for 2 at 7.83-7.76 ppm together with 
a multiplet integrating for 3 at 7.59-7.51 ppm, where this signal 
overlapped with that of H4. The presence of H2 was observed as a 
doublet at 8.04 ppm, integrating for 1. The result of the mass spectral 
analysis of 256.0518 amu correlated with the expected mass of  
256.0529 amu. 
 
7.3.8 Synthesis of R/S-(5-chloro-1H-indol-3-yl)(phenyl)methanol - 74-R/S 
 
Scheme 88 
 
For reducing the ketone 73 to the alcohol 74-R/S, compound 73 was dissolved in dry 
tetrahydrofuran and dry ethanol, and was treated with sodium borohydride at 0°C to obtain 
74-R/S (Scheme 88). The reaction mixture was heated to 30°C for 18 hours. 
 To our dismay, the product was obtained in a low yield of 33%. We proposed that without  
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the ester group, the compound might be more reactive and we repeated the experiment only at  
0°C. Unfortunately, the reaction did not proceed. Upon this, we considered that the product 
might dissolve in the aqueous layer. We acidified the aqueous layer before we extracted the 
product with ethyl acetate. Still, the same yield was obtained. 
In the 
13
C NMR spectrum of compound 74-R/S, the loss of the ketone 
was observed with the shift of C11 to 31.4 ppm. An O-H stretch was 
observed in the infrared spectrum at 3452 cm
-1
, where the result of the 
mass spectral analysis of 256.0520 amu correlated with the expected 
mass of 256.0529 amu. 
 
7.3.9 Attempted synthesis of R/S-5-chloro-3-(methoxy(phenyl)methyl)- 
1H-indole – 67-R/S 
 
Scheme 89 
 
In attempting the synthesis of compound 67-R/S from 74-R/S, the same reaction procedure 
was used as for synthesising compound 62-R/S with the use of p-toluenesulphonic acid in 
methanol (Scheme 89). By monitoring the reaction by means of TLC, both the presence of 
the starting material 74-R/S and the product 67-R/S was seen. The reaction did not proceed to 
completion. Upon purification of the product 67-R/S by means of column chromatography, a 
low yield of 8% was obtained. This decomposed within a day, where two compounds were 
again seen on the TLC. This product decomposed back to the starting material, where only a 
faint trace of product 67-R/S was observed in the 
1
H NMR spectrum when the signals were 
integrated, and also in the IR spectrum. 
This observed decomposition just shows what a stabilising effect the ester functionality has 
on the indole system by the delocalisation of electrons, as compound 59-R/S is stable with the 
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ester functionality in the 2-position of the indole, and could even be stored at room 
temperature. 
 
7.4 TOWARDS SEPARATING THE DIASTEREOMERS 
7.4.1 Attempted synthesis of ethyl 5-chloro-1-((7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-
1-yl)methylsulfonyl)-3-(methoxy(phenyl)methyl)-1H-indole-2-carboxylate – 77 
We proposed that if we were to introduce a chiral auxiliary onto the indole, diastereomers 
would form, in which case it might be possible to separate these diastereomers.  
(1R)-(-)-10-Camphorsulphonic acid 75-R was thus converted into (1R)-(-)-10-
camphorsulphonic acid chloride 76-R by heating it to 30°C in the presence of thionyl 
chloride (Scheme 90). By monitoring the reaction by means of TLC, it was noted that the 
product 76-R had a significantly higher Rf (Rf = 0.60, 40% EtOAc/Hexane) than the starting 
material, which remained on the baseline of the TLC. 
Scheme 90 
 
In protecting compound 59-R/S with (1R)-(-)-10-camphorsulphonic acid chloride 76-R to 
obtain compound 77 (Scheme 91), we used the same procedure as for protecting the indole 
with tosyl chloride in the presence of sodium hydroxide.  
Scheme 91 
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This reaction proceeded smoothly with the formation of the product, indicated with an Rf of 
0.43 on the TLC plate, just above that of the indole starting material 59-R/S and below that of 
the camphorsulphonic acid chloride 76-R. However, after purification, we realised that the 
product obtained was not compound 77, but rather compound 78. It is possible that 76-R 
converted back to the acid 75-R (or it might be that it was not successfully synthesised in the 
first place, since we do not have sufficient spectroscopic data for this compound), where it 
substituted the methoxy moiety at the proposed position upon cleavage of the methoxy 
moiety (Scheme 92). 
Scheme 92 
 
In the 
1
H NMR spectrum, the indole -NH was observed as a singlet integrating for 1 at  
11.83 ppm. Moreover, the presence of 10 aromatic protons was observed and in addition to 
this, an additional CH2 signal was observed, together with the right amount of CH3 signals. It 
is thus evident that the 
1
H NMR spectrum did not represent that of compound 77. 
With the result of the mass spectral analysis, a mass of 575.2136 amu was found which 
correlated to the calculated mass [M86+NH4]
+
 of 575.1983 amu. However, this mass is not 
within the 5 ppm range of the calculated mass and the signal found in the mass spectrum does 
not adhere to the M+2 rule for chloride atoms. Therefore the signal found does not contain a 
chloride atom and could not represent the mass of compound 77. In addition to this, a mass of 
566.1183 amu was found which adhered to the M+2 rule for chloride atoms. This mass 
correlated to the calculated mass of compound 78 [M87+Na]
+
 of 566.1380 amu. Again this 
mass is not within the 5 ppm range of the calculated mass, but it is more likely the mass of 
compound 78 than that of the proposed mass of compound 77.  
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If this is the case, it would explain the presence of the indole –NH signal in the 1H NMR 
spectrum, in which case we would then have an additional CH3 signal present. The additional 
signals could be due to the presence of impurities or solvents. 
 
7.4.2 Investigating the separation of the diastereomers 
Whether we have obtained compound 77 or 78, we would have expected the diastereomers to 
be separable. However, this was not the case. In our attempt to separate the two diastereomers 
by means of LC-MS separation and analysis, we used an acetonitrile and 0.1% formic acid 
solvent system, where various gradients were tried. Before we proceeded with this analysis, 
we only removed the very polar impurities with column chromatography on silica gel so that 
we could judge our separation according to the other peaks in the obtained UV and MS 
spectra (Figure 28). 
Figure 28 
LC-MS spectra 
 
For the mass of 566.1380 amu, a single peak was seen in the spectra obtained from both the 
UV and MS detectors, but we were unable to separate this peak into a doublet by varying the 
solvent gradient. In all cases a single peak was observed. 
As we were unable to separate the diastereomers, we submitted the synthesised compounds as 
racemic mixtures for efficacy evaluation. 
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7.5 EFFICACY RESULTS PERTAINING TO COMPOUND 59-R/S  
AND THE DERIVATIVES THEREOF 
7.5.1 Comparing the efficacy results obtained 
When we analysed the efficacy results obtained, we were astonished. Not only were we able 
to improve on the IC50 value of 0.1 µM of 2, but we were able to obtain a compound with an 
IC50 value of 1 nM, as active as the most active NNRTI on the market, rilpivirine (Table 15). 
Note that these compounds were tested as racemic compound mixtures, where we expected a 
higher inhibition activity for the one enantiomer and a lower activity for the other. The 
activity results for rilpivirine were obtained with the same assay as was used for determining 
the inhibition activity of our compounds. 
Table 15 
Efficacy results (IC50/µM and CC50/µM) 
 
Compound R IC50/µM CC50/µM 
2 Cyclopropyl 0.085±0.015 30.3±3.3 
59-R/S OMe 0.0008±0.0001 30.0±0.9 
71-R/S OEt 0.033±0.013 22.8±4.1 
72-R/S OH 1.151±0.17 22.7±1.6 
Rilpivirine  0.0013±0.0004  
 
It was noticed that the inhibition activity of compound 71-R/S which contains the ethoxy 
moiety, was significantly less than that of compound 59-R/S which contains the methoxy 
moiety. This indicated that the ethoxy moiety might have been too big for the Val179 binding 
pocket and that we have reached our size limit for this binding pocket. However, the activity 
of compound 71-R/S was indeed greater than that of compound 2 which contains the 
cyclopropyl moiety.  
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Whether this enhanced interaction is due to increased polarity, size, or the slight difference in 
the bond angles, we are not entirely sure. We propose that the size of the moiety together 
with the polarity might be the most probable cause for these improved results. Moreover, we 
suggest that with the methoxy moiety enhancing the inhibition activity significantly, this 
might also be the weakest link in the molecular design, as this moiety was introduced under 
acidic conditions and it cleaved when we introduced the chiral auxiliary. We therefore 
suggest that the methyl moiety might not survive in vivo. It is thus critical to find bioisosteres 
for the methoxy moiety or to introduce other functionalities at this position for interactions in 
the Val179 binding pocket. 
 
7.6 CONCLUDING REMARKS PERTAINING TO CHAPTER 7 
With the work discussed in this chapter at first not being considered as part of the main 
project, we were quite surprised with the results we were able to obtain by just thinking 
outside of the box. Obtaining the 1 nM IC50 value for the methoxy-containing compound  
59-R/S, was merely an eye-opener when we consider the fact that the results obtained in this 
chapter was of racemic compound mixtures. Moreover, with our best compound also having 
the best molecular modelling results, this emphasises the use of molecular modelling as a tool 
in ligand design.  
Finally, with the efficacy results obtained, together with the molecular modelling results, this 
enables us to strategize and bring forth new compounds to synthesise in future projects. We 
thought it wise to bring this project to an end on this high note, as the synthesis of these 
newly designed compounds might require an entirely different synthetic route.  
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CHAPTER 8 – CONCLUSION 
In this project, we were able to investigate three of the main areas of interaction of the 
NNRTI compound to the NNRTI binding pocket, namely the interactions to the Tyr181, the 
Val179, and the Lys101 binding pockets. We were able to produce both positive and negative 
outcomes regarding these interactions. 
For the interaction to the Tyr181 binding pocket, we were unsuccessful in synthesising a 
heterocyclic ring for this interaction and we were thus unable to find an appropriate substitute 
for the phenyl ring. 
In our quest to find an appropriate bioisostere for the ester functionality for the interaction to 
Lys101, we were also unsuccessful. We were able to introduce an amide functionality which 
proved to be less active than the ester functionality, and we were able to synthesise a tetrazole 
ring in this position, which proved to be significantly less active than the ester functionality. 
We proposed that the decreased activity of the tetrazole ring might not have been entirely due 
to a weaker interaction, but that the significant increase in polarity might have had a negative 
effect on the inhibition results as had been observed with the carboxylic acid. 
Lastly, we came across something much more significant. Not only were we able to fully 
investigate the extent of the inhibition effect of the cyclopropyl moiety by synthesising an 
exact compound, compound 16, without any interaction in this position, but we were able to 
increase the activity of our compounds from an IC50 value of 0.1 µM to 1 nM by exchanging 
the cyclopropyl moiety for a methoxy moiety. 
Moreover, the compounds synthesised in Chapter 7, such as the methoxy-containing 
compound 59-R/S, was submitted for efficacy evaluation as racemic mixtures. This opened a 
new research door for our team as we expect the one enantiomer to be significantly more 
active than the other. 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 9 – Future work 
_______________________________ 
117 
 
CHAPTER 9 – FUTURE WORK 
9.1 BUILDING ON POSITIVE RESULTS 
9.1.1 The compound containing the methoxy moiety 
In this project, the methoxy-containing compound 59-R/S and the ethoxy-containing 
compound 71-R/S have shown the greatest inhibition activity, even though these compounds 
were submitted for the efficacy assays as racemic mixtures. It is thus evident that future work 
could sprout from this idea, where a good starting point would be to obtain the R- and the  
S-enantiomers separately. 
A proposed idea was to synthesise the racemic mixture, to protect the indole 59-R/S with a 
chiral auxiliary, and then to separate the resulting diastereomers (Scheme 93). However, by 
means of a quick evaluation of this method in Chapter 7, we realised that this method might 
be tedious. Not only did we find problems with the methoxy moiety cleaving during the 
reaction, but we found that were unable to separate the formed diastereomers by means of 
LC-MS separation. We considered this method first before we went through all the trouble of 
synthesising the racemic mixture in bulk and then trying to separate the diastereomers by 
means of preparative column chromatography. 
Scheme 93 
 
Another proposed idea, was to synthesise the desired enantiomers by means of an 
enantioselective reduction with the use of a CBS-catalyst (Scheme 94).
176, 177
 The R- and the 
S-catalysts are commercially available and could be used to obtain both the R- and the  
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S-enantiomers of the alcohol moiety (61-R and 61-S) in good yield under mild reaction 
conditions.
174
 These catalysts are expensive, but only a small amount is needed for the 
reaction to proceed, and more importantly, the desired enantiomer would be obtained. When 
Corey et al. performed the reduction on various ketones, it was found that reactions that 
proceeded with the S-catalyst mostly produced the S-product.
174
 Finally, iodomethane could 
be used to form the desired methoxy moiety. Moreover, with compound 59-R/S being a 
crystalline white solid, we propose that the separate enantiomers could be purified by 
recrystallization, where the chirality could be confirmed by means of X-ray crystallography. 
Scheme 94 
 
 
9.1.2 The compound containing both the methoxy and the methyl moieties,  
compound 60-S 
With the design of the methoxy containing compound 59-R/S which had an IC50 value of  
1 nM, we have also investigated the binding energy of other compounds. The compound with 
the lowest binding energy found in this project was compound 60-S. For this reason we 
propose that this S-enantiomer could have a greater inhibition activity than that expected for 
the pure S-enantiomer of compound 59-R/S. Moreover, as found with compound 59-R/S, the 
binding energy of the R-enantiomer was significantly higher and therefore we would expect a 
lower inhibition activity than that of the S-enantiomer. 
In synthesising compound 60-R/S, we proposed that by starting from compound 3 we would 
be able to introduce the methyl by means of a Grignard reaction, whereupon the alcohol  
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79-R/S that is formed could be methylated to obtain the methoxy moiety 60-R/S  
(Scheme 95). However, this suggested synthetic route would not produce the pure 
enantiomers as desired. Moreover, by pursuing a quick reaction literature search on the 
Reaxys
®
 search engine, we found no evidence of a Grignard reaction proceeded on this part 
of our molecule or on a ketone located on the adjacent carbon atom of the 3-position of the 
indole.  
Scheme 95 
 
With the on-going struggle encountered in this project to introduce functionalities onto the 
carbons connected to the 2- and 3-positions of the indole, one might reconsider the methods 
used to synthesise indole containing compounds. Another proposed method is to introduce 
the functionalities first, and then to form the indole ring. The only criterion for this synthetic 
route is that the functionalities must be able to withstand the reaction conditions used for the 
ring formation. 
Various different synthetic procedures for the formation of indoles by means of a reductive 
cyclisation have been reported by using palladium catalysts.
181, 182
 However, a milder 
reduction was reported by Fürstner et al. in 1994, where they formed indoles from the 
reduction coupling of oxo amides with the use of titanium (III) chloride as catalyst  
(Scheme 96).
183, 184
 More recently other methods for the formation of indoles by means of a 
reductive cyclisation in the presence of titanium (III) chloride has been reported  
(Scheme 97).
185
 With our compounds, substituents are required at both the 2- and the  
3-position of the indole and the required functionalities might be sensitive to harsh reaction 
conditions. For this reason, considering titanium (III) chloride as catalyst might be the better 
option. 
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Scheme 96 
 
Scheme 97 
 
 
 
9.2 BIOISOSTERES 
9.2.1 Bioisosteres for the methoxy moiety 
The introduction of the methoxy moiety for the interaction in Val179 has shown a significant 
improvement in the inhibition activity of our compounds. However, bearing in mind that this 
moiety was introduced via a reversible SN1 mechanism, this moiety is the Achilles‘ heel in 
our design as it would most likely not survive in vivo. For this reason we have to consider 
using bioisosteres for this moiety.  
Moreover, before we would consider the use of these bioisosteres, a thorough investigation 
should be made to evaluate what makes this methoxy moiety that much more favoured. 
According to the binding energy calculations, the methyl moiety is more favoured than the 
ethyl moiety, and the methoxy moiety is more favoured than the ethoxy moiety. We have 
established that the smaller methoxy moiety is indeed more active than the ethoxy moiety, 
which indicted the size limit for moieties occupying the Val179 binding pocket. In addition to 
this, the methoxy moieties overall had lower binding energies compared to that of the more 
hydrophobic methyl moieties. This served as an indication that the increased polarity might 
be favoured. This could easily be investigated by comparing the activity results of the ethyl 
moiety to that of the methoxy moiety as these two moieties would most likely occupy the 
same space in the Val179 binding pocket (Figure 29). 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 9 – Future work 
_______________________________ 
121 
 
Figure 29 
The methoxy moiety 60-S (left) and the ethyl moiety 57-S (right) in the NNRTI binding pocket 
  
  
When we investigated the space of the Val179 binding pocket by means of the binding 
energy calculations, we have also found that by having a hydrophobic interaction together 
with a polar interaction was favoured, as with compound 61-S (Figure 30). This is also one 
aspect to consider when hunting for new bioisosteres for the methoxy moiety. 
Figure 30 
Compound 61 
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9.2.2 Bioisosteres for the ester functionality 
In our quest in finding an appropriate bioisostere for the ester functionality, we were thus 
unsuccessful. Both the amide functionality and the tetrazole ring that we were to synthesise 
decreased the inhibition activity of our compound. We suspect that this might have been due 
to the increased polarity of these compounds which might have affected the movement across 
cell membranes. 
When we discussed the oxazole and the oxadiazole rings for possible bioisosteres, we have 
shown that we would have expected these ring systems to adhere to the necessary interactions 
to Lys101 while not obstructing the rest of the functionalities of the molecule. However, we 
were unsuccessful to synthesise these ring systems onto the 2-position of the indole. Another 
method to synthesise these compounds, would perhaps be as suggested in the previous 
section by first introducing the functionalities and forming the indole ring, or to first 
introduce the ring systems by means of a Stille coupling reaction and then to introduce the 
rest of the functionalities onto the compound (Scheme 98). We were thus unable to test this 
theory since the reagents that are required for this reaction did not arrive before the 
completion of this project, even though it was ordered well in advance. 
Scheme 98 
 
 
We propose that the polarity of the oxazole ring should not have such a great effect on the 
inhibition activity of the compound since the ring also contains two carbon atoms. The effect 
thereof could be investigated by adding a methyl substituted oxazole ring onto the 2-position 
of the indole (Scheme 99). The size of the substituted moieties should be limited as too large 
substituents might sterically obstruct the other functionalities on other areas of the compound, 
which might also result in a lower inhibition activity. 
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Scheme 99 
 
 
9.3 CONCLUDING REMARKS PERTAINING TO CHAPTER 9 
In this project, the most active compound that we were able to synthesise, compound 59-R/S, 
was submitted for efficacy analysis as a racemic mixture. By separating the two enantiomers, 
we would expect the S-enantiomer to be more active than the R-enantiomer. Moreover, we 
would expect the same for compound 60-S, which was the designed compound with the 
lowest binding energy. Interesting to note, was that the methyl moiety was favoured facing to 
the back of the molecule and the methoxy moiety was favoured facing to the front of the 
molecule. We would expect that compound 60-S having both these moieties, would be more 
active than compound 59-S. 
With the presence of the methyl moiety enhancing the inhibition activity significantly, we 
propose that this is also the Achilles‘ heel of this design. In addition to this, these molecules 
all still have the ester functionality at the 2-position of the indole, for which we were not able 
to find a suitable bioisostere yet. It is thus critical to find bioisosteres for the methoxy moiety 
and the ester functionality in order make these compound valid drug candidates. 
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CHAPTER 10 – EXPERIMENTAL 
10.1 GENERAL PROCEDURES 
10.1.1 Purification of solvents and reagents. 
Chemicals used in these experiments were purchased from Merck or Sigma Aldrich. Solvents 
used for chromatographic purposes were distilled by means of conventional distillation 
procedures. Solvents used for reaction purposes were dried over the appropriate drying agents 
and then distilled under nitrogen gas. Tetrahydrofuran was distilled from sodium metal, using 
benzophenone as indicator. Dichloromethane, dichloroethane, dimethylformamide and 
acetonitrile were distilled from calcium hydride. Ethanol was distilled from magnesium 
turnings and iodine. Diethyl ether was bought with a ≥98% purity grade from Sigma Aldrich 
and then dried on activated 3Å molecular sieves.  
 
10.1.2 Chromatography 
Thin layer chromatography was performed using Merck silica gel 60 F254 coated on 
aluminium sheets. Compounds on the TLC plates were viewed under UV light and if 
necessary stained using prepared solutions of KMnO4, DMP, or ninhydrin, followed by 
heating. 
Column chromatography was performed using Merck silica gel (particle size  
0.063-0.200 mm, 60 Å). 
Compounds submitted for efficacy evaluation (HIV phenotypic assay) were submitted for 
purity determination by means of UPLC-MS by using a 1% formic acid to acetonitrile 
gradient, using a Waters Synapt G2 on a Waters BEH C18, 2.1 x 100 mm column. 
 
10.1.3 Spectroscopic and physical data 
NMR spectra (
1
H, 
13
C, COSY and gHSQC) were recorder on a 300 MHz Varian VNMRS  
(75 MHz for 
13
C), a 400 MHz Varian Unity Inova (101 MHz for 
13
C), or a 600 MHz Varian 
Unity Inova (150 MHz for 
13
C). Chemical shifts (δ) are reported in ppm and J-values are 
given in Hz. 
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Mass spectrometry was performed on a Waters SYNAPT G2. Infrared spectra were recorded 
on a Thermo Nicolet Nexus 470 by means of Attenuated Total Reflectance (ART) mode.  
Melting points were obtained using a Gallenkamp Melting Point Apparatus and are 
uncorrected. 
 
10.1.4 Other general procedures 
All reactions were carried out under a positive pressure of nitrogen gas unless water was used 
as a solvent. The glassware was flame-dried while under vacuum before being purged with 
nitrogen gas. Condensers were pre-dried at 120°C for a minimum of two hours. 
Solvents were removed in vacuo, where we are referring to removal of the bulk solvent using a 
rotary evaporator followed by removal of trace amounts of solvent using a high vacuum pump at 
ca. 0.08 mm Hg. 
 
10.2 EXPERIMENTAL WORK PERTAINING TO CHAPTER 3 
10.2.1 Towards the cyclopropyl indole inhibitor - 2 
10.2.1.1 Ethyl 3-benzoyl-5-chloro-1H-indole-2-carboxylate - 3 
A 100 mL three-neck round bottom flask was fitted with a reflux condenser and charged with 
dry dichloroethane (40 mL). This was cooled to 0°C by means of an ice-bath. Aluminium 
chloride (2 equivalents, 2.38 g, 17.9 mmol) was added, followed by the dropwise addition of 
freshly distilled benzoyl chloride (2 equivalents, 2.08 mL, 17.9 mmol) by means of a syringe. 
The reaction mixture was left to stir for 30 minutes to form a dark orange solution. Ethyl  
5-chloro-1H-indole-2-carboxylate 1 (2.00 g, 8.94 mmol) was added and the reaction mixture 
was refluxed at 85°C for 4 hours.  
The reaction mixture was quenched on ice and a saturated aqueous solution of sodium 
bicarbonate was added to neutralize the reaction mixture. The product was extracted with 
ethyl acetate (3 x 40 mL) and the organic layer was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was concentrated in vacuo to yield the residue that was 
purified by column chromatography (5% EtOAc/Hexane) to afford the title compound 3 
(2.52 g, 7.69 mmol, 86%) (Rf = 0.45, EtOAc/Hexane), as a light yellow powder.  
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Mp 165-167°C. IR (ATR, cm
-1
): 3058-2987 (C-H str), 1692 
(C=O str) and 1641 (C=C str), 1523 (N-H bend), 1449, 1335, 
1256 (C-O str), 1214. 
1
H NMR (300 MHz, CDCl3) δ 9.36 (s, 
1H, H1), 7.86 (m, 2H, ArH), 7.72 (d, J = 1.9 Hz, 1H, H4), 7.61 – 
7.54 (m, 1H, H15), 7.48 – 7.40 (m, 3H, ArH and H7), 7.34  
(dd, J = 8.8, 2.0 Hz, 1H, H6), 4.04 (q, J = 7.1 Hz, 2H, H9), 0.87 (t, 
J = 7.2 Hz, 3H, H10). 
13
C NMR (75 MHz, CDCl3) δ 192.5, 161.1, 139.3, 133.9, 133.2, 129.6, 
128.6, 128.4, 128.3, 127.8, 127.00 (C6), 121.5 (C4), 119.4, 113.2 (C7), 61.9 (C9), 13.5(C10). 
HRMS: calcd for C18H15NO3Cl [M+H]
+
, 328.0740, found 328.0734. 
 
10.2.1.2 1-Tert-butyl 2-ethyl 3-benzoyl-5-chloro-1H-indole-1,2-dicarboxylate - 4 
Ethyl 3-benzoyl-5-chloro-1H-indole-2-carboxylate 3 (1.00 g, 3.05 mmol) and di-tert-butyl 
dicarbonate (1.3 equivalents, 0.91 mL, 4.0 mmol) was added to 20 mL dry tetrahydrofuran in 
a 50 mL two-neck round bottom flask at 30°C. A catalytic amount of  
4-dimethylaminopyridine was added and the reaction mixture was left to stir for 30 minutes 
to form an orange solution. 
The solvent was removed in vacuo to yield the crude indole compound, which was purified 
by column chromatography (5% EtOAc/Hexane) to afford the title compound 4 (1.23 g,  
2.87 mmol, 94%) (Rf = 0.59, 40% EtOAc/Hexane), as a yellow solid. 
Mp 76-78°C. IR (ATR, cm
-1
): 3277-2867(C-H str), 1752 and 
1718(C=O str), 1651(C=C str) 1444, 1353, 1235 (C-O str), 1207, 
1156. 
1
H NMR (300 MHz, CDCl3) δ 8.15 – 8.11 (m, 1H, H7), 
7.85 – 7.80 (m, 2H, ArH), 7.67 – 7.58 (m, 2H, H4 and H15), 7.53 – 
7.45 (m, 2H, ArH), 7.41 (dd, J = 9.0, 2.1 Hz, 1H, H6), 3.95 (q,  
J = 7.2 Hz, 2H, H9), 1.64 (d, J = 4.5 Hz, 9H, H22), 1.09 (t, J = 7.2 
Hz, 3H, H10). 
13
C NMR (75 MHz, CDCl3) δ 191.0, 161.4, 148.4, 
138.5, 134.2, 133.8, 133.4, 130.2, 129.3, 128.7, 128.0, 127.3 (C6), 
121.5 (C4), 121.2, 116.4 (C7), 86.6, 62.4 (C9), 27.9 (C22), 13.6 (C10). HRMS: calcd for 
C23H23NO5Cl [M+H]
+
, 429.1265, found 428.1267. 
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10.2.1.3 1-Tert-butyl 2-ethyl 5-chloro-3-(1-phenylvinyl)-1H-indole-1,2-dicarboxylate - 6 
and  ethyl 5-chloro-3-(1-phenylvinyl)-1H-indole-2-carboxylate - 5  
Dry tetrahydrofuran (20 mL) was pre-cooled to 0°C in a 100 mL three-neck round bottom 
flask fitted with a rubber septum. Methyltriphenylphosphonium bromide (3.5 equivalents, 
876 mg, 2.45 mmol) was added to this, followed by the slow addition of 1.4M n-butyllithium  
(3 equivalents, 1.50 mL, 2.10 mmol). The reaction mixture was heated to 30°C for about  
45 minutes to form the ylide as an orange solution. 
In a separate 100 mL two-neck round bottom flask fitted with a dropping funnel, dry 
tetrahydrofuran (20 mL) was pre-cooled to 0°C by means of an ice-bath and 1-tert-butyl-  
2-ethyl-3–benzoyl-5-chloro-1H-indole-1,2-dicarboxylate 4 (300 mg, 0.701 mmol) was added. 
The ylide mixture was transferred to the dropping funnel by means of a syringe and this was 
then added dropwise into the reaction mixture to leave a milky orange solution. It was slowly 
heated to 30°C for 2 hours until all the starting material has been consumed. 
The reaction was quenched with a saturated aqueous solution of ammonium chloride. The 
products were extracted with ethyl acetate (3 x 30 mL) and the organic layer washed with 
brine, dried over magnesium sulphate and filtered. The solvent was removed in vacuo to yield 
the crude indole compound that was purified by column chromatography  
(5% EtOAc/Hexane) to yield the two desired products, 6 (106 mg, 0.249 mmol, 35%)  
(Rf = 0.57, 20% EtOAc/Hexane), as an yellow oil and 5 (51mg, 0.16 mmol, 22%) (Rf = 0.20, 
20% EtOAc/Hexane), as an yellow powder. 
IR (ATR, cm
-1
): 3053-2980 (C-H str), 1734 (C=O str), 1449, 
1352, 1224 (C-O str), 1154. 
1
H NMR (300 MHz, DMSO-d6) δ 
8.10 – 8.05 (m, 1H, H4), 7.50 (dd, J = 8.9, 2.2 Hz, 1H, H6), 7.37 – 
7.26 (m, 5H, ArH), 7.21 (d, J = 1.8 Hz, 1H, H7), 5.96 (d,  
J = 0.8 Hz, 1H, H18), 5.43 (d, J = 0.7 Hz, 1H, H18), 4.05 – 3.96 
(m, 2H, H9), 1.58 (s, 9H, H22), 1.08 (dd, J = 9.3, 5.0 Hz, 3H, H10).  
13
C NMR (75 MHz, DMSO-d6) δ 160.6, 147.5, 138.4, 137.6, 
133.0, 128.5, 127.9, 127.7, 127.5, 126.1, 125.9, 122.4, 119.4, 
117.7 (C18), 115.9 (C7), 85.2, 60.9 (C9), 26.7 (C22), 13.0 (C10). HRMS: calcd for 
C24H25NO4Cl [M+H]
+
, 426.1472, found 426.1484. 
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Mp 130-132°C. IR (ATR, cm
-1
): 3065-2990 (C-H str), 1678 
(C=O str), 1524 (C=C str), 1458, 1255 (C-O str), 1065. 
1
H NMR 
(600 MHz, DMSO-d6) δ 12.14 (s, 1H, H1), 7.50 (d, J = 8.8 Hz, 
1H, H7), 7.38 (d, J = 2.0 Hz, 1H, H4), 7.30 – 7.22 (m, 6H, H6 and 
ArH), 5.96 (d, J = 1.1 Hz, 1H, H18), 5.32 (d, J = 1.1 Hz, 1H, H18), 
4.01 (q, J = 7.1 Hz, 2H, H9), 0.93 (t, J = 7.1 Hz, 3H, H10).  
13
C NMR (151 MHz, DMSO-d6) δ 161.2, 141.5, 140.8, 135.0, 
128.9, 128.6, 127.9, 126.4, 125.8, 125.6 (C6), 125.4, 121.5, 119.9 (C4), 117.3 (C18), 114.9 
(C7), 60.8 (C9), 14.1 (C10). HRMS: calcd for C19H17NO2Cl [M+H]
+
, 326.0948, found 
326.0947. 
 
10.2.1.4 Attempted synthesis of ethyl 5-chloro-3-(1-phenylcyclopropyl)- 
1H-indole-2-carboxylate - 2 
From 6: 
Dry dichloromethane (5 mL) was pre-cooled to 0°C in a 50 mL three-neck round bottom 
flask fitted with a rubber septum. Diethyl zinc (20 equivalents, 2.82 mL, 2.82 mmol) was 
added dropwise, followed by the gradual addition of glacial acetic acid (20 equivalents,  
0.22 mL, 2.8 mmol) and diiodomethane (20 equivalents, 0.2 mL, 2.8 mmol) in 20 minute 
intervals. After another 20 minutes, 1-tert-butyl 2-ethyl 5-chloro-3-(1-phenylvinyl)-1H-
indole-1,2-dicarboxylate 6 (60 mg, 0.14 mmol) was added and the reaction was left to stir at 
30°C for 1½ hours. 
The reaction was quenched with a saturated aqueous ammonium chloride solution and the 
product extracted with ethyl acetate (3 x 30 mL). The organic layer was washed with brine, 
dried over magnesium sulphate and filtered. The solvent was removed in vacuo to yield the 
crude indole compound which was purified by column chromatography  
(40% EtOAc/Hexane) to afford a mixture of the unprotected starting material 5 and the 
product 2 (Rf = 0.20, 20% EtOAc/Hexane), which we were unable to separate by means of 
column chromatography. 
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From 5: 
The same procedure and same equivalents was used as for preparing 2 from 6. Ethyl  
5-chloro-3-(1-phenylvinyl)-1H-indole-2-carboxylate 5 (46 mg, 0.14 mmol) was used, in 
which case the starting material decomposed. 
 
10.2.2 Introducing the tosyl protecting group 
10.2.2.1 Ethyl 3-benzoyl-5-chloro-1-tosyl-1H-indole-2-carboxylate - 7 
Dry dimethylformamide (5 mL) was pre-cooled to 0°C by means of an ice-bath in a 50 mL 
two-neck round bottom flask. Upon this, 60% sodium hydride (1.5 equivalents, 36.6 mg, 
0.915 mmol) was added, followed by the addition of ethyl 3-benzoyl-5-chloro-1H-indole-2-
carboxylate 3 (200 mg, 0.610 mmol). The reaction mixture was left to stir for 15 minutes, 
whereupon p-toluenesulfonyl chloride (1.2 equivalents, 140 mg, 0.732 mmol) was added and 
the reaction mixture was left to stir at 30°C for 18 hours to form a milky orange suspension. 
The reaction mixture was quenched by pouring it into a mixture of ethyl acetate and saturated 
solution of aqueous sodium bicarbonate. The product was extracted with ethyl acetate  
(3 x 30 mL), whereupon the organic phase was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was concentrated in vacuo to yield the residue that was 
purified by column chromatography (20% EtOAc/Hexane) to afford the title compound 7 
(237 mg, 0.492 mmol, 81%) (Rf = 0.42, 20% EtOAc/Hexane), as a yellow oil. 
IR (ATR, cm
-1
): 3056-2931 (C-H str), 1733 (C=O str), 1653 
(C=C str), 1445, 1375, 1258 (C-O str), 1176. 
1
H NMR (400 
MHz, CDCl3) δ 8.02 – 7.95 (m, 3H, H4 and ArH), 7.76 (m,  
2H, ArH), 7.63 – 7.58 (m, 1H, H15), 7.54 (dd, J = 2.1, 0.5 Hz, 1H, 
H7), 7.49 – 7.43 (m, 2H, ArH), 7.38 (dd, J = 9.0, 2.5 Hz, 1H, H6), 
7.35 – 7.29 (m, 2H, ArH), 4.07 (q, J = 7.2 Hz, 2H, H9), 2.41 (s, 
3H, H24), 1.17 (dd, J = 9.9, 4.4 Hz, 3H, H10). 
13
C NMR (101 
MHz, CDCl3) δ 190.6, 161.1, 146.4, 138.2, 135.0, 134.6, 133.9, 
133.6, 131.0, 130.3, 129.9, 129.4, 129.3, 129.2, 128.9 (C6), 128.8, 
128.0, 127.4, 122.0 (C4), 121.9, 115.9 (C7), 63.1 (C9), 22.0 (C24), 13.7 (C10). HRMS:  calcd 
for C25H21NO5SCl [M+H]
+
, 482.0829, found 482.0822. 
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10.2.2.2 Ethyl 5-chloro-3-(1-phenylvinyl)-1-tosyl-1H-indole-2-carboxylate - 8 
The same procedure was used as for preparing compound 6 in section 8.2.2.3.   
The equivalents used were as follows: methyltriphenylphosphonium bromide  
(3.5 equivalents, 457 mg, 1.28 mmol), 1.4M n-butyllithium (3 equivalents, 0.80 mL,  
1.1 mmol) and ethyl 3-benzoyl-5-chloro-1-tosyl-1H-indole-2-carboxylate 7 (176 mg,  
0.365 mmol) 
The crude indole compound was purified by column chromatography (20% EtOAc/Hexane) 
to yield the two desired product 8 (172 mg, 0.358 mmol, 98%) (Rf = 0.57,  
20% EtOAc/Hexane), as a yellow oil. 
IR (ATR, cm
-1
): 3055-2984 (C-H str), 1729 (C=O str), 1597 
(C=C str), 1445, 1373, 1258 (C-O str), 1174. 
1
H NMR  
(300 MHz, DMSO-d6) δ 8.05 (d, J = 8.9 Hz, 1H, H7), 7.87 (d, 
 J = 8.5 Hz, 2H, ArH), 7.51 (d, J = 2.1 Hz, 1H, H6), 7.48 (t,  
J = 4.9 Hz, 2H, ArH), 7.36 – 7.30 (m, 3H, ArH), 7.23 – 7.17 (m, 
2H, ArH), 7.08 (d, J = 2.0 Hz, 1H, H4), 5.93 (s, 1H, H18), 5.40 (s, 
1H, H18), 4.15 (q, J = 7.1 Hz, 2H, H9), 3.32 (s, 3H, H24), 1.16 (t, 
J = 7.1 Hz, 3H, H10). 
13
C NMR (75 MHz, DMSO-d6) δ 160.4, 
145.7, 137.7, 137.1, 133.2, 132.4, 129.7, 129.7, 129.6, 128.7, 
128.0, 127.9 (C6), 126.5, 125.9, 124.6 (C4), 119.9 (C18), 118.1, 116.1 (C7), 61.6 (C9), 20.6 
(C24), 13.0 (C10). HRMS:  calcd for C26H23NO4SCl [M+H]
+
, 480.1036, found 480.1028. 
 
10.2.2.3 Attempted synthesis of ethyl 5-chloro-3-(1-phenylcyclopropyl)- 
1H-indole-2-carboxylate – 2 
The same procedure was used as for preparing compound 2 from 6 in section 8.2.2.4.   
The equivalents used were as follows: diethyl zinc (20 equivalents, 4.16 mL, 4.16 mmol),  
glacial acetic acid (20 equivalents, 0.32 mL, 4.2 mmol), diiodomethane (20 equivalents,  
0.32 mL, 4.2 mmol) and ethyl 5-chloro-3-(1-phenylvinyl)-1-tosyl-1H-indole-2-carboxylate 8 
(100 mg, 0.208 mmol)  
The reaction did not proceed and the starting material 8 was recovered. 
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10.2.3 Introducing the cyclopropyl by means of the Friedel-Crafts alkylation 
10.2.3.1 Tert-butyldimethyl(1-phenylvinyloxy)silane - 13 
Acetophenone 12 (0.49 mL, 4.2 mmol) was added to dry diethyl ether (5 mL) in a 100 mL  
two-neck round bottom flask and cooled to 0°C by means of an ice-bath. Potassium 
bis(trimethylsilyl)amide (1.2 equivalents, 1.00 g, 4.99 mmol) was added and the reaction was 
left to stir at 30°C for 1 hour. This was again cooled to 0°C and tert-butyldimethylsilyl 
chloride (1.2 equivalents, 753 mg, 4.99 mmol) was added, whereupon the reaction was left to 
stir at 30°C for 18 hours. 
The reaction was quenched with a saturated aqueous ammonium chloride solution and the 
product extracted with diethyl ether (3 x 40 mL). The organic layer was washed with brine, 
dried over magnesium sulphate and filtered. The solvent was removed in vacuo to yield the 
crude indole compound. Due to decomposition, this product was not purified and used as is 
for the next synthetic step. 
For analytical purposes, this was purified by column chromatography (3% EtOAc/Hexane to 
afford the title compound 13 (317 mg, 1.35 mmol, 33%) (Rf = 0.68, 5% EtOAc/Hexane), as a 
colourless oil. 
IR (ATR, cm
-1
): 2956-2859 (C-H str), 1613 (C=C str), 1467, 1309, 
1257 (C-O str). 
1
H NMR (400 MHz, DMSO-d6) δ 7.62 – 7.57 (m, 
2H, ArH), 7.40 – 7.29 (m, 3H, ArH), 5.01 (d, J = 1.9 Hz, 1H, H18), 
4.42 (d, J = 1.9 Hz, 1H, H18), 0.99 – 0.94 (m, 9H, H22), 0.21 – 0.18 
(m, 6H, H20). 
13
C NMR (101 MHz, DMSO-d6) δ 154.9, 137.0, 133.2, 128.7, 128.4, 128.3, 
128.1, 124.8, 91.3 (C18), 25.7 (C22), 18.0 (C20). HRMS:  calcd for C14H23OSi [M+H]
+
, 
235.1518, found 235.1523. 
 
10.2.3.2 Tert-butyldimethyl(1-phenylcyclopropoxy)silane - 14 
Dry diethyl ether (5 mL) was pre-cooled to 0°C in a 100 mL two-neck round bottom flask 
fitted with a rubber septum. Diethyl zinc (11.5 equivalents, 14.7 mL, 1.47 mmol) was added 
dropwise, followed by the gradual addition of diiodomethane (11 equivalents, 1.1 mL,  
1.4 mmol). Tert-butyldimethyl(1-phenylvinyloxy)silane 13 (300 mg, 1.28 mmol) was added 
and the reaction was left to stir at 30°C for 2 hours. 
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The reaction was quenched with a saturated aqueous ammonium chloride solution and the 
product extracted with diethyl ether (3 x 30 mL). The organic layer was washed with brine, 
dried over magnesium sulphate and filtered. The solvent was removed in vacuo to yield the 
crude indole compound which was purified by column chromatography (3% EtOAc/Hexane) 
to afford the title compound 14 (312 mg, 1.25 mmol, 98%) (Rf = 0.56, 5% EtOAc/Hexane) as 
a colourless oil. 
IR (ATR, cm
-1
): 2954-2858 (C-H str), 1458, 1243 (C-O str), 1029. 
1
H NMR (400 MHz, DMSO-d6) δ 7.33 – 7.17 (m, 5H, ArH), 1.10 
(m, 2H, CprH), 1.03 – 0.95 (m, 2H, CprH), 0.87 – 0.81 (m, 9H, 
H22), 0.00 – 0.07 (m, 6H, H20). 
13
C NMR (101 MHz, DMSO-d6) δ 
146.0, 144.2, 128.0, 127.8, 126.2, 125.3, 123.8, 57.7, 25.8 (C22), 18.1 (C20), 16.4 (CprC). 
HRMS: calcd for C15H25OSi [M+H]+, 249.1675, found 249.1666. 
 
10.2.3.3 (1-Chlorocyclopropyl)benzene – 10 
A 50 mL two-neck round bottom flask was charged with trimethyl 
(1-phenylcyclopropoxy)silane 14 (232 mg, 1.12 mmol) and dry acetonitrile (10 mL). This 
was cooled to ─15°C by means of an acetone ice-bath before the slow addition of thionyl 
chloride (1.2 equivalents, 0.10 mL, 1.4 mmol). The reaction mixture was allowed to slowly 
heat to 0°C for 30 minutes to form a pale yellow solution. 
The product was extracted with diethyl ether (3 x 30 mL) and the organic layer was washed 
with a saturated aqueous solution of sodium bicarbonate (20 mL). The organic layer was 
washed with brine, dried over magnesium sulphate and filtered, whereupon the solvent was 
removed in vacuo to yield the crude product 10 (125 mg, 0.889 mmol, 79%) (Rf = 0.66,  
5% EtOAc/Hexane), as a clear oil. 
1
H NMR (400 MHz, CDCl3) δ 7.37 – 7.25 (m, 5H, ArH), 1.28 – 1.23 (m, 
2H, CprH), 1.06 – 1.01 (m, 2H, CprH). 
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10.2.3.4 Attempted synthesis of 5-chloro-3-(1-phenylcyclopropyl)-1H-indole – 11 
A 50 mL two-neck round bottom flask was charged with dry dichloromethane (10 mL) and 
was cooled to 0°C by means of an ice-bath. To this was added 5-chloroindole 9 (108 mg, 
0.711 mmol) and (1-chlorocyclopropyl)benzene 10 (1 equivalent, 100 mg, 0.711 mmol). 
Aluminium chloride (1 equivalent, 95 mg, 0.71 mmol) was added and the reaction was left to 
stir for 12 hours at 30°C. 
The reaction was quenched with water on ice and extracted with ethyl acetate. The organic 
layer was washed with a saturated aqueous solution of sodium bicarbonate (20 mL) and 
brine, dried over magnesium sulphate and filtered. Upon workup, three compounds was seen 
on the TLC (Rf = 0.12, 0.31, 0.53, 20% EtOAc/Hexane). The solvent was removed in vacuo 
and the three compounds formed were separated by column chromatography  
(10% EtOAc/Hexane), where product 15 (23 mg, 0.085 mmol) (Rf = 0.12,  
20% EtOAc/Hexane), with the cleaved cyclopropyl ring, was isolated as a racemic mixture.  
1
H NMR (400 MHz, CDCl3) δ 8.00 (s, 1H, H1), 7.59 (d, J = 7.6 Hz, 
1H, ArH), 7.37 (d, J = 8.1 Hz, 1H, ArH), 7.23 – 7.16 (m, 2H, ArH), 
7.12 – 7.03 (m, 3H, ArH), 6.75 (t, J = 7.4 Hz, 1H, ArH), 6.67 (d,  
J = 7.7 Hz, 1H, ArH), 5.26 (t, J = 8.7 Hz, 1H, H11), 3.48 (m, 1H, H18a), 
3.21 (m, 1H, H18b), 1.25 (t, 3H, H19). 
 
 
10.3 EXPERIMENTAL WORK PERTAINING TO CHAPTER 4 
10.3.1 Introducing the dimethyl interaction in the Val179 binding pocket and omitting 
this interaction. 
10.3.1.1 (2-Chloropropan-2-yl)benzene – 18 
A 100 mL two-necked round bottom flask was charged with 2-phenylpropan-2-ol 20  
(500 mg, 3.67 mmol) and dry acetonitrile (10 mL). This was cooled to 0°C by means of in 
ice-bath for the addition of thionyl chloride (1.2 equivalents, 0.30 mL, 4.4 mmol). The 
reaction mixture was allowed to heat to 30°C for 18 hours to form a pale yellow solution. 
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The product was extracted with diethyl ether (3 x 30 mL) and the organic layer was washed 
with a saturated aqueous solution of sodium bicarbonate (20 mL) and brine This was dried 
over magnesium sulphate and filtered, whereupon the solvent was removed in vacuo to yield 
the crude product 18 (397 mg, 2.91 mmol, 79%) (Rf = 0.79, 20% EtOAc/Hexane), as an off 
white solid. 
 IR (ATR, cm
-1
): 2954-2858 (C-H str), 1458, 1243, 1029. 
 
 
10.3.1.2 Attempted synthesis of 5-chloro-3-(2-phenylpropan-2-yl)-1H-indole – 19 
With aluminium chloride in dichloroethane: 
A 50 mL two-neck round bottom flask was charged with dry dichloromethane (10 mL) and 
cooled to 0°C by means of an ice-bath. To this was added 5-chloroindole 9 (108 mg,  
0.711 mmol) and (1-chlorocyclopropyl)benzene 18 (1 equivalent, 100 mg, 0.711 mmol). 
Aluminium chloride (1 equivalent, 95 mg, 0.71 mmol) was added and the reaction was left to 
stir at 30°C for 18 hours. 
This reaction did not proceed and another equivalent of aluminium chloride was added. The 
reaction was again heater to 30°C for 4 hours. With no result, the reaction mixture was heated 
to for 18 hours. The reaction did not proceed and the starting material was recovered. 
 
With iron(III) chloride in nitromethane: 
The same procedure was used as above with nitromethane (10 mL) as solvent.  
The equivalents used were as follows: 5-chloroindole 9 (108 mg, 0.711 mmol),  
2-phenylpropan-2-ol 20 (1 equivalent, 97 mg, 0.71 mmol) and iron(III) chloride  
(1 equivalent, 115 mg, 0.711 mmol). 
The reaction did not proceed and the starting material was recovered. 
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With p-toluenesulphonic acid in nitromethane: 
The same procedure was used as above with nitromethane (10 mL) as solvent.  
The equivalents used were as follows: 5-chloroindole 9 (108 mg, 0.711 mmol),  
2-phenylpropan-2-ol 20 (1 equivalent, 97 mg, 0.71 mmol) and p-toluenesulphonic acid 
monohydrate (1 equivalent, 135 mg, 0.711 mmol). 
The reaction did not proceed and the starting material was recovered. 
 
With aluminium chloride in nitromethane: 
The same procedure was used as above with nitromethane (10 mL) as solvent at 30°C for  
18 hours. The equivalents used were as follows: 5-chloroindole 9 (108 mg, 0.711 mmol),  
2-phenylpropan-2-ol 20 (1 equivalent, 97 mg, 0.71 mmol) and aluminium chloride  
(1 equivalent, 95 mg, 0.71 mmol). 
The reaction was quenched with water on ice and extracted with ethyl acetate. The organic 
layer was washed with a saturated aqueous solution of sodium bicarbonate (20 mL) and 
brine, dried over magnesium sulphate and filtered. The solvent was removed in vacuo and the 
compounds formed were separated by column chromatography (10% EtOAc/Hexane) to 
yield the two compounds (33 mg, 0.12 mmol, 17% )(Rf = 0.48, 20% EtOAc/Hexane) and  
(15 mg, 0.054 mmol, 8% )(Rf = 0.19, 20% EtOAc/Hexane) as white powders. 
We were thus unable to definitely identify which product was the desired alkylation product 
by analysing the 
1
H NMR spectrum due to impurities in the aromatic region. 
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10.3.1.3 Attempted synthesis of ethyl 5-chloro-3-(2-phenylpropan-2-yl)- 
1H-indole-2-carboxylate – 17 
The same procedure was used as above for preparing compound 19 with aluminium chloride 
in nitromethane in section 8.3.1.2.   
The equivalents used were as follows: ethyl 5-chloro-1H-indole-2-carboxylate 1 (159 mg, 
0.711 mmol), 2-phenylpropan-2-ol 20 (1 equivalent, 97 mg, 0.71 mmol) and aluminium 
chloride (1 equivalent, 95 mg, 0.71 mmol). 
The reaction did not proceed and all of the starting material 1 was recovered. 
 
10.3.1.4 Ethyl 3-benzyl-5-chloro-1H-indole-2-carboxylate -16 
A 50 mL two-neck round bottom flask was charged with trifuoroacetic acid (10 mL) and 
cooled to 0°C by means of an ice-bath. Ethyl 3-benzoyl-5-chloro-1H-indole-2-carboxylate 3 
(2.90 g, 8.80 mmol) was added, followed by the addition of triethylsilane (20 equivalents, 
28.1 mL, 176 mmol). The reaction mixture was heated to 30°C for 4 h until all of the starting 
material was consumed. Upon completion, the yellow precipitate that formed was filtered off 
and washed with hexane. No further purification was needed to afford the product 16  
(900 mg, 2.87 mmol, 32%) as a pale yellow powder with a purity of 99% as determined by 
LC-MS. 
Mp 203-204°C. IR (ATR, cm
-1
): 3300 (N-H str), 2980-2898  
(C-H str), 1678 (C=O str), 1603 (C=C str), 1541 (N-H bend), 
1455, 1381, 1256 (C-O str), 1202. 
1
H NMR (300 MHz,  
DMSO-d6) δ 11.84 (s, 1H, H1), 7.67 (d, J = 2.0 Hz, 1H, H7), 7.44 
(d, J = 8.8 Hz, 1H, H6), 7.29 – 7.19 (m, 5H, H4 and ArH), 7.17 – 
7.09 (m, 1H, H15), 4.42 (s, 2H, H11), 4.36 (q, J = 7.1 Hz, 2H, H9), 
1.32 (t, J = 7.1 Hz, 3H, H10). 
13
C NMR (75 MHz, DMSO-d6) δ 161.5, 141.0, 134.7, 128.2, 
128.2, 128.1, 125.8, 125.1, 124.7, 124.6, 121.1, 119.7 (C7), 114.3 (C6), 60.5 (C9), 29.6 (C11), 
14.2 (C10). HRMS: calcd for C18H17NO2Cl [M+H]
+
, 314.0948, found: 314.0956. 
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10.4 EXPERIMENTAL WORK PERTAINING TO CHAPTER 5 
10.4.1 Introducing the nitrile and interactions in the Val179 binding pocket 
10.4.1.1 Ethyl 5-chloro-3-(cyanomethyl)-1H-indole-2-carboxylate – 23 
A 100 mL round bottom flask was charged with diethylamine (1 equivalent, 0.20 mL,  
2.2 mmol), followed by the sequential addition of glacial acetic acid (2.4 equivalents,  
0.30 mL, 5.4 mmol), 37% formaldehyde in water (3.6 equivalents, 0.23 mL, 8.1 mmol), and 
water (0.5 mL). Ethyl 5-chloro-1H-indole-2-carboxylate 1 (500 mg, 2.24 mmol) was added 
and the reaction mixture was heated to 30°C for 2 hours. Upon completion, the reaction 
mixture was basified with 1M sodium hydroxide. The product was extracted with ethyl 
acetate (3 x 40 mL) and the organic layer was washed with brine, dried over magnesium 
sulphate and filtered. The filtrate was concentrated in vacuo to yield the crude amine as a 
yellow solid. 
This was dissolved in methanol (5 mL) in a 100 mL round bottom flask. Potassium cyanide 
(2.5 equivalents, 368 mg, 5.69 mmol) was dissolved in water (0.5 mL) and added to the 
reaction mixture, followed by the addition of iodomethane (3 equivalents, 0.40 mL,  
6.8 mmol). This was heated to 30°C for 18 hours.    
Upon completion, the product was extracted with ethyl acetate (3 x 40 mL) and the organic 
layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(20% EtOAc/Hexane) to afford the title compound 23 (41 mg, 0.16 mmol, 7%) (Rf = 0.46, 
40% EtOAc/Hexane), as a white powder. 
Mp 194-196. IR (ATR, cm
-1
): 3341 (N-H str), 2995-2930  
(C-H str), 2249 (C≡N str), 1673 (C=O str), 1541 (N-H bend), 
1459, 1380, 1338, 1248 (C-O str). 
1
H NMR (300 MHz, CDCl3) 
δ 8.98 (s, 1H, H1), 7.77 (dd, J = 1.7, 0.8 Hz, 1H, H4), 7.35 (dd,  
J = 2.5, 1.3 Hz, 2H, H7 and H6)), 4.48 (q, J = 7.1 Hz, 2H, H9), 4.21 (d, J = 1.6 Hz, 2H, H11), 
1.51 – 1.43 (m, 3H, H10). 
13
C NMR (75 MHz, CDCl3) δ 161.1, 127.8, 127.4 (C6), 127.1, 
119.6 (C4), 113.5 (C7), 110.4, 62.0 (C9), 14.5 (C10), 13.7 (C11). HRMS: calcd for 
C13H12N2O2Cl [M+H]
+
, 263.0585, found 263.0581. 
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10.4.1.2 2-(5-Chloro-1H-indol-3-yl)acetonitrile – 32 
The same procedure was used as above for preparing compound 23 in section 8.4.1.1.   
The equivalents used were as follows: diethylamine (1 equivalent, 1.80 mL, 16.5 mmol), 
glacial acetic acid (2.3 equivalents, 2.20 mL, 38.6 mmol), 37% formaldehyde in water  
(3.4 equivalents, 1.70 mL, 59.2 mmol), water (4 mL), 5-chloroindole 9 (2.50 g, 16.5 mmol), 
methanol (40 mL), potassium cyanide (2.5 equivalents, 2.70 g, 41.2 mmol), water (3 mL) and 
iodomethane (5.21 equivalents, 5.10 mL, 85.9 mmol). 
The residue obtained was purified by column chromatography (20% EtOAc/Hexane) to 
afford the title compound 32 (2.70 g, 14.1 mmol, 85%) (Rf = 0.17, 20% EtOAc/Hexane), as 
an orange powder. 
Mp 107-109°C. IR (ATR, cm
-1
): 3359 (N-H str), 3085-2924  
(C-H str), 2251 (C≡N str), 1718, 1662, 1573, 1463. 1H NMR  
(300 MHz, DMSO-d6) δ 11.32 (s, 1H, H1)), 7.65 (d, J = 2.1 Hz, 1H, 
H4), 7.45 – 7.39 (m, 2H, H7 and H2), 7.14 (dd, J = 8.6, 2.1 Hz, 1H, 
H6), 4.05 (d, J = 0.8 Hz, 2H, H11). 
13
C NMR (75 MHz, DMSO-d6) δ 134.7, 127.1, 125.9 
(C2), 123.7, 121.6 (C6), 119.4 (C4), 117.4, 113.4 (C7), 103.7, 13.1 (C11). HRMS: calcd for 
C10H8N2Cl [M+H]
+
, 191.0376, found 191.0372. 
 
10.4.1.3 Tert-butyl 5-chloro-3-(cyanomethyl)-1H-indole-1-carboxylate - 33 
2-(5-Chloro-1H-indol-3-yl)acetonitrile 32 (950 mg, 4.98 mmol) and di-tert-butyl dicarbonate 
(1.2 equivalents, 1.40 mL, 5.98 mmol) was added to dry tetrahydrofuran (20 mL) in a 50 mL 
two-neck round bottom flask at 30°C. A catalytic amount of 4-dimethylaminopyridine was 
added and the reaction mixture was heated to 30°C for 30 minutes to form a clear orange 
solution. 
The solvent was removed in vacuo to yield the crude indole compound, which was purified 
by column chromatography (10% EtOAc/Hexane) to afford the title compound 33 (1.00 g, 
3.44 mmol, 69%) (Rf = 0.51, 20% EtOAc/Hexane), as a yellow solid. 
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Mp 91-95°C. IR (ATR, cm
-1
): 2985-2939 (C-H str), 1725 (C=O str), 
1597 (C=C str), 1451, 1368, 1251 (C-O str), 1154, 1062. 
1
H NMR  
(400 MHz, CDCl3) δ 8.10 (d, J = 8.8 Hz, 1H, H7), 7.66 (s, 1H, H2), 
7.49 (d, J = 1.7 Hz, 1H, H4), 7.33 (dd, J = 8.9, 2.0 Hz, 1H, H6), 3.80 – 
3.67 (m, 2H, H11), 1.67 (s, 9H, H22). 
13
C NMR (101 MHz, cdcl3) δ 
129.8, 129.0, 125.7 (C2), 125.6 (C6), 118.1 (C4), 116.9 (C7), 116.8, 
109.0, 84.9, 28.3 (C22), 14.4, 14.4 (C11). HRMS:  calcd for C15H16N2O2Cl [M+H]
+
, 291.0900, 
found 291.0905. 
 
10.4.1.4 Attempted synthesis of tert-butyl 5-chloro-3-(2-cyanopropan-2-yl)- 
1H-indole-1-carboxylate – 34 
A 50 mL two-neck round bottom flask was fitted with a rubber septum and charged with dry 
tetrahydrofuran (5 mL.) which was cooled to ─78°C by means of an acetone and dry ice bath. 
To this was added 1.4M n-butyllithium (4.5 equivalents, 3.50 mL, 5.21 mmol), followed by 
the slow addition of diisopropylamine (4.5 equivalents, 0.73 mL, 5.2 mmol). The reaction 
mixture was left to stir for 15 minutes. 
In a separate 100 mL three-neck flask fitted with a rubber septum, 2-(5-chloro-1-tosyl-1H-
indol-3-yl)acetonitrile 33 (400 mg, 1.16 mmol) was dissolved in dry tetrahydrofuran (5 mL) 
and cooled to ─78°C. The base was added dropwise by means of a syringe and the dark red 
reaction mixture was left to stir for 15 minutes. Iodomethane (3 equivalents, 0.30 mL,  
3.5 mmol) was added and the reaction was left allowed to heat to 30°C for 2 hours. 
This resulted in the formation of many by-products. We repeated the reaction and left the 
reaction mixture at ─78°C for 12 hours, we found a significant amount of starting material 
was still left and the same by-products formed again. Upon this, we considered using a milder 
base, lithium hexamethyldisilazane. Once again, the same by-products formed. 
 
10.4.1.5 2-(5-Chloro-1-tosyl-1H-indol-3-yl)acetonitrile - 35 
A 100 mL round bottom flask was charged with dichloromethane (10 mL) and water (2 mL).  
2-(5-chloro-1H-indol-3-yl)acetonitrile 32 (200 mg, 1.05 mmol), sodium hydroxide  
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(1.5 equivalents, 63 mg, 1.6 mmol) and p-toluenesulfonyl chloride (1.5 equivalents, 293 mg, 
1.57 mmol) was added and the reaction was allowed to stir at 30°C for 4 hours. 
Upon completion, the reaction was quenched with water. The product was extracted with 
ethyl acetate (3 x 30 mL) and the organic layer was washed with ammonium chloride and 
brine, dried over magnesium sulphate and filtered. The filtrate was concentrated in vacuo to 
yield the residue that was purified by column chromatography (10% EtOAc/Hexane) to 
afford the title compound 35 (239 mg, 0.693 mmol, 66%) (Rf = 0.46, 20 EtOAc/Hexane), as 
an orange powder. 
Mp 154-157°C. IR (ATR, cm
-1
): 3175-2932 (C-H str), 2261  
(C≡N str), 1593 (C=C str), 1443, 1370, 1293, 1169, 1121, 1093. 
 
1
H NMR (300 MHz, CDCl3) δ 7.94 (dd, J = 8.9, 0.5 Hz, 1H, H7), 
7.79 – 7.73 (m, 2H, ArH), 7.63 (t, J = 1.2 Hz, 1H, H2), 7.47 (d,  
J = 1.7 Hz, 1H, H4), 7.34 (dd, J = 8.9, 2.0 Hz, 1H, H6), 7.29 – 7.24 
(m, 2H, ArH), 3.71 (d, J = 1.2 Hz, 2H, H11), 2.36 (d, J = 6.1 Hz, 3H, 
H24). 
13
C NMR (75 MHz, CDCl3) δ 145.7, 134.7, 133.5, 130.2, 
129.9, 129.7, 126.9, 125.9 (C6), 125.8 (C2), 118.6 (C4), 116.3, 115.0 (C7), 110.8, 21.6, 14.4 
(C11).  HRMS: cacld for C17H13N2O2SClNa [M+Na]
+
, 367.0284, found 367.0271. 
 
10.4.1.6 Purification of 2-(5-chloro-1H-indol-3-yl)acetonitrile – 32  
2-(5-Chloro-1-tosyl-1H-indol-3-yl)acetonitrile 35 (150 mg, 0.435 mmol) was dissolved in dry 
tetrahydrofuran (10 mL) and dry ethanol (5 mL) in a 50 mL two-neck round bottom flask. 
Potassium hydroxide was added (4 equivalents, 97 mg, 1.7 mmol) and the reaction was 
heated to 30°C for 6 hours. 
The reaction was quenched with a saturated aqueous solution of ammonium chloride  
(20 mL). The product was extracted with ethyl acetate (3 x 20 mL) and the organic layer was 
washed with brine, dried over magnesium sulphate and filtered. The filtrate was concentrated 
in vacuo to yield the residue that was purified by column chromatography  
(10% EtOAc/Hexane) to afford the title compound 32 (64 mg, 0.34 mmol, 79%) (Rf = 0.17, 
20% EtOAc/Hexane), as an orange powder with a purity of 97% as determined by means of 
LC-MS. 
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Mp 107-109°C. IR (ATR, cm
-1
): 3359 (N-H str), 3085-2924  
(C-H str), 2251 (C≡N str), 1718, 1662, 1573, 1463. 1H NMR  
(300 MHz, DMSO-d6) δ 11.32 (s, 1H, H1)), 7.65 (d, J = 2.1 Hz, 1H, 
H4), 7.45 – 7.39 (m, 2H, H7 and H2), 7.14 (dd, J = 8.6, 2.1 Hz, 1H, H6), 
4.05 (d, J = 0.8 Hz, 2H, H11). 
13
C NMR (75 MHz, DMSO-d6) δ 134.7, 127.1, 125.9 (C2), 
123.7, 121.6 (C6), 119.4 (C4), 117.4, 113.4 (C7), 103.7, 13.1 (C11). HRMS: calcd for 
C10H8N2Cl [M+H]
+
, 191.0376, found 191.0372. 
 
10.4.1.7 2-(5-Chloro-1-tosyl-1H-indol-3-yl)-2-methylpropanenitrile – 36 
A 50 mL two-neck round bottom flask was fitted with a rubber septum and charged with dry 
tetrahydrofuran (5 mL) which was cooled to ─78°C by means of an acetone and dry ice bath. 
To this was added 1.4M n-butyllithium (4.5 equivalents, 3.50 mL, 5.21 mmol), followed by 
the slow addition of hexamethyldisilazane (4.5 equivalents, 1.20 mL, 5.21 mmol). The 
reaction mixture was left to stir for 15 minutes. 
In a separate 100 mL three-neck flask fitted with a rubber septum, 2-(5-chloro-1-tosyl-1H-
indol-3-yl)acetonitrile 35 (400 mg, 1.16 mmol) was dissolved in dry tetrahydrofuran (5 mL) 
and cooled to ─78°C. The base was added dropwise by means of a syringe and the dark red 
reaction mixture was left to stir for 15 minutes. Iodomethane (3 equivalents, 0.30 mL,  
3.5 mmol) was added and the reaction was allowed to heat to ambient temperature for  
2 hours. 
The reaction was quenched with a saturated aqueous solution of ammonium chloride  
(20 mL). The product was extracted with ethyl acetate (3 x 20 mL) and the organic layer was 
washed with brine, dried over magnesium sulphate and filtered. The filtrate was concentrated 
in vacuo to yield the residue that was purified by column chromatography  
(20% EtOAc/Hexane) to afford the title compound 36 (281 mg, 0.750 mmol, 65%)  
(Rf = 0.57, 40% EtOAc/Hexane), as a white solid. 
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Mp 137-138°C. IR (ATR, cm
-1
): 3138-3102 (C-H str), 2990 (C≡N str), 
1597 (C=C str), 1449, 1369, 1306, 1158, 1092. 
1
H NMR (300 MHz, 
CDCl3) δ 7.92 (d, J = 8.9 Hz, 1H, H7), 7.79 – 7.72 (m, 3H, H4 and 
ArH)), 7.51 (s, 1H, H2), 7.32 (dd, J = 8.9, 2.0 Hz, 1H, H6), 7.30 – 7.24 
(m, 2H, ArH), 2.38 (s, 3H, H24), 1.80 (s, 6H, H18 and H19). 
13
C NMR 
(75 MHz, CDCl3) δ 145.7, 134.7, 134.0, 130.2, 129.5, 128.7, 126.9, 
125.6 (C6), 123.5 (C2), 123.0, 122.4, 120.1 (C4), 115.0 (C7), 30.9, 30.9, 
27.4 (C18 and C19), 21.6 (C24). HRMS: calcd for C19H17N2O2SClNa [M+Na]
+
, 395.0597, 
found 395.0609. 
 
10.4.1.8 2-(5-Chloro-1H-indol-3-yl)-2-methylpropanenitrile – 37 
The same procedure was used as for preparing compound 32 from 35 in section 8.4.1.6.   
The equivalents used were as follows: tetrahydrofuran (10 mL), dry ethanol (5 mL), 
potassium hydroxide (4 equivalents, 90 mg, 1.6 mmol), 2-(5-chloro-1-tosyl-1H-indol-3-yl)-2-
methylpropanenitrile 36 (150 mg, 0.402 mmol).  
The residue that was isolated was purified by column chromatography (10% EtOAc/Hexane) 
to afford the title compound 37 (65 mg, 0.30 mmol, 74%) (Rf = 0.37, 40% EtOAc/Hexane), 
as a clear oil with a purity of 99% as determined by LC-MS. 
IR (ATR, cm
-1
): 3352 (N-H str), 2983-2930 (C-H str), 2232 (C≡N str), 
1568, 1463, 1338. 
1
H NMR (300 MHz, DMSO-d6) δ 11.41 (s, 1H, 
H1), 7.71 (d, J = 2.0 Hz, 1H, H4), 7.47 – 7.40 (m, 2H, H2 and H7), 7.19 
– 7.13 (m, 1H, H6), 1.76 (s, 6H, H18 and H19). 
13
C NMR (75 MHz, 
DMSO-d6) δ 135.4, 125.3, 124.5 (C2), 123.9, 123.7, 121.6 (C6), 117.9 
(C4), 115.0, 113.7 (C7), 30.4, 27.3 (C18 and C19). HRMS:  calcd for C12H12N2Cl [M+H]
+
, 
219.0689, found 219.0689. 
 
10.4.1.9 1-(5-Chloro-1-tosyl-1H-indol-3-yl)cyclopropanecarbonitrile – 38 
A 50 mL two-neck round bottom flask fitted with a rubber septum was charged with dry 
tetrahydrofuran which was cooled to ─78°C by means of an acetone and dry ice bath. To this 
was added 1.4M n-butyllithium (6 equivalents, 4.90 mL, 6.96 mmol), followed by the slow 
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addition of hexamethyldisilazane (6 equivalents, 1.40 mL, 6.96 mmol). The reaction was left 
to stir for 15 minutes. 
In a separate 100 mL three-neck flask fitted with a rubber septum, 2-(5-chloro-1-tosyl-1H-
indol-3-yl)acetonitrile 35 (400 mg, 1.16 mmol) was dissolved in dry tetrahydrofuran (5 mL) 
and cooled to ─78°C. One half of the base was added dropwise by means of a syringe and the 
dark red reaction mixture was left to stir for 15 minutes. 1,2-Dibromoethane (3 equivalents,  
0.30 mL, 3.5 mmol) was added and the reaction was left to stir for 2 hours. The rest of the 
base was added and the reaction mixture was stirred for 12 hours. 
The reaction was quenched with a saturated aqueous solution of ammonium chloride  
(20 mL). The product was extracted with ethyl acetate (3 x 20 mL) and the organic layer was 
washed with brine, dried over magnesium sulphate and filtered. The filtrate was concentrated 
in vacuo to yield the residue that was purified by column chromatography  
(20% EtOAc/Hexane) to afford the title compound 38 (186 mg, 0.500 mmol, 43%)  
(Rf = 0.60, 40% EtOAc/Hexane), as a yellow powder. 
Mp 188-120°C. IR (ATR, cm
-1
): 3118-3053 (C-H str), 2238 (C≡N str), 
1595 (C=C str), 1447, 1367, 1189-1146 (S=O). 
1
H NMR (300 MHz, 
DMSO-d6) δ 8.02 (s, 1H, H2), 7.96 (d, J = 8.9 Hz, 1H, H7), 7.94 – 7.86 
(m, 2H, ArH), 7.79 (d, J = 1.8 Hz, 1H, H4), 7.44 (m, 3H, H6 and 
ArH),2.33 (s, 3H, H24), 1.70 (dd, J = 7.7, 4.7 Hz, 2H, CprH), 1.51(dd, 
J= 7.8,5.0 Hz, 2H, CprH). 
13
C NMR (75 MHz, DMSO-d6) δ 146.1, 
133.7, 132.8, 130.5 (C2), 130.4, 128.5, 127.1, 127.0, 125.5 (C6), 122.0, 
118.8 (C4), 117.5, 115.2 (C7), 21.1 (C24), 15.4 (CprC), 4.7. HRMS: calcd for C19H19N3O2SCl 
[M+NH4]
+
, 388.0887, found 388.0884. 
 
10.4.1.10 1-(5-Chloro-1H-indol-3-yl)cyclopropanecarbonitrile - 39 
The same procedure was used as for preparing compound 32 from 35 in section 8.4.1.6.   
The equivalents used were as follows: tetrahydrofuran (10 mL), dry ethanol (5 mL), 
potassium hydroxide (4 equivalents, 103 mg, 1.83 mmol), 1-(5-chloro-1-tosyl-1H-indol-3-yl) 
cyclopropanecarbonitrile 38 (170 mg, 0.458 mmol). 
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The residue that was isolated was purified by column chromatography (10% EtOAc/Hexane) 
to afford the title compound 39 (77 mg, 0.36 mmol, 76%) (Rf = 0.40, 40% EtOAc/Hexane), 
as yellow crystals with a purity of 99% as determined by LC-MS. 
Mp 148-152°C. IR (ATR, cm
-1
): 3345 (N-H str), 3127-3013 (C-H str), 
2234 (C≡N str), 1680 (C=C str), 1572 (N-H bend), 1454, 1426, 1295. 
1
H NMR (300 MHz, DMSO-d6) δ 11.40 (s, 1H, H1), 7.70 – 7.64 (m, 
1H, H4), 7.48 (s, 1H, H2), 7.42 (dd, J = 7.8, 2.6 Hz, 1H, H7), 7.16 (dd, 
 J = 8.6, 2.1 Hz, 1H, H6), 1.74 – 1.52 (m, CprH), 1.47 – 1.17 (m, 2H, CprH).  
13
C NMR (75 MHz, DMSO-d6) δ 134.8, 127.4, 126.4 (C2), 124.0, 123.2, 121.9 (C6),  
117.1 (C4), 113.7 (C7), 109.9, 15.1 (CprC), 5.0. HRMS: calcd for C12H10N2Cl [M+H]
+
, 
217.0533, found 217.0533. 
10.4.2 Towards the heterocyclic rings 
10.4.2.1 Attempted synthesis of 3-(2-(5-Chloro-1-tosyl-1H-indol-3-yl)propan-2-yl)- 
1,2,4-oxadiazole – 40 
A 100 mL two-neck flask was fitted with a reflux condenser and was charged with dry 
ethanol (20 mL). To this was added 2-(5-chloro-1-tosyl-1H-indol-3-yl)-2-
methylpropanenitrile 36 (400 mg, 1.07 mmol), potassium carbonate (5 equivalents, 739 mg, 
5.35 mmol) and hydroxylamine hydrochloride (5 equivalents, 372 mg, 5.35 mmol). The 
reaction mixture was refluxed at 85°C for 12 hours, whereupon the hot reaction mixture was 
filtered and the solids washed with hot ethanol (20 mL). The filtrate was concentrated in 
vacuo to yield the amidoxime as a yellow solid. 
This was added to triethyl orthoformate (20 mL) in a 100 mL two-neck round bottom flask 
fitted with a reflux condenser. Boron trifluoride diethyl etherate (0.35 equivalents, 0.05 mL, 
0.4 mmol) was added slowly and the reaction mixture was heated to reflux at 100°C for 
1 hour. 
Upon completion, the product was extracted with ethyl acetate (3 x 20 mL) and the organic 
layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(20% EtOAc/Hexane). Unfortunately, the desired compound was thus not obtained. 
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10.4.2.2 Attempted synthesis of 3-(2-(1H-tetrazol-5-yl)propan-2-yl)- 
5-chloro-1-tosyl-1H-indole – 41 
A 100 mL two-neck round bottom flask was charged with dry dimethylformamide (10 mL).  
2-(5-Chloro-1-tosyl-1H-indol-3-yl)-2-methylpropanenitrile 36 (205 mg, 0.594 mmol), 
ammonium chloride (6 equivalents, 193 mg, 3.60 mmol) and sodium azide (6 equivalents, 
234 mg, 3.60 mmol) was added, whereupon the reaction mixture was refluxed at 125°C for 
18 hours. 
Unfortunately, this reaction did not proceed as desired as many by-products formed as 
monitored by means of TLC. 
 
10.5 EXPERIMENTAL WORK PERTAINING TO CHAPTER 6 
10.5.1 Synthesis of the amide functionality 
10.5.1.1 5-Chloro-1H-indole-2-carboxylic acid – 47 
Into a 100 mL two-neck flask fitted with a reflux condenser, ethyl 5-chloro-1H-indole-2-
carboxylate 1 (500 mg, 2.24 mmol) and potassium hydroxide (4 equivalents, 501 mg,  
8.94 mmol) was dissolved in a mixture of ethanol (20 mL) and distilled water (8 mL). The 
reaction mixture was refluxed for 1 ½ hours at 85°C. 
Upon completion, the reaction mixture was diluted with water (30 mL) and the starting 
material was extracted with ethyl acetate (2 x 30 mL). The aqueous layer was acidified with 
6M hydrochloric acid and the product was extracted with ethyl acetate (3 x 30 mL). The 
organic layer was dried over magnesium sulphate and filtered, whereupon the solvent was 
concentrated in vacuo to obtain the product 47 as a white solid in quantitative yield  
(Rf = 0.00, 40% EtOAc/Hexane), that needed no further purification. 
Mp 296-298°C. IR (ATR, cm
-1
): 3427 (O-H str), 3133-2359  
(C-H str), 1651(C=O str), 1534 (C=C str), 1435, 1325, 1252.  
1
H NMR (300 MHz, DMSO-d6) δ 11.96 (s, 1H, H1), 7.71 (d,  
J = 2.1 Hz, 1H, H4), 7.44 (dd, J = 8.8, 0.7 Hz, 1H, H7), 7.24 (dd,  
J = 8.8, 2.1 Hz, 1H, H6), 7.07 (dd, J = 2.2, 0.8 Hz, 1H, H3). 
13
C NMR 
(75 MHz, DMSO-d6) δ 162.5, 135.6, 129.9, 127.8, 124.4 (C6), 121.0 (C4), 114.1 (C7), 106.8 
(C3). HRMS: calcd for C9H5NO2Cl [M-H]
+
, 194.0009, found 194.0011. 
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10.5.1.2 3-Benzyl-5-chloro-1H-indole-2-carboxylic acid – 50 
The same procedure was used as above for preparing compound 47 from 1 in section 8.5.1.1.   
The equivalents used were as follows: ethyl 3-benzyl-5-chloro-1H-indole-2-carboxylate 16 
(2.00 g, 6.37 mmol), potassium hydroxide (4 equivalents, 1.43 g, 25.5 mmol), ethanol  
(20 mL), water (8 mL). The reaction mixture was refluxed for 2 hours at 85°C. 
The product 50 was obtained as a white solid in quantitative yield (Rf = 0.00,  
20% EtOAc/Hexane) with a purity of 99% as determined by LC-MS. 
Mp 270-273°C. IR (ATR, cm
-1
): 3393 (N-H str), 3029-2600  
(O-H str), 2595-2352 (C-H str), 1661 (C=O str and C=C str), 1548 
(N-H bend), 1440, 1331, 1250 (C-O str). 
1
H NMR (300 MHz, 
DMSO-d6) δ 11.72 (s, 1H, H1), 7.60 (d, J = 2.0 Hz, 1H, H4), 7.40 (d, 
J = 8.8 Hz, 1H, H7), 7.29 – 7.17 (m, 5H, H6 and ArH), 7.16 – 7.09 (m, 
1H, H15), 4.42 (s, 2H, H11). 
13
C NMR (75 MHz, DMSO-d6) δ 163.1, 
141.2, 134.5, 128.2, 125.7 (C15), 124.7 (C6), 124.0, 120.5 (C4), 119.6, 114.2 (C7), 29.5 (C11). 
HRMS:  calcd for C16H13NO2Cl [M+H]
+
, 286.0635, found 286.0624. 
 
10.5.1.3 5-Chloro-1H-indole-2-carboxamide – 49 
A 100 mL two-neck flask was fitted with a reflux condenser, upon which 5-chloro-1H-
indole-2-carboxylic acid 47 (100 mg, 0.511 mmol) and thionyl chloride (15 mL) was added 
to a mixture of chloroform (5 mL) and dimethylformamide (0.25 mL). The reaction mixture 
was refluxed at 75°C for 18 hours. 
Upon completion, the reaction mixture was added dropwise into a 600 mL beaker charged 
with ammonium hydroxide (35 mL) and ice (15 mL), which was allowed to react while 
stirring for 2 hours. An orange-brown precipitate formed that was filtered off and washed 
with water and then hexane. This residue that was isolated was purified by column 
chromatography (80% EtOAc/Hexane) to afford the title compound 49 (82 mg, 0.42 mmol, 
82%) (Rf = 0.33, 20% EtOAc/Hexane), as an orange powder with a purity of 93% as 
determined by LC-MS. 
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Mp 234-237°C. IR (ATR, cm
-1
): 3431 and 3173 (N-H str), 2985  
(C-H str), 1650 (C=O str), 1614 (C=C str), 1530 (N-H bend), 1422, 
1398, 1332. 
1
H NMR (300 MHz, DMSO-d6) δ 11.73 (s, 1H, H1), 
8.01 (s, 2H, H9), 7.67 (d, J = 2.1 Hz, 1H, H4), 7.41 (m, H9 and H7), 
7.22 – 7.13 (m, 1H, H6), 7.09 (dd, J = 2.1, 0.7 Hz, 1H, H3). 
13
C NMR (75 MHz, DMSO-d6) 
δ 162.4, 134.9, 133.3, 128.2, 124.1, 123.4 (C6), 120.5 (C4), 113.9 (C7), 102.6 (C3). HRMS: 
calcd for C9H8N2OCl [M+H]
+
, 195.0325, found 195.0337. 
 
10.5.1.4 3-Benzyl-5-chloro-1H-indole-2-carboxamide – 52  
The same procedure was used as above for preparing compound 50 from 47 in  
section 8.5.1.3.   
The equivalents used were as follows: 3-benzyl-5-chloro-1H-indole-2-carboxylic acid 50 
(1.90 g, 6.65 mmol ), thionyl chloride (15 mL), chloroform (5 mL), dimethylformamide  
(0.25 mL), ammonium hydroxide (75 mL) and ice (25 mL). 
The crude residue that was obtained was purified by column chromatography  
(80% EtOAc/Hexane) to afford the title compound 52 (1.14 g, 4.01 mmol, 60%) (Rf = 0.18, 
40% EtOAc/Hexane), as an orange powder with a purity of 93% as determined by LC-MS. 
Mp 200-202°C. IR (ATR, cm
-1
): 3299-3023 (N-H str), 1671 and 
1648 (C=O str), 1601 (C=C str), 1525 (N-H bend), 1455, 1398, 
1349. 
1
H NMR (300 MHz, DMSO-d6) δ 11.54 (s, 1H, H1), 7.45 – 
7.41 (m, 1H, H4), 7.35 (dd, J = 8.0, 4.4 Hz, 1H, H7), 7.26 – 7.18 (m, 
4H, ArH), 7.18 – 7.08 (m, 2H, H6 and H15), 4.03 (d, J = 5.9 Hz, 2H, 
H11). 
13
C NMR (75 MHz, DMSO-d6) δ 164.4, 141.3, 134.4, 131.1, 
128.8, 128.7, 128.3, 126.2 (C15), 124.1, 123.0 (C6), 119.1 (C4), 113.8 (C7), 30.2 (C11). 
HRMS: calcd for C16H14N2OCl [M+H]
+
, 285.0795, found 285.0800. 
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10.5.2 Synthesis towards the heteroaromatic rings 
10.5.2.1 3-Benzyl-5-chloro-1H-indole-2-carbonitrile – 53  
A 250 mL two-neck round bottom flask, fitted with a reflux condenser was charged with dry 
dichloroethane (20 mL), 3-benzyl-5-chloro-1H-indole-2-carboxamide 52 (840 mg,  
2.95 mmol) and phosphorus(V) oxychloride (5 equivalents, 1.40 mL, 1.48 mmol). This was 
refluxed at 85°C for 18 hours. 
Upon completion, the reaction mixture was poured onto ice (20 mL) and neutralized with  
1M sodium hydroxide. The product was extracted with ethyl acetate (3 x 20 mL) and the 
organic layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate 
was concentrated in vacuo to yield the residue that was purified by column chromatography 
(10% EtOAc/Hexane) to afford the title compound 53 (590 mg, 1.17 mmol, 40%) (Rf = 0.37, 
40% EtOAc/Hexane) as an off white powder. 
Mp 113-116°C. IR (ATR, cm
-1
): 3309 (N-H str), 3057-3032 (C-H str), 
2218 (C≡N str), 1600 (C=C str), 1538 (N-H bend), 1471, 1437, 1369, 
1303, 1057. 
1
H NMR (300 MHz, DMSO-d6) δ 12.41 (s, 1H, H1), 7.71 
(t, J = 2.8 Hz, 1H, H4), 7.45 (dd, J = 8.8, 1.6 Hz, 1H, H7), 7.35 – 7.32 
(m, 1H, H6), 7.32 – 7.26 (m, 4H, ArH), 7.19 (m, 1H, H15), 4.21 (s, 2H, 
H11). 
13
C NMR (75 MHz, DMSO-d6) δ 139.7, 135.4, 128.6, 128.3, 
126.4 (C15), 125.9 (C6), 125.2, 120.8 (C4), 114.2 (C7), 106.0, 30.0 (C11). HRMS: calcd for 
C16H11N2ClNa [M+Na]
+
, 290.2642, found 290.2642. 
 
10.5.2.2 Attempted synthesis of 3-benzyl-5-chloro-2-(1H-tetrazol-5-yl)-1H-indole - 46 
A 100 mL two-neck round bottom flask was charged with dry dimethylformamide (10 mL).  
3-benzyl-5-chloro-1H-indole-2-carbonitrile 53 (205 mg, 0.594 mmol), ammonium chloride  
(6 equivalents, 193 mg, 3.60 mmol) and sodium azide (6 equivalents, 234 mg,  
3.60 mmol) was added, whereupon the reaction mixture was refluxed at 125°C for 18 hours. 
Unfortunately, many by-products formed and the desired product 46 was not isolated. 
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10.5.2.3 3-Benzyl-5-chloro-1-tosyl-1H-indole-2-carbonitrile – 54 
A 100 mL round bottom flask was charged with dichloromethane (10 mL) and water (2 mL).  
3-Benzyl-5-chloro-1H-indole-2-carbonitrile 53 (1.00 g, 3.75 mmol), sodium hydroxide  
(1.5 equivalents, 225 mg, 5.62 mmol) and p-toluenesulfonyl chloride (1.5 equivalents, 1.00 g, 
5.62 mmol) was added and the reaction was allowed to stir at 30°C for 18 hours. 
Upon completion, the reaction was quenched with water. The product was extracted with 
ethyl acetate (3 x 30 mL) and the organic layer was washed with ammonium chloride and 
brine. The solvent was dried over magnesium sulphate and filtered, whereupon the filtrate 
was concentrated in vacuo to yield the residue that was purified by column chromatography 
(10% EtOAc/Hexane) to afford the title compound 54 (1.60 g, 3.71 mmol, 98%) (Rf = 0.54, 
40% EtOAc/Hexane), as an off white powder. 
 Mp 154-156°C. IR (ATR, cm
-1
): 2926 (C-H str), 2225 (C≡N str), 
1593 (C=C str), 1485, 1385, 1256, 1172, 1131, 1086. 
1
H NMR  
(300 MHz, DMSO-d6) δ 8.14 (dd, J = 9.0, 4.0 Hz, 1H, H7), 7.93 – 7.85 
(m, 1H, ArH), 7.85 – 7.79 (m, 2H, H4 and ArH), 7.65 (m, 1H, H6), 7.46 
(t, J = 7.0 Hz, 2H, ArH), 7.32 – 7.23 (m, 2H, ArH), 7.20 (dd, J = 9.0, 
4.4 Hz, 3H, ArH), 4.22 (d, J = 5.3 Hz, 2H, H11), 2.35 (s, 3H, H24). 
 
13
C NMR (75 MHz, DMSO-d6) δ 146.9, 137.4, 134.8, 132.6, 130.8, 
130.7, 129.7 (C6), 129.4, 128.9, 128.7, 128.2, 126.8 (C4), 126.8, 126.7, 
123.9, 122.5, 121.2, 16.4 (C7), 115.9, 111.6, 107.9, 29.9 (C11),  
21.1 (C24). HRMS: calcd for C23H18N2O2SCl [M+H]
+
, 421.0778, found 421.0782. 
 
10.5.2.4 3-Benzyl-5-chloro-2-(1H-tetrazol-5-yl)-1H-indole - 46 
A 100 mL two-neck round bottom flask was charged with dry dimethylformamide (10 mL).  
3-Benzyl-5-chloro-1-tosyl-1H-indole-2-carbonitrile 54 (250 mg, 0.594 mmol), ammonium 
chloride (6 equivalents, 193 mg, 3.60 mmol) and sodium azide (6 equivalents, 234 mg,  
3.60 mmol) was added, whereupon the reaction mixture was refluxed at 125°C for 18 hours. 
Upon completion, the reaction was quenched on ice (10 mL) and concentrated hydrochloric 
acid (10 mL). The product was extracted with ethyl acetate (3 x 30 mL) and the organic layer 
was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
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concentrated in vacuo to yield the crude indole tetrazole compound (Rf = 0.05,  
40% EtOAc/Hexane). 
This was dissolved in dry tetrahydrofuran (10 mL) and dry ethanol (5 mL) in a 50 mL  
two-neck round bottom flask. Potassium hydroxide was added (4 equivalents, 134 mg,  
2.38 mmol) and the reaction was heated to 30°C for 6 hours. 
The reaction was quenched with a saturated aqueous solution of ammonium chloride  
(20 mL). The product was extracted with ethyl acetate (3 x 20 mL) and the organic layer was 
washed with brine, dried over magnesium sulphate and filtered. The filtrate was concentrated 
in vacuo to yield the residue that was purified by column chromatography  
(10% EtOAc/Hexane) to afford the title compound 46 (41 mg, 0.13 mmol, 22%) (Rf = 0.10, 
80% EtOAC/Hexane), as a yellow waxy solid with a purity of 82% as determined by means 
of LC-MS. 
IR (ATR, cm
-1
): 3649-3300 (N-H str), 3250 (C-H str), 1599  
(C=C str and N-H bend), 1452, 1024, 995. 
1
H NMR (300 MHz, 
DMSO-d6) δ 11.69 (s, 1H, H1), 7.46 (d, J = 2.0 Hz, 1H, H4), 7.41 
(d, J = 8.6 Hz, 1H, H7), 7.32 – 7.26 (m, 2H, ArH), 7.21 (dt,  
J = 7.4, 5.1 Hz, 2H, ArH), 7.14 – 7.05 (m, 2H, H15, H6), 4.52 (s, 2H, 
H11). 
13
C NMR (75 MHz, DMSO-d6) δ 141.5, 134.9, 129.0, 128.3, 
128.1, 125.6, 123.5, 122.2 (C6), 118.2 (C4), 113.3 (C7), 64.9, 29.6 (C11). HRMS: calcd for 
C16H13N5Cl [M+H]
+
, 310.0859, found 310.0859. 
 
10.5.2.5 Attempted synthesis of 2-(3-benzyl-5-chloro-1H-indol-2-yl)oxazole – 42 
Preparation of 2,2-diethoxyethanol 
A 250 mL two-neck round bottom flask was fitted with a reflux condenser and was charged 
with ethanol (10 mL). Upon this, 2-bromo-1,1-diethoxyethane was added (10 mL,  
0.151 mol ), followed by the addition of potassium hydroxide (1.1 equivalent, 9.30 g,  
0.166 mol ). The reaction mixture was refluxed at 85°C for 18 hours.  
The reaction mixture was neutralised with 1M hydrochloric acid and the product was 
extracted with ethyl actetate. The organic layer was washed brine, dried over magnesium 
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sulphate and filtered. The filtrate was concentrated in vacuo to yield the crude colourless 
liquid (Rf = 0.52, 20% EtOAc/Hexane).  
IR (ATR, cm
-1
): 3339 (O-H str), 2978-2869 (C-H str), 1378, 1330, 
1248 (C-O str), 1095. 
 
Attempted synthesis using 2,2-diethoxyethanol 
A 100 mL two-neck round bottom flask was fitted with a reflux condenser and was charged 
with dimethylformamide (5 mL). To this was added 3-benzyl-5-chloro-1-tosyl-1H-indole-2-
carbonitrile 54 (250 mg, 0.593 mmol) and concentrated sulphuric acid (5 mL). The reaction 
mixture was heated to 30°C for 30 minutes to form a white suspension. 
To this was added an excess amount of 2,2-diethoxyethanol (1 mL), whereupon the reaction 
mixture turned into a clear yellow solution. This was refluxed at 120°C for 18 hours. 
By monitoring the reaction by means of TLC (20% and 80% EtOAc/Hexane), only a single 
compound was noticed on the baseline. In isolating this compound, the reaction mixture was 
neutralised with 3M sodium hydroxide and the product was extracted with ethyl acetate. The 
organic layer was washed brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the crude compound that was purified by means of column 
chromatography (80% EtOAc/Hexane). 
We were thus unable to obtain a pure enough 
1
H NMR in order to say whether the desired 
product was obtained. However, the compound that was isolated seemed to be the amide as 
two signals were seen in that region of the spectrum. 
 
Attempted synthesis using 2-bromo-1,1-diethoxyethane 
A 100 mL two-neck round bottom flask was fitted with a reflux condenser and was charged 
with 6M sulphuric acid (5 mL). To this was added 3-benzyl-5-chloro-1-tosyl-1H-indole-2-
carbonitrile 54 (250 mg, 0.593 mmol) the reaction mixture was heated to 40°C for 1 hour 
until all of the starting material was consumed. 
Stellenbosch University  http://scholar.sun.ac.za
Chapter 10 – Experimental 
_______________________________ 
152 
 
The reaction mixture was neutralised with 3M sodium hydroxide and the product was 
extracted with ethyl acetate. The organic layer was washed brine, dried over magnesium 
sulphate and filtered, whereupon the filtrate was concentrated in vacuo to yield the crude 
intermediate as a brown solid. 
A second 100 mL two-neck round bottom flask was fitted with a reflux condenser and was 
charged with 1,4-dioxane (10 mL). To this was added the crude amide intermediate and an 
excess amount of 2-bromo-1,1-diethoxyethane (0.5 mL). The reaction mixture was refluxed 
at 120°C for 18 hours. 
To our dismay, the same result was obtained as in the procedure above. 
 
10.6 EXPERIMENTAL WORK PERTAINING TO CHAPTER 7 
10.6.1 Towards compound 59-R/S and the derivatives thereof 
10.6.1.1 R/S-ethyl 5-chloro-3-(hydroxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate – 61-R/S 
Ethyl 3-benzoyl-5-chloro-1-tosyl-1H-indole-2-carboxylate 7 (700 mg, 1.45 mmol) was 
dissolved in dry methanol (20 mL) and dry tetrahydrofuran (2 mL) in a 50 mL two-neck 
round bottom flask. This was cooled to 0°C by means of an ice-bath. Sodium borohydride  
(3 equivalents, 164 mg, 4.36 mmol) was added and the reaction mixture was slowly heated to 
30°C for 18 hours. 
Upon completion, the product was extracted with ethyl acetate (3 x 20 mL) and the organic 
layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(20%, EtOAc/Hexane) to afford the title compound 61-R/S (400 mg, 0.827 mmol, 57%)  
(Rf = 0.17, 20% EtOAc/Hexane), as a clear oil. 
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IR (ATR, cm
-1
): 3532-3337 (O-H str), 3097-2968 (C-H str), 1710 
(C=O str), 1596 (C=C str), 1446, 1370, 1333, 1157. 
1
H NMR 
(300 MHz, CDCl3) δ 8.17 – 8.10 (m, 1H, ArH), 7.94 (dd, J = 8.9, 
0.6 Hz, 1H, H7), 7.79 – 7.73 (m, 2H, ArH), 7.70 – 7.60 (m, 2H, 
ArH), 7.54 – 7.27 (m, 4H, H4, H6 and ArH).7.23 – 7.17 (m, 2H, 
ArH), 6.13 (s, 1H, H11), 4.52 – 4.41 (m, 2H, H9), 2.46 (d,  
J = 4.4 Hz, 3H, H24), 1.45 – 1.37 (m, 3H, H10). 
13
C NMR  
(75 MHz, CDCl3) δ 162.8, 145.5, 143.5, 141.1, 135.0, 133.9, 
133.7, 130.2, 130.0, 129.7, 129.6, 129.1, 128.6, 128.5, 127.8 (C6), 
127.2, 127.0, 126.1, 121.7 (C4), 116.4 (C7), 68.9 (C11), 62.9 (C9), 21.5 (C24), 13.9 (C10). 
HRMS: calcd for C25H22NO5SClNa [M+Na]
+
, 506.0831, found 506.0831. 
 
10.6.1.2 R/S-ethyl 5-chloro-3-(methoxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate - 62-R/S 
Ethyl 5-chloro-3-(hydroxy(phenyl)methyl)-1-tosyl-1H-indole-2-carboxylate 61-R/S (1.14 g,  
2.36 mmol) was dissolved in dry methanol (30 mL) and dry tetrahydrofuran (5 mL) in a  
50 mL two-neck round bottom flask. p-Toluenesulphonic acid (3 equivalents, 1.30 g,  
7.08 mmol) was added and the reaction mixture was heated slowly to 30°C for 18 hours. 
Upon completion, the product was extracted with ethyl acetate (3 x 20 mL) and the organic 
layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(5% EtOAc/Hexane) to afford the title compound 62-R/S (449 mg, 0.901 mmol, 38%)  
(Rf = 0.43, 20% EtOAc/Hexane), as a white solid. 
Mp 125-128°C. IR (ATR, cm
-1
): 2987-2932 (C-H str), 1745 and 
1709 (C=O str), 1596 (C=C str), 1446, 1372, 1258 (C-O str), 
1171, 1089. 
1
H NMR (600 MHz, CDCl3) δ 7.93 – 7.89 (m, 1H, 
H7), 7.75 – 7.70 (m, 2H, ArH), 7.51 (d, J = 2.0 Hz, 1H, H4), 7.40 
– 7.36 (m, 2H, ArH), 7.30 – 7.26 (m, 3H, ArH), 7.25 – 7.21 (m, 
1H, H6), 7.17 (dd, J = 6.8, 6.4 Hz, 2H, ArH), 5.58 (s, 1H, H11), 
4.57 – 4.44 (m, 2H, H9), 3.31 (s, 3H, H26), 2.33 (d, J = 7.2 Hz, 
3H, H24), 1.51 – 1.36 (m, 3H, H10). 
13
C NMR (151 MHz, 
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CDCl3) δ 162.2, 145.4, 139.7, 135.2, 133.8, 130.9, 130.0, 129.6, 128.9, 128.3, 127.6 (C6), 
127.2, 126.9, 126.4, 126.3, 122.2 (C4), 116.3 (C7), 77.7 (C11), 62.7 (C9), 57.1 (C26), 21.6 
(C24), 14.1 (C10). HRMS: calcd for C26H24NO5SClNa [M+Na]
+
, 520.0993, found 520.0988. 
 
10.6.1.3 R/S-ethyl 5-chloro-3-(methoxy(phenyl)methyl)- 
1H-indole-2-carboxylate – 59-R/S 
The same procedure was used as for preparing compound 32 from 35 in section 8.4.1.6.   
The equivalents used were as follows: ethyl 5-chloro-3-(methoxy(phenyl)methyl)-1-tosyl-
1H-indole-2-carboxylate 61-R/S (400 mg, 0.803 mmol), dry tetrahydrofuran (10 mL), dry 
ethanol (5 mL)  and potassium hydroxide (4 equivalents, 180 mg, 3.21 mmol). 
The residue that was obtained was purified by column chromatography (20% EtOAc/Hexane) 
to afford the title compound in quantitative yield 59-R/S (Rf = 0.52, 40% EtOAc/Hexane), as 
a white powder with a purity of 96% as determined by means of LC-MS. 
Mp 91-95°C. IR (ATR, cm
-1
): 3314 (N-H str), 2980-2819  
(C-H str), 1684 (C=O str), 1600 (C=C str), 1534 (N-H bend), 
1449, 1378, 1246 (C-O str). 
1
H NMR (300 MHz, CDCl3) δ 8.89 
(s, 1H, H1), 8.01 (s, 1H,H4), 7.79 (d, J = 8.3 Hz, 1H, H7), 7.52 (d, 
J = 7.9 Hz, 2H, ArH), 7.38 – 7.16 (m, 4H, H6 and ArH), 6.37 (s, 
1H, H11), 4.45 (q, J = 7.1 Hz, 2H, H9), 3.51 – 3.30 (m, 3H, H26), 
1.49 – 1.37 (m, 3H, H10). 
13
C NMR (75 MHz, CDCl33) δ 161.6, 144.7, 141.8, 134.4, 133.3, 
129.8, 128.3, 127.9, 127.3, 126.8, 126.7, 126.3, 124.8, 123.5, 123.0, 112.8, 78.6 (C11), 66.8, 
61.4 (C9), 57.2 (C26), 21.6, 14.7 (C10). HRMS: calcd for C19H18NO3ClNa [M+Na]
+
, 
366.0873, found 366.0878. 
 
10.6.1.4 R/S-ethyl 5-chloro-3-(ethoxy(phenyl)methyl)-1-tosyl- 
1H-indole-2-carboxylate -70-R/S 
Ethyl 5-chloro-3-(hydroxy(phenyl)methyl)-1-tosyl-1H-indole-2-carboxylate 61-R/S (150 mg, 
0.310 mmol) was dissolved in dry ethanol (30 mL) and dry tetrahydrofuran (5 mL) in a  
50 mL two-neck round bottom flask. p-Toluenesulphonic acid (3 equivalents, 177 mg, 0.930 
mmol) was added and the reaction mixture was heated slowly to 30°C for 18 hours. 
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Upon completion, the product was extracted with ethyl acetate (3 x 20 mL) and the organic 
layer was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(5% EtOAc/Hexane) to afford the title compound 70-R/S (135 mg, 0.264 mmol, 85%)  
(Rf = 0.65, 40% EtOAc/Hexane), as a white solid. 
Mp 102-105°C. IR (ATR, cm
-1
): 3095-2906 (C-H str), 1717 
(C=O str), 1596 (C=C str), 1446, 1372, 1254 (C-O str), 1177, 
1088. 
1
H NMR (300 MHz, DMSO-d6) δ 7.97 (d, J = 8.9 Hz, 1H, 
H7), 7.81 – 7.76 (m, 3H, H4 and ArH), 7.51 (dd, J = 7.9, 1.8 Hz, 
2H, ArH), 7.48 – 7.36 (m, 4H, H6 and ArH), 7.36 – 7.21 (m, 2H, 
ArH), 5.73 (s, 1H, H11), 4.50 – 4.38 (m, 2H, H9), 4.07 (q,  
J = 7.1 Hz, 2H, H26), 2.35 – 2.25 (m, 3H, H24), 1.40 – 1.32 (m, 
3H, H10), 1.22 – 1.14 (m, 3H, H27). 
13
C NMR (75 MHz,  
DMSO-d6) δ 161.5, 146.1, 144.8, 139.8, 134.1, 132.7, 130.2 (C6), 
130.1, 129.7, 129.0, 128.5, 128.4, 127.8, 127.5 (C4), 126.9, 126.4, 125.7, 121.1, 116.6 (C7), 
74.9 (C11), 67.4 (C26), 64.1, 62.5 (C9), 21.1 (C24), 14.9 (C10), 14.5 (C27). HRMS: calcd for 
C27H26NO5SClNa [M+Na]
+
, 534.1118, found 534.1200. 
 
10.6.1.5 R/S-ethyl 5-chloro-3-(ethoxy(phenyl)methyl)- 
1H-indole-2-carboxylate -71-R/S 
The same procedure was used as for preparing compound 32 from 35 in section 8.4.1.6.   
The equivalents used were as follows: ethyl 5-chloro-3-(ethoxy(phenyl)methyl)-1-tosyl-1H-
indole-2-carboxylate 70-R/S (115 mg, 0.223 mmol), dry tetrahydrofuran (10 mL), dry ethanol  
(5 mL) and potassium hydroxide (4 equivalents, 50 mg, 0.89 mmol).  
The residue that was isolated was purified by column chromatography (20% EtOAc/Hexane) 
to afford the title compound 71-R/S (31 mg, 0.087 mmol, 39%) (Rf = 0.60, 
40% EtOAc/Hexane), as a white solid with a purity of 99% as determined by means of 
LC-MS. 
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Mp 136-137°C. IR (ATR, cm
-1
): 3422-3333 (N-H str), 2986-
2866 (C-H str), 1711 (C=O str), 1683 (C=C str), 1544 (N-H 
bend), 1442, 1311, 1245 (C-O str), 1227. 
1
H NMR (600 MHz,  
DMSO-d6) δ 11.93 (s, 1H, H1), 7.73 (d, J = 2.1 Hz, 1H, H4), 7.42 
(d, J = 8.8 Hz, 1H, H7), 7.39 (d, J = 7.3 Hz, 2H, ArH), 7.27 (t,  
J = 7.7 Hz, 2H, ArH), 7.22 (dd, J = 8.8, 2.1 Hz, 1H, H6), 7.17 (t,  
J = 7.3 Hz, 1H, ArH), 6.40 (s, 1H, H11), 4.37 (q, J = 7.1 Hz, 2H, H9), 3.50 – 3.37 (m, 2H, 
H26), 1.33 (t, J = 7.1 Hz, 3H, H10), 1.15 (t, J = 7.0 Hz, 3H, H27). 
13
C NMR (151 MHz, 
DMSO-d6) δ 161.7, 142.8, 135.4, 128.6, 127.4, 126.5, 125.5, 75.9 (C11), 64.4 (C26),  
61.3 (C9), 15.6 (C27), 14.7 (C10). HRMS: calcd for C18H15NO2Cl [M-C2H5O]
+
, 312.0791, 
found 312.0786. 
 
10.6.1.6 R/S-ethyl 5-chloro-3-(hydroxy(phenyl)methyl)- 
1H-indole-2-carboxylate – 72-R/S 
The same procedure was used as for preparing compound 61-R/S from 7 in section 8.6.1.1.   
The equivalents used were as follows: ethyl 3-benzoyl-5-chloro-1H-indole-2-carboxylate 3 
(1.20 g, 3.66 mmol), dry methanol (20 mL), dry tetrahydrofuran (2 mL) and sodium 
borohydride (3 equivalents, 414 mg, 11.0 mmol)  
The residue that was obtained was purified by column chromatography (20% EtOAc/Hexane) 
to afford the title compound 72-R/S (640 mg, 1.94 mmol, 53%) (Rf = 0.51, 
40% EtOAc/Hexane), as an orange solid with a purity of 95% as determined by means of 
LC-MS. 
Mp 169-171°C. IR (ATR, cm
-1
): 3339 (O-H str), 2978-2869  
(C-H str), 1671 (C=O str), 1536 (N-H bend), 1448, 1378, 1330, 
1248 (C-O str), 1095. 
1
H NMR (300 MHz, DMSO-d6) δ 11.82 
(s, 1H, H1), 7.81 (d, J = 2.0 Hz, 1H, H4), 7.50 – 7.38 (m, 3H, H7 
and ArH), 7.33 – 7.24 (m, 2H, H6 and ArH), 7.24 – 7.13 (m, 2H, 
ArH), 6.71 (d, J = 3.9 Hz, 1H, H11), 5.95 (d, J = 3.9 Hz, 1H, OH), 
4.47 – 4.31 (m, 2H, H9), 1.36 (t, J = 7.1 Hz, 3H, H10). 
13
C NMR (75 MHz, DMSO-d6) δ 
161.8, 145.4, 135.3, 128.4, 126.8, 126.6, 126.2, 126.0 (C6), 125.2, 124.2, 123.8, 122.5 (C4), 
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114.6 (C7), 67.5 (C11), 61.2 (C9), 14.7 (C10). HRMS: calcd for C18H15NO2Cl [M-OH]
+
, 
312.0791, found 312.0789. 
 
10.6.1.7 (5-Chloro-1H-indol-3-yl)(phenyl)methanone - 73 
A 250 mL two-neck round bottom flask was charged with dry dichloroethane (20 mL) 
whereupon this was cooled to 0°C by means of an ice-bath. Aluminium chloride  
(2 equivalents, 2.60 g, 19.8 mmol) was added, followed by the dropwise addition of benzoyl 
chloride (2 equivalents, 2.30 mL, 19.8 mmol). The reaction was left to stir for 30 min. Upon 
this, 5-chloroindole 9 (1.50 g, 9.90mmol) was added and the reaction mixture was heated to 
40°C for 1½ hours to form a black suspension.  
The reaction mixture was quenched on ice and a saturated solution of sodium bicarbonate, 
whereupon the product was extracted with ethyl acetate (3 x 40 mL) and the organic layer 
was washed with brine, dried over magnesium sulphate and filtered. The filtrate was 
concentrated in vacuo to yield the residue that was purified by column chromatography  
(20% EtOAc/Hexane) to afford the title compound 73 (1.40 g, 5.64 mmol, 57%) (Rf = 0.42, 
40% EtOAc/Hexane), as an orange-yellow powder. 
Mp 270-271°C. IR (ATR, cm
-1
): 3153-2906 (C-H str), 1587 (C=O str 
and C=C str), 1566 (N-H bend), 1473, 1437, 1368, 1211, 1141.  
1
H NMR (300 MHz, DMSO-d6) δ 12.25 (s, 1H, H1), 8.24 (d, J = 2.0 
Hz, 1H, H7), 8.04 (d, J = 2.5 Hz, 1H, H2), 7.83 – 7.76 (m, 2H, ArH), 
7.67 – 7.59 (m, 1H, H15), 7.59 – 7.51 (m, 3H, H4 and ArH), 7.29 (dd, 
 J = 8.6, 2.2 Hz, 1H, H6). 
13
C NMR (75 MHz, DMSO-d6) δ 189.8, 
140.1, 137.0 (C2), 135.2, 131.3, 128.5, 128.4, 127.4, 126.6, 123.2 (C6), 120.6 (C7),  
114.5 (C4), 113.9. HRMS: calcd for C15H11NOCl [M+H]
+
, 256.0529, found 256.0518. 
 
10.6.1.8 R/S-(5-chloro-1H-indol-3-yl)(phenyl)methanol – 74-R/S 
The same procedure was used as for preparing compound 61-R/S from 7 in section 8.6.1.1.   
The equivalents used were as follows: (5-chloro-1H-indol-3-yl)(phenyl)methanone 73  
(1.60 g, 6.25 mmol), dry methanol (20 mL), dry tetrahydrofuran (2 mL) and sodium 
borohydride (3 equivalents, 708 mg, 18.8 mmol). 
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The residue that was obtained was purified by column chromatography (20% EtOAc/Hexane) 
to afford the title compound 74-R/S (532 mg, 2.06 mmol, 33%) (Rf = 0.43,  
40% EtOAc/Hexane), as an orange powder. 
Mp 80-83°C. IR (ATR, cm
-1
): 3452 (O-H str), 3059-2865 (C-H str), 
1600 (C=C str), 1570 (N-H bend), 1459 (C=C str), 1247 (C-O str), 
1096. 
1
H NMR (300 MHz, DMSO-d6) δ 11.03 (t, J = 10.8 Hz, 1H, 
H1), 7.40 – 7.25 (m, 5H, H7 and ArH), 7.24 – 7.16 (m, 1H, H4), 7.09 – 
7.01 (m, 2H, H6 and ArH), 6.92 (d, J = 1.9 Hz, 1H, H2), 5.84 (d,  
J = 7.2 Hz, 1H, H11). 
13
C NMR (75 MHz, DMSO-d6) δ 170.3, 144.3, 
135.0, 128.2, 127.6, 126.0, 125.4 (C2), 122.9, 120.9 (C6), 118.1 (C4), 117.7, 113.1 (C7),  
31.4 (C11). HRMS: calcd for C15H11NOCl [M-H]
+
, 256.0529, found 256.0520. 
 
10.6.1.9 Attempted synthesis of R/S-5-chloro-3-(methoxy(phenyl)methyl)- 
1H-indole – 67-R/S 
The same procedure was used as for synthesising compound 62-R/S in section 8.6.1.2. 
The equivalents used were as follows: (5-chloro-1H-indol-3-yl)(phenyl)methanol 74-R/S  
(500 mg, 1.94 mmol), dry methanol (30 mL), dry tetrahydrofuran (5 mL) and  
p-toluenesulphonic acid (3 equivalents, 369 mg, 5.82 mmol).  
The residue that was formed was purified by column chromatography (5% EtOAc/Hexane) to 
afford the title compound 67-R/S (40 mg, 0.15 mmol, 8%) (Rf = 0.63, 40% EtOAc/Hexane), 
as a yellow powder. 
Unfortunately, this compound decomposed back to the starting material 74-R/S. 
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10.6.2 Synthesis regarding the separation of the diastereomers. 
10.6.2.1 Attempted synthesis of ethyl 5-chloro-1-((7,7-dimethyl-2-
oxobicyclo[2.2.1]heptan-1-yl)methylsulfonyl)-3-(methoxy(phenyl)methyl)-1H-indole-2-
carboxylate – 77 
Synthesis of (1R)-(-)-10-camphorsulfonic acid chloride 76-R 
A 100 mL two-neck round bottom flask was charged with dry dimethylformamide (10 mL) 
and (1R)-(-)-10-camphorsulphonic acid 75-R (1.00 g, 3.99 mmol). This was cooled to 0°C for 
the addition of thionyl chloride (10 mL). The reaction mixture was allowed to heat to 30°C 
for 1 hour to form a pale yellow solution. 
The product was extracted with ethyl acetate (3 x 30 mL) and the organic layer was washed 
with sodium bicarbonate (20 mL). The organic layer was washed with brine, dried over 
magnesium sulphate and filtered, whereupon the solvent was removed in vacuo to yield the 
crude product 76-R (772 mg, 3.08 mmol, 77%) (Rf = 0.60, 40% EtOAc/Hexane), as an 
orange oil. 
Introducing the chiral auxiliary 
A 100 mL round bottom flask was charged with dichloromethane (10 mL) and water (2 mL). 
Ethyl 5-chloro-3-(methoxy(phenyl)methyl)-1H-indole-2-carboxylate 59-R/S (100 mg, 
0.291 mmol), sodium hydroxide (1.5 equivalents, 17 mg, 0.44 mmol) and (R)-camphor-(10)-
sulfonic acid chloride 76-R (1.5 equivalents, 109 mg, 0.436 mmol) was added and the 
reaction was allowed to stir at 30°C for 18 hours. 
Upon completion, the reaction was quenched with water. The product was extracted with 
ethyl acetate (3 x 30 mL) and the organic layer was washed with ammonium chloride and 
brine, dried over magnesium sulphate and filtered. The filtrate was concentrated in vacuo to 
yield the residue that was purified by column chromatography (10% EtOAc/Hexane) to 
afford compound 78 (154 mg, 0.276 mmol, 95%) (Rf = 0.43, 20% EtOAc/Hexane), as a 
brown oil. 
With 2D NMR analysis, together with the mass spectrum analysis, we concluded that it was 
more probable that we synthesised compound 78 where the camphorsulphonic acid 75-R 
protected the alcohol that formed in situ, rather than the indole -NH.  
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IR (ATR, cm
-1
): 2925-2852 (C-H str), 1743, 1708 (C=O str), 
1599 (C=C str), 1451, 1374, 1250 (C-O str), 1153, 1025.  
1
H NMR (300 MHz, DMSO-d6) δ 11.83 (s, 1H, H1), 7.85 – 
7.76 (m, 2H, ArH), 7.67 (d, J = 2.1 Hz, 1H, H4), 7.46 – 7.37 
(m, 3H, H7 and ArH), 7.27 – 7.22 (m, 3H, H6 and ArH), 7.16 – 
7.10 (m, 1H, ArH), 4.42 (s, 1H, H11), 4.36 (q, J = 7.1 Hz, 2H, 
CH2), 4.07 – 3.98 (m, 2H, CH2), 3.83 (d, J = 0.6 Hz, 1H, H31), 2.88 (dt, J = 33.1, 12.3 Hz, 
2H, CH2), 2.76 – 2.54 (m, 2H, CH2), 2.45 – 2.24 (m, 4H), 2.00 – 1.96 (m, 3H, CH3), 1.31 (dd, 
J = 9.5, 4.7 Hz, 3H, CH3), 1.23 (s, 3H, CH3), 1.21 – 1.13 (m, 3H, CH3). 
13
C NMR (75 MHz, 
DMSO-d6) δ 170.7, 161.9, 144.45, 141.4, 139.0, 135.1, 133.2, 130.5, 130.4, 129.6, 129.1, 
128.9, 128.6, 128.6, 128.5, 127.7, 127.6, 126.2, 125.5 (C6), 125.1, 124.7, 121.5, 120.1 (C4), 
114.6 (C7), 60.9, 60.1, 30.0, 29.4, 21.4, 21.2, 14.6, 14.5. HRMS: calcd for C28H30NO6SClNa 
[M+Na]
+
, 566.1380, found 566.1183. 
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CHAPTER 11 – ADDENDUM A 
11.1 RESEARCH OUTPUTS 
A provisional patent is applied for based on the work discussed in Chapter 7 and the hit 
compound 59-R/S found. The manuscript is currently in progress. In addition to this, a paper 
was submitted for peer review, where the contribution from this thesis was on the importance 
of the binding interaction in the Val179 binding pocket. Finally, the majority of the work 
discussed in this thesis, together with some work from our research team, could be published 
once the provisional patent is finalised. 
 
11.1.1 Provisional patent  
Substituted indoles as novel potent HIV NNRTIs 
S. C. Pelly, W. A. L. van Otterlo, R. Müller, A. E. Basson. 
 
11.1.2 Paper submitted for peer review  
Exploring cyclopropyl indole derivatives as novel HIV NNRTIs 
M. Hassam, A. E. Basson, R. Müller, L. Morris, W. A. L. van Otterlo and S. C. Pelly. 
The paper submitted to the journal Bioorganic and Medicinal Chemistry Letters.  
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